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The development of a multicellular organism is dependent upon interactions between 
the underlying genetic sequence, epigenomic processes and environmental cues. These 
interactions are complex, and understanding the exact role that each plays in directing 
transcription remains difficult. One of the more well studied epigenomic 
modifications, cytosine DNA methylation, plays a fundamental role in modulating 
gene activity. This modification has primarily been associated with gene repression, 
but recent evidence has highlighted that DNA methylation also correlates with gene 
activation, and that variation in methylation patterning occurs across species. 
In the honey bee DNA methylation predominately occurs intragenically, and is 
associated with active transcription. The discovery that DNA methylation is critical to 
caste determination in the bee and additional correlations between DNA methylation, 
behaviour and phenotype, has made the honey bee an interesting model organism from 
which we can gain insight into the role of DNA methylation. Whilst it has been shown 
extensively in plants and mammals that DNA methylation patterns are frequently 
dependent on genotype, few studies of the honey bee have interpreted differential 
DNA methylation patterns in the context of the underlying genetic sequence.  
Here, we show that differences in the underlying genetic sequence correlate with 
differential methylation of the gene coding for lysosomal α-mannosidase (LAM), 
demonstrating that several LAM epialleles exist in the honey bee population. These 
epialleles correlate with context-dependent transcriptional changes, with significant 
effects on LAM expression observed during larval development. To understand how 
such changes might affect larval growth and phenotype we used a knockdown 
approach, inhibiting LAM activity during early larval stages using the indolizidine 
alkaloid swainsonine. We show that such treatment causes sub-lethal effects during 
larval and pupal stages, and causes loco-like symptoms and death in newly emerged 
bees. Our findings suggest that LAM function in the honey bee is conserved, and we 
propose that the LAM epialleles might affect larval metabolism and growth. By 
influencing metabolism in the bee the LAM epialleles could generate substantial 
variation in complex traits, which would be beneficial to a colony whose stability is 
dependent upon high levels of phenotypic variation.  
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From genotype to phenotype: DNA methylation and the honey bee 
 
1.1 Genotype to Phenotype 
The existence of a multicellular organism depends upon the transformation of an 
apparently simple, static genetic ‘code’ into function. With perfect timing the genetic 
information contained within that first single cell is translated into a series of complex 
cellular signals that guide development. As each cell differentiates, unique 
transcriptional profiles are established and their functional roles are specified. This 
transition from genotype to phenotype, termed epigenesis, is infinitely complex and 
results from interactions between the underlying genetic sequence, chemical 
modifications to DNA and chromatin, and environmental cues. Yet, how exactly do 
these layers of information contribute to establishing phenotype?  
Foremost, the DNA sequence itself interacts with the transcriptional machinery to 
produce the multitude of proteins necessary for a functioning organism. The human 
genome, for instance, encodes approximately 21 000 protein-coding genes whose 
sequences are transcribed to generate our proteome1. Gene transcription occurs when 
RNA Polymerase II (RNA Pol II) interacts with these genomic regions to produce a 
transcript. This is governed by numerous functional elements such as enhancers, or 
promoters contained within these protein-coding regions, that interact with various 
activators and transcription factors to facilitate the assembly of the pre-initiation (PIC) 
complex and subsequent transcription by RNA Pol II.  
Importantly, to generate the full repertoire of proteins required to produce a complex 
and fully functioning organism each gene must be expressed in a proper spatiotemporal 
pattern. This is achieved by the coordinated action of numerous control mechanisms 
which have evolved to tightly regulate transcription. These range from modulating 
transcription initiation and elongation, which can alter whether a gene is expressed or 
not and how a transcript is processed, to post-translational processes that can, for 
instance, fine-tune the level of a transcript through the degradation of an mRNA 
product. Each of these layers represents an important mechanism through which gene 
expression can be controlled. Here, some of the mechanisms that regulate transcription 
initiation and elongation will be briefly outlined.  
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1.2 Regulating transcription 
Transcription initiation 
One of the first stages of regulation involves modulating whether transcription can be 
initiated. To transcribe a genomic region DNA must be accessible; critical proteins 
such as transcription factors must be able to bind to an appropriate sequence and 
initiate transcription by RNA Pol II. DNA is complexed with histone proteins to form 
the nucleosome, which is compacted within the cell in association with a number of 
accessory proteins to form chromatin. Transcription is highly dependent on this 
packaging of DNA, for the three-dimensional structure of chromatin and the position 
of nucleosomes determines if a genomic region is accessible, thus by modulating 
chromatin structure transcription can be controlled2,3. 
By condensing chromatin a genomic region can be made inaccessible to RNA Pol II, 
and transcription prevented4. In mammals this is exemplified by the dosage 
compensation seen in females, where transcriptional silencing of one of the two X-
chromosomes occurs, and the inactive X-chromosome maintained in a 
heterochromatic, condensed, state5,6. This is in contrast with regions of active 
transcription, where the maintenance of chromatin in a relaxed, open state, termed 
euchromatin, facilitates the binding of regulatory proteins which can elicit 
transcription. For instance, it has been shown that by clearing promoter regions of 
nucleosomes relevant transcription factors can bind to a site and initiate 
transcription7,8.  Importantly, these local chromatin changes and nucleosome 
positioning do not simply influence whether a gene is active or not, but also how a 
given transcript is processed.  
Transcription elongation 
Once transcription has initiated transcription elongation occurs, and the nascent 
transcript is extended by RNA pol II. To produce a mature mRNA transcript one key 
step involves the splicing of intronic sequences, and this frequently sees the use of 
alternative splice sites. By differentially incorporating intronic and exonic regions into 
the final product, what is termed alternative splicing, multiple mRNA variants can be 
generated from a single gene. Critically, this process greatly increases the diversity of 
proteins expressed within an organism, for tissue- and cell-type specific expression 
patterns to be established9. In Drosophila melanogaster this is, quite famously, 
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highlighted by alternative splicing of the gene Dscam, where 38 016 distinct mRNA 
products can potentially be expressed10. 
The regulation of alternatively spliced variants occurs, in part, through modulating the 
rate at which elongation occurs during transcription. Splicing frequently occurs co-
transcriptionally, and it has been shown that pausing of RNA Pol II during 
transcription can lead to exon inclusion11. Additionally, nucleosomes have been found 
to be enriched at exons, indicating that their positioning may influence exon 
recognition and therefore alternative splicing12. Thus by altering chromatin structure 
and nucleosome positioning, control can be gained not only over whether a gene is 
active or not, but also what transcript is produced. These processes represent a 
fundamental means by which gene expression is regulated, and they are controlled by 
epigenetic processes. 
The epigenetic control of gene expression 
Literally meaning ‘upon’ genetics, epigenetics encompasses those mechanisms or 
processes that are involved in facilitating transcriptional changes. Various covalent 
modifications are made to DNA itself or the histone proteins around which DNA is 
wrapped; these modifications are numerous, and include methylation, acetylation, 
phosphorylation, ubiquitination, and SUMOylation, all of which contribute to changes 
in gene expression. The manner in which these modifications can influence 
transcription is complex, and it is likely that a given mark can lead to both a gene’s 
activation and repression, depending on its location and the genomic context13,14.  
Importantly, none of these modifications work in isolation, instead they interact 
together to produce a unique epigenetic cellular ‘signature’. 
This signature, termed a cell’s epigenome, describes all epigenetic modifications found 
across the genome. For each cell type within an organism, and across different 
developmental stages and disease states the epigenome will vary, leading to a vast 
number of possible epigenomes15. By piecing together how each individual epigenetic 
modification contributes to expressional changes within an individual cell the link 
between genotype and phenotype can be understood. Large scale pursuits, analysing 
patterns of DNA methylation, histone modifications, chromatin accessibility and RNA 
expression across diverse cell lineages, are leading to a greater understanding of how 
the epigenome contributes to cell specification and development, and how alterations 
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to the epigenome contribute to disease and phenotypic variation16,17. They also reflect 
the difficulty associated with defining the exact role that an individual epigenetic 
modification plays in directing transcriptional changes. This difficulty will be 
discussed in the context of one of the more well-known epigenetic modifications, DNA 
methylation. 
1.3 DNA methylation 
Establishing and maintaining DNA methylation patterns 
Cytosine DNA methylation, the addition of a methyl group to a cytosine residue that 
primarily occurs in the CpG (CG) dinucleotide context, plays a fundamental role in 
modulating gene activity. The realisation that this covalent modification could stably 
propagate information throughout development led to considerable research into its 
role as an epigenetic mark18,19. It has since been shown that DNA methylation plays a 
key role in biological processes such as X-inactivation, genomic imprinting, and 
transposon silencing across a number of organisms. In each of these instances 
methylation is engaged in gene silencing, and this remains one of the more commonly 
considered functions of DNA methylation. This is evident in mammals where the 
methylation of promoter regions has long since been associated with gene repression20. 
However, considerable variation in the distribution of methylation across organisms, 
and additional evidence that methylation associates with active transcription indicates 
that the relationship between DNA methylation and transcription is complex, and not 
fully understood21. 
The overall level and patterns of DNA methylation that are established across a 
genome, what is termed a methylome, are established in a cell- and tissue-specific 
manner. Throughout embryogenesis and cell specification DNA methyltransferases 
(DNMTs) establish DNA methylation patterns and then maintain these patterns across 
cell divisions. Two families of DNMTs exist; the DNMT1 family, which preferentially 
methylates hemimethylated cytosine residues, and the DNMT3 family, which 
catalyses the de novo methylation of DNA22. Both these families are well conserved 
and they are present across a wide variety of vertebrates and invertebrates, albeit with 
the loss and/or gain of some homologues (see Table 1).  
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Table 1: The distribution of DNMTs across selected vertebrates and 
invertebrates. The squares indicate the number of genes coding for DNMT paralogs, 
‒ indicates their absence.  
 Species Common 
name 
DNMT1 DNMT3 
Vertebrates Homo sapiens  Human ■ ■■■ 
Mus musculus Mouse ■ ■■■ 
Invertebrates 
Apis mellifera Honey bee ■■ ■ 
Nasonia spp Jewel Wasps ■■■ ■ 
Nematostella 
vectensis  
Sea anemone ■ ■ 
Tribolium castaneum  Flour beetle ■ ‒ 
Drosophila 
melanogaster  
Vinegar fly ‒ ‒ 
Caenorhabditis 
elegans  
Nematode ‒ ‒ 
Whilst for some organisms, such as Drosophila melanogaster and Caenorhabditis 
elegans, very little or no DNA methylation in the CpG context occurs, in other species 
cytosine methylation is critical. In mammals the lack of the DNMT3a and DNMT3b 
enzymes leads to lethality, and in Apis mellifera their activity has been shown as 
fundamental to the development of distinct castes, the queen and worker bee23-26. In 
D. melanogaster and C. elegans, where no detectable levels of 5mC (5-
methylcytosine) have been found, adenine N6-methylation (6mA) has recently been 
identified, highlighting that whilst 5mC is the predominant methylation mark in 
mammals and A. mellifera, this is not common to all species27,28. Here, the role for 
cytosine methylation will be reviewed. 
Initially, it was considered that DNA methylation patterns were established by the de 
novo activity of the DNMT3 family during embryogenesis and then these patterns were 
maintained by DNMT1, the ‘maintenance’ DNMT. However, recent work indicates 
otherwise, with the role of DNMT1 in establishing methylation patterns being 
redefined to include de novo activity, and additional evidence showing that both the 
DNMT1 and DNMT3 family are required for the maintenance of methylation29,30. 
Furthermore, patterns are governed not only by the de novo and maintenance activity 
of DNMTs, but by the passive loss of methylation during replication and active 
demethylation by the family of ten eleven translocation (TET) dioxygenases. These 
enzymes oxidise 5mC to 5-hydroxymethylcytosine (5hmC) that can be further 
converted to 5-formyl-cytosine (5fC) and 5-carboxyl-cytosine (5caC), leading to the 
reversal of methylation marks31. 
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It has become clear that the activity of these enzymes is coordinated and/or influenced 
by a multitude of factors that act synergistically to establish methylation patterns. 
Methyltransferases and demethylases are recruited to genomic locations via their 
interactions with other epigenetic marks, such as histone modifications, and these 
interactions are influenced by the chromatin environment and underling DNA 
sequence30,32. For instance, the activity of transcription factors such as CTCF have 
been shown to induce active demethylation33 and reduce methylation at a genomic 
region, with increases in methylation observed when CTCF binding is disrupted by 
genetic polymorphisms34. Additionally, the relationship between histone 
modifications and DNA methylation have been well described35, and have been shown 
to have direct effects on the methylation status of a region36. The differential 
methylation of histone tails can either recruit or prevent members of the DNMT3 
family from binding a genomic region37,38; for instance H3K36me3, a modification 
commonly associated with gene repression, has been shown to guide DNMT3a to a 
region in mammals39.  
This dynamic process of introducing and removing methyl marks culminates in the 
establishment of distinct genome-wide methylation patterns. The recent advances in 
sequencing technologies has allowed for the analysis of such patterns across many 
eukaryotes, revealing new roles for DNA methylation. 
The role of DNA methylation in directing transcription 
The targeting of methylation across the genome appears to take on two distinct types 
of patterns: global DNA methylation and mosaic DNA methylation21. In the case of 
global DNA methylation, which is typical of vertebrates, the genome is densely 
methylated throughout most tissues and developmental stages. In humans, for instance, 
the majority of CpG sites across the genome are methylated with the exception of small 
unmethylated domains, typically near regulatory regions such as promoters, termed 
CpG islands40. This is in contrast with plant, fungal and invertebrate genomes where 
distinct domains are methylated and unmethylated in a ‘mosaic’ fashion, see figure 
1.121,41. The overall level of this mosaic methylation varies; for instance invertebrates 
such as A. mellifera present with a much lower level of methylation when compared 
to plants such as Arabidposis thaliana or other invertebrates such as Ciona 




DNA methylation has long been associated with the transcriptional silencing of 
genomic regions. Across a wide range of organisms it is frequently targeted to 
repetitive elements and transposons; A. thaliana and Populus trichocarpa, together 
with the mouse and zebrafish all exhibit such methylation, and disruption of DNA 
methylation leads to the reactivation of these elements, showing that the methylation 
of these regions is critical to silencing42-44. Additionally genomic imprinting, whereby 
a gene or chromosomal region is transcriptionally controlled in a parent-of-origin 
manner, is frequently associated with methylation and silencing. In mammals and 
plants imprinted genes are differentially methylated and disruption of DNA 
methyltransferase activity leads to the aberrant expression of the maternal and/or 
paternal transcript45,46.  
Whilst DNA methylation has been utilised in these organisms to maintain genome 
stability and regulate imprinted regions this is not common to all species. Moderate 
levels of methylation have been observed across transposons in invertebrates such as 




Figure 1.1: DNA methylation patterning in vertebrates and invertebrates. 
Vertebrate genomes are typically densely methylated; such global DNA methylation 
is in contrast with invertebrate genomes, where mosaic methylation occurs. In the 
honey bee such mosaic methylation occurs across actively transcribed genes, with 
enrichment found in exons. The black dots indicate those genomic regions where 
methylation typically occurs at high levels. 
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but other invertebrate genomes do not exhibit such methylation. In the case of A. 
mellifera, where transposons are not as frequent, transposons are not targeted for 
methylation, although this may be a function of their low frequency25,42. Additionally, 
not all species utilise DNA methylation to establish imprints; organisms such as C. 
elegans do not methylate their genome in the CpG context, yet still present with 
imprinted genes, and there is no current evidence for genomic imprinting via DNA 
methylation in A. mellifera47. It thus appears that while DNA methylation can be 
critical for transcriptional silencing in many contexts this is not always the case.  
One of the better conserved features of eukaryotic DNA methylation is the distribution 
of methylation at gene bodies. Gene body methylation has been identified across 
numerous organisms, and it is likely that its occurrence predates the last common 
ancestor of plants and animals42. It is characterised by methylation across the introns 
and exons of protein-coding genes, with enrichment found at exons, and is typically 
associated with active transcription. In humans, where there is a higher density of gene 
body methylation than intergenic regions, low promoter methylation and high gene 
body methylation correlates with highly expressed genes48. A. thaliana displays a 
similar relationship, where those genes moderately expressed are characterised by high 
intragenic methylation49. 
In invertebrates, methylation predominantly occurs across gene bodies. C. intestinalis, 
the parasitoid wasp Nasonia vitripennis, the carpenter ant Camponotus floridanus, 
A.mellifera and lower Metazoa such as the sea anemone Nematostella vectensis  all 
display high levels of gene body methylation, and those regions with high gene body 
methylation also correlate with genomic regions that are actively transcribed 25,42,50-53. 
In A. mellifera, intragenic DNA methylation is higher in exons than introns, and those 
genes which are highly methylated are often those that are ubiquitously expressed, 
with evidence that this type of methylation modulates the expression of these 
transcripts51,54. These common findings, that intragenic DNA methylation is associated 
with active transcription has important implications for understanding how this 
epigenomic mark might direct transcription. 
The correlation between intragenic DNA methylation and the expression of 
‘housekeeping’ genes has led to the suggestion that DNA methylation functions in 
these contexts by preventing spurious transcription. By methylating intragenic regions 
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the initiation of transcription at cryptic sites within coding regions can be prevented55. 
For those genes which are frequently transcribed, such as the ubiquitously expressed 
housekeeping genes, this would represent an important mechanism whereby 
transcription can be controlled, and transcriptional noise reduced49,56. This hypothesis 
is supported by recent work which has demonstrated that gene body methylation is 
negatively correlated with transcriptional noise57. However, alternative suggestions, 
based on work in A. thaliana, indicate that it is the rate of transcription of these 
moderately expressed transcripts that induces intragenic methylation, as opposed to 
methylation itself influencing transcription49.  
Yet given that key differences in the DNA methylation system exist between A. 
thaliana and other eukaryotic model organisms this relationship between intragenic 
methylation and the rate of transcription may not be universal. DNA methylation 
patterns in A. thaliana and other flowering plants are established via an RNA-directed 
DNA methylation system (RdDM) where RNA molecules, small interfering RNAs 
(siRNAs), guide de novo methylation58,59. The proposed model, that transcription itself 
causes intragenic methylation, is based upon the spurious transcription of these 
siRNAs49.  In mammals and other invertebrate models there is no current evidence for 
an RdDM system and as such the intragenic DNA methylation seen in these species 
will likely have alternate functions. 
Indeed, several lines of evidence indicate a number of functional roles for intragenic 
DNA methylation, including the regulation of non-coding RNAs and transcription 
elongation. Both microRNAs (miRNAs) and long non-coding RNA (lncRNA) 
transcripts have been shown to be influenced by intragenic DNA methylation, with 
important transcriptional consequences60-62. Additionally, by altering chromatin 
structure DNA methylation can reduce the efficiency of transcription elongation63.  
Intragenic DNA methylation has been shown to influence elongation; exonic 
differential methylation modulates binding of the CTCF transcription factor, altering 
RNA Pol II processing and the alternative splicing of a transcript in mammals11. 
Further evidence that intragenic DNA methylation modulates alternative splicing64,65 
and leads to the cell- and tissue-specific expression of alternative transcripts66 across 
a number of species suggests that this function of intragenic DNA methylation is 
commonplace, and likely to have important biological consequences60. 
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Does DNA methylation itself direct gene expression? 
As an epigenetic regulator DNA methylation clearly has several roles in regulating 
transcription, including both gene repression and activation depending on the genomic 
context. Whilst there are a number of cases where DNA methylation has been shown 
to directly influence transcription much evidence is largely correlative, derived from 
genome-wide analyses and does not explicitly show that DNA methylation itself drives 
such changes25,42,67. Experimentally demonstrating a clear cause-and-effect 
relationship is, of course, difficult, but functionally analysing specific instances of 
differential methylation can provide insight into when and where DNA methylation 
modulates transcription. 
The Oct3/4 gene, whose expression level is tightly controlled during embryogenesis 
to facilitate appropriate cell specification and maintenance of pluripotency, is a good 
example of when DNA methylation plays a secondary role. Early in development 
trans-acting factors protect this region from being methylated, but as development 
progresses this region eventually becomes methylated and transcriptional silencing 
occurs68. This link between DNA methylation and silencing could indicate that DNA 
methylation itself causes the repression of this region, but while DNA methylation 
certainly plays a part in such silencing the activity of other trans-acting factors and 
histone modifications initiates repression. Histone deacetylation, followed by histone 
methylation (H3K9) of the Oct3/4 promoter has been shown to precede DNA 
methylation, indicating that DNA methylation itself does not silence transcription of 
this region, but rather maintains such silencing69. 
Yet, evidence also indicates that DNA methylation can play an active role in directing 
transcription. Shukla et al11, for instance provide a direct relationship between DNA 
methylation and alternative splicing. Throughout lymphocyte development the 
variable inclusion of exons of the CD45 transcript results in the expression of 
alternative isoforms. In their study Shukla et al11 found the alternative splicing of this 
transcript, rather than being associated with histone methylation as in the case of 
Oct3/4, is modulated by differential DNA methylation. DNA methylation influences 
binding of the CTCF transcription factor, causing pausing of RNA Pol II and exon 
inclusion. Similar findings have been reported elsewhere64, demonstrating that in 
certain contexts differential DNA methylation will modulate cell- and tissue-specific 
gene expression profiles. 
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Both these studies highlight the different roles that DNA methylation can play in 
modulating transcription. Indeed, several recent studies show that depending on the 
genomic context, DNA methylation can play both an active and passive role in eliciting 
transcriptional changes, and these changes are often associated with sequence 
variation70,71. In fact, Schübeler recently highlighted that much variation seen in 
methylation patterns is hard-wired in the genetic sequence72. 
Given that it is becoming increasingly apparent that DNA methylation interacts with 
other epigenetic modifications, such as histone modifications35,73 and is influenced by 
genetic variation74-77 it is important to interpret any associations between DNA 
methylation and transcription in the context of these other epigenetic and genetic 
changes. Understanding whether alternate factors, such as the underlying DNA 
sequence, play a more substantive role in generating phenotypic variation than DNA 
methylation has become important avenue of research within the epigenetics field72. 
1.4 The link between genetic variation, epiallelic variation and phenotype 
The effects of sequence variation on transcription and phenotype are well-known. 
Some estimates suggest that one in every thousand SNP will potentiate phenotypic 
variation and such polymorphisms contribute substantially to various disease 
processes and the heritability of complex traits78. Indeed, whilst not every mutation 
will lead to the deleterious effects associated with disease, all mutations will have some 
effect on fitness, even if their effects are marginal or essentially neutral79. In many 
respects the influence of genetic polymorphisms on epigenetic processes largely drives 
variation; SNPs have been shown to influence transcription factor binding, chromatin 
state and histone modifications across many species74,75,77. This in turn alters 
transcription and generates phenotypic variation. 
Cis- and trans-acting polymorphisms frequently associate with differentially 
methylated regions in mammals, affecting both imprinted and non-imprinted regions. 
These cases have been well-documented and numerous studies have established 
linkage between allelic variation and a methylated state across many cell-types80-82. A 
comparison of methylation profiles in mice, for instance, has demonstrated that allele-
specific methylation (ASM) is extensive, predominately occurring as a result of cis-
polymorphisms81, and studies of the human genome report similar findings, with ASM 
frequently associating with allele-specific expression (ASE)67,80. In fact, recent 
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estimates suggest that genetic polymorphisms affect methylation at thousands of CpG 
sites across a variety of cell types70,71.  
Variability in DNA methylation patterning is known to occur between cell and tissue 
types67, and these patterns can vary with age and developmental stage, and between 
individuals and disease states, such as cancer. While differential methylation is 
frequently targeted, methylation also occurs stochastically, leading to a mixture of 
patterns within a cell population, what is termed epigenetic polymorphism or epiallelic 
variation83. Such epiallelic variation can be extensive and causes phenotypic variation; 
a recent study demonstrated significant inter-individual variation in DNA methylation, 
primarily gene-body methylation, and showed that this variation affected mRNA 
splicing for instance84.  
The effect of epiallelic variation on phenotype has been documented in a number of 
organisms. In many plant species methylated epialleles are known to affect complex 
traits such as flowering and pathogen resistance85 and in mammals several examples 
of heritable methylated epialleles have been reported and linked to diseases such as 
diabetes86 . While these methylated epialleles frequently occur independently of 
genetic variation within a population87, what are termed pure stochastic epialleles, 
many cases are, indeed, genotype-driven. The underlying sequence can interact with 
environmental cues to induce metastable epialleles, or the underlying sequence alone 
can induce obligatory methylated epialleles, which are not influenced by the 
environment and are inherited in a Mendelian manner, as is the case with allele-
specific methylation (see Table 2)88.  




Obligatory An epiallele that is determined by genotype 
Facilitated An epiallele that is partly genotype-driven, but is also influenced 
by stochastic events 
Pure 
An epiallele that occurs due to stochastic events and is in no way 
influenced by genotype. 
 
Substantial work in social insects like A. mellifera has shown that differential DNA 
methylation patterns correlate with transcriptional changes and phenotypic variation, 
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but fewer studies interpret these changes in the context of any underlying sequence 
variation. Given that phenotypic differences in A. mellifera are generated by tightly 
controlled epigenetic changes any impact that genetic variation might have on this 
epigenetic layer of information could be profound.  It is therefore important to explore 
this link between genotype, epiallelic variation and phenotype in the honey bee. 
1.5 DNA methylation in Apis mellifera 
A. mellifera is known to possess two copies of DNMT1 together with one copy of 
DNMT3, and has become an indispensable model for exploring the relationship 
between DNA methylation, gene expression, and phenotype, particularly in respect to 
how gene body methylation influences active transcription23,89. It has been shown that 
DNA methylation in A. mellifera is enriched in gene-bodies, where it predominately 
occurs in exons. This methylation is typically found across those genes that are highly 
conserved and code for ubiquitously expressed products that are critical to metabolic 
processes54,65.   
Within a honey bee hive queen, worker and drone castes exist; haploid drones develop 
from unfertilised eggs and diploid females, queens and workers, develop from 
fertilised eggs. The development of queen and worker castes within the hive is 
dependent on the differential feeding of larvae. For the first three days of life all 
individuals are fed a diet of royal jelly, a somewhat mysterious mixture of proteins, 
carbohydrates and lipids produced from the secretions of the mandibular and 
hypopharyngeal glands of nurse bees. After day three worker-destined larvae are 
switched from a diet of royal jelly to worker jelly, whilst queen-destined larvae remain 




Figure 1.2: Honey bee development. Differential feeding of diploid larvae after day 
3 leads to the development of the sterile worker bee and long-lived, reproductive 
queen. Drones develop from unfertilised eggs. 
 
The differential feeding of larvae either royal jelly or worker jelly leads to the 
establishment of distinct gene expression profiles that elicit the metabolic and 
hormonal changes necessary for the development of either a queen or sterile 
worker65,91-93. The molecular basis of these environmentally-induced changes are 
epigenetic, and whilst it remains unclear the extent to which other epigenetic marks 
direct these changes, DNA methylation is critical. Knocking down DNMT3 in 
developing larvae mimics the effects of royal jelly, causing queen development24, and 
additional evidence shows that the genomes of queens and workers are differentially 
methylated54. How do these differentially methylated regions lead to the distinct 
morphology of a queen or worker, and phenotype in the bee more broadly?  
Several lines of evidence suggest that in the honey bee intragenic methylation 
contributes to the expression of alternatively spliced transcripts. High intragenic DNA 
methylation has been observed near alternatively spliced sites, and the differential 
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methylation of these regions correlates with the expression of caste-specific 
alternatively spliced transcripts23,65. In one instance the gene encoding a 
transmembrane protein is alternatively spliced to produce two protein isoforms; the 
inclusion of an alternative exon containing a stop codon leads to the expression of a 
short isoform. The expression of this short isoform is decreased in worker bee brain, 
where the region spanning the alternatively incorporated exon is found to be heavily 
methylated, in comparison to the queen brain, where this region is not heavily 
methylated23. DNA methylation may therefore, as found by Shukla et al11, modulate 
expression via influencing alternative splicing. 
Of course, these findings do not negate the possibility that other epigenetic 
modifications in the bee are involved such cell- and developmental- specific 
expression patterns, or that these differential methylation patterns occur in response to 
transcriptional changes, rather than directing them.  In fact, histone modifications94, 
and microRNAs95, for instance, are being revealed as integral to caste determination 
in the bee, reinforcing the view that rather than a single epigenetic modification driving 
transcriptional change, phenotype stems from the sum of all epigenetic marks96. The 
association between intragenic DNA methylation and alternative splicing has been 
shown to be partly modulated by histone deacetylation64, and the identified histone 
deacetylase inhibitor activity in royal jelly94 certainly suggests that more than just 
DNA methylation is at play. 
Since the discovery that DNA methylation was essential to caste determination in the 
bee24 research into how DNA methylation guides phenotype in A. mellifera has been 
extensive. Not only has differential methylation been implicated in queen and worker 
development, but it has been implicated in behavioural traits, learning and 
memory23,97. Additionally, evidence for parent-of-origin effects on phenotype in the 
bee98-100 coupled with the role for DNA methylation in mammalian imprinting45, has 
led to much speculation as to whether genomic imprinting via DNA methylation 
occurs in the honey bee101. What effects might methylated epialleles have on 




1.6 Epiallelic variation and division of labour in the honey bee 
The multiple mating of honey bee queens, where a queen mates with multiple drones 
to produce a colony, generates a genetically diverse population. This high genetic 
variability within a colony leads to increased phenotypic variation, which becomes 
advantageous when a hive must respond to a range of external and internal cues; for 
instance multiply-mated hives present with increased behavioural flexibility, and have 
been shown to have better foraging outcomes and thermoregulation within a hive102,103.  
The stability of a honey bee hive is dependent on division of labour, where within a 
colony individuals specialise in different tasks and the collective activity of all such 
individuals is what allows for a fully functioning hive. The most obvious example is 
the reproductive division of labour between the queen and worker, where the queen 
engages in egg-laying behaviour and workers, for the most part, do not. Amongst 
workers a further division of labour occurs; workers specialise in a range of tasks 
including queen attendance, the nursing of brood, corpse removal, guarding the hive 
entrance and foraging. Specialisation in these tasks is dependent on worker age, what 
is referred to as age polyethism, where young bees engage in in-hive activities such as 
nursing and older bees are more likely to forage outside104. 
Of course, such behaviours must remain flexible to counter any changes in colony 
conditions, such as fluctuations in colony size and changing resource availability, and 
workers are able to switch between tasks when required. A reduction in the number of 
foragers causes young bees to become precocious foragers105 and where colonies see 
a reduction in the numbers of young workers foragers revert to nursing behaviours106. 
This switching and behavioural flexibility requires that a worker perceive an external 
cue which exceeds their response threshold; inter-individual variation in this response 
threshold exists, and is influenced by genetic variability104. 
This link between genetic variability and division of labour has long since been 
explored. Substantial evidence links differences in patrilines within a hive to changes 
in behavioural traits, with evidence that genetic background can predispose an 
individual worker to specialise in a particular task within the hive102,103,107,108. How 
might genotype predispose an individual to a particular behaviour? Epigenetic 
differences are known to exist between subcastes in the honey bee109 and other social 
insects, such as the carpenter ant110. If genotype influences the epigenetic layer of 
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information in the honey bee, as has been demonstrated extensively in mammals and 
plants, then this epiallelic variation could explain the differences seen in complex traits 
such as those behavioural switches seen in the bee96. Determining the extent of 
genotype-driven epiallelic variation in the honey bee is, therefore, of interest. 
1.7 Project aims 
Whilst many correlations between differential DNA methylation and complex traits in 
the honey bee exist, fewer studies have investigated whether such epiallelic variation 
is also dependent on genotype. With a specific focus on DNA methylation, it was the 
aim of this project to assess how the underlying nucleotide sequence might influence 
DNA methylation patterning in the bee. To achieve this goal, the relationship between 
genotype, differential DNA methylation and gene expression was explored in the 
context of factors known to influence epigenetic states, namely developmental and 
tissue-specific effects. The primary aims of this thesis were to identify whether 
obligatory methylated epialleles exist in the honey bee population, and to understand 
how such epialleles influence phenotypic variation. 
1.8 Evidence for methylated epialleles in the honey bee  
To understand the relationship between genotype and differential DNA methylation in 
the honey bee further, the Maleszka laboratory utilised a hypothesis-free approach.  A 
genome-wide comparison of diploid worker and haploid drone methylomes was 
performed on embryos from multiple hives. The analysis, performed by Robert 
Kucharski, aimed to identify those genomic regions where a correlation between 
sequence variation and differential methylation existed. A correlation between 
sequence variation and differential methylation of the gene coding for lysosomal α-
mannosidase (LAM) was identified in this analysis.  
This finding provided an opportunity to explore the relationship between genotype, 
DNA methylation and phenotype more closely. What might the phenotypic 
consequences of LAM variation be? Here, LAM function will be briefly outlined. 
1.9 A brief overview of lysosomal α-mannosidase  
Localised within the lysosome, the enzyme Lysosomal α-mannosidase (LAM) plays a 
critical role in catalysing the hydrolysis of asparagine-linked oligosaccharides during 
catabolism111,112. This enzyme has a broad substrate specificity, for it hydrolyses at 
α1,2, α1,3 and α1,6 linkages during catabolism111. Structural characterisation of LAM 
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in mammals and the invertebrate D. melanogaster have shown that LAM is 
proteolytically cleaved into five peptides (A-E), with peptides A and B forming the 
active-site domain113,114. 
LAM is a critical metabolic enzyme. Where mutations disrupt the active site LAM is 
rendered non-functional, and in mammals this results in the lysosomal storage disease 
α-mannosidosis115-118. In cases of α-mannosidosis the deficiency of LAM leads to the 
accumulation of partially degraded mannose-rich oligosaccharides within the 
lysosome. This causes extensive lysosomal vacuolation, disrupting the cellular 
structure of many tissues including the kidneys and brain, and leads to mental 
retardation, hearing loss, skeletal abnormalities and immune deficiency in 
humans119,120.  
Presently, little investigation into the function of LAM in the bee has been undertaken. 
One report in the solitary bee, Megachile rotundata, suggests LAM may play a role in 
immune function121, but to our knowledge no studies of A. mellifera LAM have been 
reported. Its ubiquitous expression and role in core housekeeping processes, 
glycoprotein catabolism, is conserved across many species, and so one might expect a 
similar function for LAM in the honey bee. Given this significant gap in our 
understanding of the honey bee LAM, and the possible existence of LAM epialleles in 
the honey bee population, an investigation into LAM function in the honey bee is 
opportune.  
1.10 Thesis overview  
The discovery that a correlation between LAM sequence variation and differential 
DNA methylation occurred lead to the question, do LAM epialleles exist in the honey 
bee population? If so, what effect might these LAM epialleles have on phenotype? 
This thesis aimed to explore these key questions. 
This thesis presents the in-depth analysis of several differentially methylated LAM 
epialleles and explores how these epialleles might influence phenotype. Chapter 2 
presents the in-depth analysis of this differentially methylated region, showing that 
methylated obligatory LAM epialleles occur and correlate with context-dependent 
transcriptional changes. Chapter 3 explores how these epialleles might affect 
phenotype by knocking down LAM enzyme activity in vitro and in vivo using the 
alkaloid swainsonine. Finally, chapter 4 presents several preliminary lines of evidence 
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which provide additional insight into LAM function and the potential effects of the 
LAM epialleles. From these findings we propose that the LAM epialleles may 
influence metabolic rate and development in larvae, and the implications of these 
findings and future directions are presented in chapter 5.  
Overall, the identification of methylated obligatory epialleles in the honey bee 
population highlights the need to interpret any correlations between differential DNA 
methylation and phenotype in the context of the underlying genetic sequence. Our 
findings add to a growing body of literature which shows that genotype-driven 
epiallelic variation is a key driver of phenotypic variation. Additionally, this thesis 
presents the first indication that the honey bee is sensitive to the indolizidine alkaloid 
swainsonine. This finding highlights the need to investigate the extent to which this 
naturally occurring alkaloid affects honey bee health. 
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Obligatory methylated epialleles in the honey bee population 
 
2.1 Background and preliminary results 
 
Epiallelic variation is a key driver of phenotypic variation. While the honey bee and 
other social insects are widely studied to understand the link between differential DNA 
methylation and complex traits little research has assessed the impact of sequence 
variation on methylation patterning. The extensive evidence in plants and mammals 
that shows the underlying sequence can have a profound impact on DNA methylation 
prompted us to determine whether epiallelic variation in the honey bee is also 
dependent on the underlying sequence. 
The first indication that obligatory methylated epialleles might exist in the honey bee 
population came from the identification of two alleles of the gene coding for lysosomal 
α-mannosidase (LAM; GB44223), LAMCΔGA and LAMC+CT, during a genome-wide 
comparison of diploid worker and haploid drone methylomes. The LAMCΔGA allele is 
characterised by a 12 bp in-frame deletion in exon 16 and is linked to a lack of 
methylation, whilst the LAMC+CT allele, without the deletion, is linked to a high level 
of methylation. This suggested that the 12 bp deletion may disrupt a site critical for 
the maintenance of methylation in this region. 
To confirm these findings several single drone inseminated (SDI) hives were 
established and the allelic variation of LAM characterised. The LAMCΔGA and 
LAMC+CT alleles occur most frequently in the nine hives analysed, and four additional, 








Table 2.1: Identified AmLAM alleles. Six alleles identified across 8 SDI hives (1-5, 
7-9) and one naturally mated hive (hive 6)  








To confirm linkage between the methylated state and the discovered AmLAM alleles 
three hives (hives 1-3) were selected for an in-depth cross-generational analysis. The 
published work presented in this chapter, ‘Differentially methylated obligatory 
epialleles modulate context-dependent LAM gene expression in the honey bee, Apis 
mellifera’, presents this analysis and is the first report of obligatory methylated 
epialleles in the honey bee population. 
Within this manuscript it is shown that the 12 bp deletion does not cause a loss of 
methylation, for the lack of methylation is also linked to the LAMC+GA and LAMT+GT 
alleles, which do not contain this deletion. Instead the high level of methylation is 
linked to a single allele, the LAMC+CT allele.  
A preliminary analysis of LAM expression in non-genotyped individuals revealed age-
dependent and caste-specific effects on LAM expression (see figure S3). In early larval 
stages, between 24-72 hours, higher LAM expression occurs in worker larvae than 
drone larvae, and late larval and pupal stages display the lowest level of LAM 
expression. Tissue-specific differences also occur, with LAM very highly expressed 
in the larval gut, much higher than either the larval head or fat bodies, and a higher 
expression observed in testes than in ovaries.  
Two developmental stages were selected for an analysis in the context of the LAM 
epialleles, the 48 hour larval and pupal stages. Additionally, given that tissue-specific 
effects were observed in our preliminary assessment of LAM expression, the adult 
brain and stomach were also analysed and these results are presented as supplementary 
material to the manuscript. 
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Our manuscript demonstrates a correlation between genotype, epiallelic variation and 
context-dependent transcriptional changes within the honey bee population. Whilst 
such correlations have been commonly reported in plants and mammals fewer 
examples have been shown in the honey bee. Our findings highlight the importance of 
closely analysing any cases of differential DNA methylation in the context of the 
underlying DNA sequence, and given the number of SNPs that occur in the honey bee 
population these effects are likely to be extensive.  
Additionally, the observed transcriptional changes indicate that the LAM epialleles 
have the potential to generate phenotypic variation within the honey bee population, 
and the context-dependent nature of these transcriptional changes reaffirms the view 
that differential intragenic DNA methylation will only associate with gene activation 
in certain contexts, and should, therefore, be interpreted in the context of additional 
factors such as cell- and tissue-specific effects, age and caste.  
 
2.2 Published manuscript 
 
The published manuscript is included in the following pages. All figures are included 
in section 2.3, with an additional supplementary figure not originally included in the 
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Differential intragenic methylation in social insects has been hailed as a prime 
mover of environmentally-driven organismal plasticity and even as evidence for 
genomic imprinting. However, very little experimental work has been done to test 
these ideas and to prove the validity of such claims. Here we analyse in detail 
differentially methylated obligatory epialleles of a conserved gene encoding 
lysosomal-alpha-mannosidase (AmLAM) in the honey bee. We combined genotyping 
of progenies derived from colonies founded by single drone inseminated queens, ultra-
deep allele-specific bisulfite DNA sequencing and gene expression to reveal how 
sequence variants, DNA methylation and transcription inter-relate.  We show that both 
methylated and non-methylated states of AmLAM follow Mendelian inheritance 
patterns and are strongly influenced by polymorphic changes in DNA. Increased 
methylation of a given allele correlates with higher levels of context-dependent 
AmLAM expression and appears to affect the transcription of a long-non-coding 
antisense RNA.  No evidence of allelic imbalance or imprinting involved in this 
process has been found. Our data suggest that by generating alternate methylation 
states that affect gene expression, sequence variants provide organisms with a high 
level of epigenetic flexibility that can be used to select appropriate responses in various 
contexts. This study represents the first effort to integrate DNA sequence variants, 
gene expression and methylation in a social insect to advance our understanding of 










The transcriptional events that lead to the development of a multicellular 
organism result from interactions between the underlying genetic sequence and an 
array of epigenomic marks that are modulated, in part, by environmental signals. 
Central to these processes is a variety of epigenetic pathways contributing to 
phenotypic plasticity and environmental adaptation 1-3. One of the key challenges in 
understanding what drives phenotypic variation lies in determining the extent to which 
the nucleotide sequence influences epigenetic states. Instances where cis- or trans- 
acting genetic polymorphisms influence an epigenetic state, what is known as an 
‘obligatory epiallele’, can have clear transcriptional effects 4. Recent work has shown 
that genetic variation is associated with altered chromatin states 5, 6 and differential 
DNA methylation 7 that appear to modify gene expression primarily through altered 
transcription factor binding 7, 8. This occurs in a highly context-dependent manner and 
as a consequence defining the exact mechanisms whereby a given epiallele can 
influence transcription and subsequently, phenotype remains a challenge. 
Obligatory methylated epialleles are known to play an important role in driving 
phenotype across a number of eukaryotes. In contrast to pure epialleles that are 
stochastically methylated, differential methylation at obligatory epialleles is driven by 
changes in the DNA sequence 4, 9, 10. In mammals these are best known to occur in 
cases of allele-specific methylation (ASM) where, primarily, cis-acting sequences 
influence methylation at a locus 11-14. This phenomenon is distinct from genomic 
imprinting, where differential DNA methylation occurs not as a function of the 
underlying sequence, but whether the loci is paternally or maternally derived 15, 16. In 
both cases such ASM can have important phenotypic consequences, with differential 
DNA methylation controlling gene expression directly, and being implicated in 
pathologies such as cancer 17, 18. 
In the invertebrate Apis mellifera, differential DNA methylation has been 
implicated in modulating both phenotypic and behavioural plasticity 19-23. Evidence 
for such roles is largely correlative with little mechanistic understanding of how DNA 
methylation can influence active transcription and alternative splicing. Consequently, 
it is not clear what determines whether methylation is causative of gene expression 
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changes versus merely being an indicator of transcriptional status and through which 
pathways this process is being coordinated. 
Whilst parent-of-origin effects have been hinted for a number of traits in this 
organism 24-27 there is currently no evidence that differentially methylated regions are 
associated with genomic imprinting. Given the extensive differential methylation that 
occurs in A. mellifera, and its association with complex traits, we wanted to investigate 
whether differentially methylated regions (DMRs) are associated with the underlying 
genetic sequence, the paternal or maternal inheritance of an allele, or whether they are 
primarily influenced by environmental cues. 
To achieve this aim we performed a genome-wide analysis of several 
sequenced methylomes, and identified a differentially methylated region, encoding 
lysosomal alpha-mannosidase (AmLAM), that appeared to correlate with DNA 
sequence variants. To confirm the existence of AmLAM epialleles we established 
several colonies with single drone inseminated queens (henceforth referred to as SDI 
hives) and performed ultra-deep next-generation bisulfite sequencing (BS-seq) of 
AmLAM amplicons to determine DNA methylation levels across individuals within 
each SDI hive. We uncovered  two distinct patterns of methylation for AmLAM, a 
highly methylated state linked to a single allele, LAMC+CT,  and an non-methylated 
state, linked to three identified alleles, LAMC+GA, LAMCΔGA, and LAMT+GT. These 
methylation states follow Mendelian inheritance patterns, confirming that a number of 
obligatory LAM epialleles exist within the honey bee population. Further analyses 
showed that this differential gene body methylation alters AmLAM expression in a 
context-dependent manner, and leads to the expression of an uncharacterised anti-
sense long-non-coding RNA (lncRNA).  
 
Results 
A differentially methylated region (DMR) in the gene encoding lysosomal α-
mannosidase  
In the process of comparing genome-wide methylation profiles in the honey 
bee haploid and diploid embryos we have come across a ~0.8 kb region, located on 
Linkage Group 4 (genome assembly 4.5), containing 20 CpGs that are highly 
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methylated (median level ~65%) only in the diploid sample. We identified this region 
as exons 16 to 18 of the gene coding for lysosomal alpha-mannosidase (AmLAM 
GB44223, Figure 1), and noticed that two sequence variants correlated with a 
particular methylation pattern (Figure S1). One allele, identified by a 12 bp deletion in 
exon 16 was found to be non-methylated, whilst a second allele, identified by two 
SNPs separated by a single cytosine residue in intron 17, was always found to be highly 
methylated. This finding prompted us to perform an in-depth characterization of 
AmLAM alleles, and investigate whether differentially methylated LAM epialleles 
exist in the honey bee population and if they are imprinted in a parent-of-origin 
manner. 
 
Identification of multiple allelic variants of AmLAM 
AmLAM encodes an ancient and highly conserved protein (Figure S2) that has 
been implicated in essential metabolic functions in eukaryotes, namely in the 
maturation and degradation of glycoprotein-linked oligosaccharides 28, 29. Its critical 
role is underscored by the symptoms of a debilitating disease affecting many organs 
and tissues in mammals including humans that is caused by mutations in the LAM 
gene 30.   In honey bees the LAM locus is 7,264 bp long and encodes 18 exons that are 
alternatively spliced yielding two mutually exclusive transcript variants with either 
exon 7 or 8 being transcribed (Figure 1). This splicing pattern is conserved in 
Drosophila 31, 32 (gene CG6206 in Figure 2 in reference 23). At present it is not clear 
if the two, only marginally different protein isoforms, have distinct catalytic activities, 
but they appear to be always co-expressed. AmLAM is ubiquitous, but shows 
markedly variable levels throughout development and in various tissues. Not 
surprisingly, AmLAM is highly expressed in the larval digestive system where there 
is approximately 150 times greater expression than in larval fat body or head (Figure 
S3).  Moderate to high levels of expression have also been detected in other tissues 
and organs including adult brains, ovaries and testes (Figure S3).   
To identify allelic variants of AmLAM we limited genetic variation in the 
analysed population and utilised honey bee colonies founded by single drone 
inseminated queens (SDI hives). By a combination of PCR-based genotyping and 
direct ultra-deep amplicon sequencing, we identified six allelic variants of LAM in the 
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honey bee population. Across the analysed region 16 sequence variations were 
identified (Table S1); these include three missense mutations and six sequence 
variations that result in either the introduction or removal of a CpG motif. The 12 bp 
in-frame deletion in exon 16 was only identified in one allele, the LAMCΔGA allele, and 
is predicted to result in the truncation of the LAM D-peptide (Figure 1 and S2). Of the 
six alleles only one, the LAMC+CT allele, contains the two SNPs found to be linked to 
a high level of methylation. We selected SDI hives which contained these two alleles, 
along with two others, LAMC+GA and LAMT+GT to further analyse the allele-
methylation relationship. (Figure S4). 
 
Next generation BS-sequencing of amplicons identifies novel obligatory 
AmLAM epialleles  
We have employed ultra-deep bisulfite sequencing of amplicons using Illumina 
MiSeq. In contrast to low-depth (<50x) genome-wide methylation profiles that are 
assembled from short <100bp reads representing combined methylomes of many 
different cell types, the MiSeq approach allows for analysing longer sequence lengths 
of 600bp and at depth of several hundred thousand reads per amplicon. The resolving 
power of this approach is sufficient to visualize all condition-specific methylation 
patterns that may be associated with dozens of distinct cell-types even if methylation 
levels in certain cell types are very low33. 
To determine the level of methylation of each allele we performed sequencing 
of two LAM amplicons, ex1617 (spanning exons 16 to 17) and ex1718 (spanning 
exons 17 to 18) that yielded an average coverage of 106,611 reads for ex1617 and 
95,985 reads for ex1718. We determined the methylation density across both 
amplicons for individuals sampled from three SDI hives (# 1, 2 and 3) that contained 
different combinations of the LAMC+GA, LAMCΔGA, LAMT+GT, and LAMC+CT alleles 
(Figure S4); total methylation density was determined by averaging the methylation 
density across both amplicons. For each SDI hive the methylation density was 
determined for the founding queen and drone and their progeny at multiple stages of 
development; this allowed for a cross-generational analysis and for potential 
developmental or tissue specific effects on the methylation density to be identified. 
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We found that the LAMC+CT allele, identified in SDI hives 1 and 2, displayed 
a mean total methylation density of 61.4% ± 10.3% (Figure 2, panel A) with no 
significant difference in the total methylation density of LAMC+CT found between the 
SDI hives (t(2)=4.30, p=.60, by a two-sample t-test). This high level of methylation is 
in contrast with the LAMCΔGA, LAMC+GA, and LAMT+GT alleles which either lacked 
methylation entirely, or displayed very low levels. Analysis of the region revealed that 
the LAMCΔGA allele, present in SDI hives 1 and 3, was found to have a mean total 
methylation density of only 2.1% ± 1.2%; the LAMC+GA allele, present only in SDI 
hive 3, 2.9% ±1.9%, and LAMT+GT,  present in SDI hives 2 and 3, 2.8 ± 1.0%. No 
significant difference in the methylation levels were found between these three alleles 
(F(2,19)=1.07, p=.36, by one-way ANOVA). In all cases the majority of the reads 
displayed no methylation; for instance 67.6-94.5% of all reads of the LAMCΔGA allele 
in SDI hive 1 lacked methylation completely, whilst the LAMC+CT allele within the 
same hive rarely displayed this lack of methylation; 12.9%-52.7% of all reads 
exhibited methylation at 20 out of the 22 CpGs present in the region analysed (Figure 
2 panel B). 
Further analysis of the methylation patterns of the LAMC+CT alleles showed 
that although there was no significant difference in the total methylation density 
between SDI hives 1 and 2 there were, within the region covered by ex1617 (Figure 
3) major differences at CpGs 4 and 9; CpG 4 was unmethylated in the allele originating 
from SDI hive 1 founding drone and CpG 9 unmethylated in the allele originating from 
SDI hive 2 founding queen. Sanger sequencing of both alleles did not reveal any 
additional, closely linked sequence variation that could explain this phenomenon.  
By performing an in-depth, cross-generational analysis of SDI hive 1 we were 
able to test whether additional factors, such as developmental stage, tissue-type or 
caste influenced methylation of the AmLAM alleles. We analysed the overall level of 
methylation at each of the 25 CpGs present in the sequenced region. The patterns of 
methylation linked to each allele followed Mendelian inheritance patterns, and 
remained relatively stable between developmental stages and tissue type (Figure 2 
panel C).  
To ascertain whether tissue-specific effects influenced the total methylation 
density of the LAM alleles we conducted a two-sample t-test for both alleles in SDI 
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hive 1. No significant effect of tissue-type was found on the LAMCΔGA allele, 
t(4)=2.78, p=.64. However, we found that there was a significantly higher total 
methylation density of the LAMC+CT allele, t(10)=2.23, p= .004, in head/brain 
(M=70.6%) samples than in thorax (M=62.6%). 
We tested age related effects on the methylation density by comparing SDI 
hive 1 adults, pupae, 96 hour larvae and a 48 hour larval individuals. A one-way 
ANOVA was conducted which showed a significant effect of age on the total 
methylation density of the LAMC+CT allele (F(3,13)=17.8, p=<.0001). Contrasts 
revealed a significant difference between the pupal (M=65.2%) and 96 hour 
(M=47.3%) stages of development, t(6)=2.50, p=.001, as well as between adult 
(M=70.1%) and 96 hour (47.3%) stages of development, t(7)=2.36, p=<.001. These 
age related effects were not found for the LAMCΔGA allele, with no significant effects 
of age on total methylation density found by one-way ANOVA, F(3,7)=2.1, p=.19. 
We conducted a one-way ANOVA to test whether caste influenced the total 
methylation density of either alleles present in SDI hive 1; no significant effect of caste 
was found on the LAMC+CT allele, F(2,14)=1.65, p=.23, nor was there an effect on the 
LAMCΔGA allele, F(2,8)=1.34, p=.32, indicating that caste does not affect the 
methylation density of the LAM alleles. 
 
AmLAM epialleles influence expression in a context-dependent manner, and 
methylation is associated with the expression of a novel lncRNA 
Next, we investigated whether the identified allele specific methylation was 
associated with changes in AmLAM expression across multiple developmental stages 
utilising quantitative PCR. The DNA methylation status of each individual was 
inferred based on genotype, with three categories analysed: diploid individuals without 
methylation, diploid individuals with one methylated allele, and diploid individuals 
with both alleles methylated.  
Across SDI hives 1 and 2 no significant difference between these three 
categories was found in the abdomen of pupae (F(2,21)= 0.71, p= .51, by one-way 
ANOVA), or in the thoraces of pupae (F(2,10)= .63, p= .55, by one-way ANOVA). In 
whole 48 hour larvae, however, LAM expression was found to increase with 
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methylation; a one-way ANOVA showed a significant difference in relative 
expression (F(2,8)= 8.88, p= .009), with contrasts revealing a significantly higher level 
of expression in individuals with both alleles methylated (M=9.9) when compared to 
individuals without methylation (M=6.3) (t(5)= 2.57, p=.001, by two-sample t-test), 
(Figure 4). Further analysis of individuals from SDI hive 1 showed that no significant 
difference in AmLAM expression was apparent between genotypes for either brain 
(t(2)= 4.30, p=.79, by a two-sample t-test), or stomach (t(3)= 3.18, p=.29, by a two-
sample t-test).   
Given that ASM is frequently associated with transcriptional changes such as 
the allelic-specific or monoallelic expression typical of genomic imprinting, we went 
on to test the possibility of allelic imbalance through the quantitation of the LAM 
alleles. In SDI hive 1 we quantitated the LAMC+CT (methylated) and LAMCΔGA (non-
methylated) alleles in heterozygous individuals and in SDI hive 3 we quantitated the 
LAMT+CT (non-methylated) and LAMCΔGA (non-methylated) alleles, also in 
heterozygous individuals. We tested pupal stages, and did not find a significant 
difference in expression between these alleles in SDI hive 1 (t(23)= 2.06, p=.24, by 
two-sample t-test) or in SDI hive 3 (t(4)=2.78, p=.30, by two-sample t-test), and in all 
cases the allelic ratio did not deviate significantly from 1:1 (with a 1:1 ratio 
representing equal expression of both alleles (Figure S5). 
Interestingly, analysis of a long RNA-coding antisense transcript shows that 
there is a strong correlation between the expression of this transcript and methylation 
across multiple stages of development. We found a significant effect of methylation 
on the relative expression of this lncRNA transcript in whole 48 hour larvae 
(F(2,8)=111.2, p<.0001, by one-way ANOVA), in the abdomen of pupae 
(F(2,10)=17.4, p<.001, by one-way ANOVA), and in the thoraces of pupae 
(F(2,10)=14.5, p=.001, by one-way ANOVA), see Figure 4, but did not find a 
significance difference for either brain (t(3)=3.18, p=.10, by two-sample t-test) or 
stomach (t(4)=2.78, p=.10, by two-sample t-test). 
Although there is no apparent correlation between distinct methylation states 
of the AmLAM locus and its splicing pattern (not shown), we cannot exclude the 
possibility that subtle differences in the relative proportion of the two spliced variants 
exist in certain situations and that such events may be influenced by methylation of 
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exons 16-18 and local chromatin conformation. However, the conservation of this 
splicing pattern in Drosophila, which lost DNA methylation enzymology, implies that 
this particular epigenomic modification is not necessary to produce both isoforms 
(gene CG6206 in Figure 2 in ref 23).  
 
Discussion 
Our analyses of multiple obligatory epialleles of the honey bee LAM gene lend 
support to the emerging view that differentially methylated regions, associated with 
guiding phenotypes in a context-dependent manner, are in part driven by the 
underlying DNA sequence. Using colonies founded by single drone inseminated 
queens (SDI hives) to follow the inheritance of the methylation patterns linked to each 
allele cross-generationally we have confirmed the allele-methylation relationship. 
Across all SDI hives we found clear linkage between a given allele and either the 
methylated or non-methylated state, with the methylation patterns following 
Mendelian inheritance patterns. The level of methylation was found to be relatively 
stable across tissue types and developmental stages, with only subtle variations 
observed for age and tissue type. In view of our findings it is likely that these variations 
reflect different programming conditions associated with specific tissues or 
developmental stages. However, they also may result from stochastic fluctuations in 
the level of DNA methylation at a given CpG site as shown recently in mammalian 
cells34.  
Evidence has highlighted the correlation between intragenic DNA methylation 
and active transcription, in both honey bees and mammals 35, 36. Our findings here 
support this view, with an increase in methylation of AmLAM correlated with an 
increase in expression. This effect, however, was not found across all contexts, but 
only in earlier stages of development when AmLAM activity is at its peak, highlighting 
that such alterations to transcription occur in a highly context-dependent manner. One 
possibility is that exonic methylation together with trans-acting factors operates as an 
enhancing system that amplifies the transcript’s levels in those situations when more 
LAM is required. More detailed examination of specific tissue and even cell types may 
reveal more situations whereby expression of AmLAM is modulated by methylation.  
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Interestingly, one allele LAMC+CT appears to occur in two methylated states 
(differential methylation occurring at CpGs 4 and 9).  At present we have not identified 
any additional underlying genetic polymorphisms which could explain these 
differences. It is possible that an unknown trans-acting factor is influencing the 
differential methylation in this region. Given that in two SDI hives this is maintained 
cross-generationally seems specific rather than stochastic. Another possibility is that 
this pattern originated in a previous generation by stochastic de novo methylation in 
the grandparents and was observed as stable in the two generations analysed in our 
study. However, if methylation density at a given region rather than differences at 
individual CpGs influences downstream transcriptional events 37, 38, the differential 
methylation of the LAMC+CT allele may not necessarily be phenotypically relevant.  
The correlation between a novel lncRNA antisense transcript produced from 
the AmLAM locus and methylation is also of interest. Again, this appears to be 
context-dependent, with more significant differences found during larval development 
and pupal stages. Given that these stages are associated with rapid growth, anatomical 
changes and the switching of key developmental pathways it is possible this lncRNA 
modulates expression of additional regulatory factors. At present we can only 
speculate on the function of this lncRNA. Although future experiments may shed more 
light on the functional importance of this gene, lncRNAs represent a special challenge 
in experimental studies even in more advanced mammalian systems39. This is best 
illustrated by many distinct models attempting to explain lncRNA molecular 
mechanisms40.  
DNA methylation in A. mellifera plays an important role in generating 
phenotypic outcomes 19, 41. Methylation in this organism occurs intragenically, where 
it is associated with active transcription, alternative splicing and appears to be largely 
involved in modulating the transcription of highly conserved ‘housekeeping’ genes 
whose products provide the essential cellular processes, in particular energy and 
metabolic flux20, 42. Such constitutively expressed genes supply essential activities 
without which cells cannot properly function. In spite of their perpetual activation the 
products of 'housekeeping' genes might be required at different levels throughout 
development43, or under changing environmental conditions. Indeed, evidence 
suggests that even the most stable transcripts are sensitive to both biotic and abiotic 
external influences 44, 45. Our data provide evidence that context-dependent levels of 
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'housekeeping' transcripts and their products can be modulated by differential 
methylation that could either intensify or weaken the transcriptional efficiency of 
constitutively expressed genes. Higher levels of AmLAM can be advantageous in 
various situations requiring an increased metabolic and energy flux, such as 
accelerated larval growth, or building the adult structures from imaginal discs. Also, 
given a relatively high activity of AmLAM in the mucus gland of male reproductive 
apparatus (not shown), these epialleles could play a role in sperm competition, an 
important part of sexual selection in honey bees and other social insects whose queens 
mate with multiple males46.  In a broader context, the coexistence of differentially 
methylated conditionally-expressed epialleles in the honey bee population could be 
highly advantageous for a self-organising system as a mechanism generating 
stochastic phenotypic variation from which the colony can select most appropriate 
responses in changing environments 47, 48.  A general idea emerging from this and 
similar studies is that epigenomic dynamics is not only influenced by polymorphic 
changes in DNA, but sequence variants may be necessary to ensure the high level of 
flexibility of the epigenetic code.  
Several authors have argued that genomic imprinting via differential 
methylation of genomic loci has to occur in haplo-diploid social insects as a 
mechanism of genomic competition within a society with high level of relatedness49, 
50.  Our data, while not excluding parental imprinting in the honey bees, explicitly 
show that differential methylation per se cannot be used to support such notions. 
Instead, meticulous genetic and molecular analyses of parent-specific expression of 
epialleles have to be conducted in various contexts.  
The extent to which sequence variants in the honey bee are associated with 
obligatory epialleles affecting both methylation and expression on the whole genome 
scale is not known. We have found at least 220,000 SNPs in the honey bee genome 
that have the potential to modify genomic methylation either by removing or adding 
the CpG target (NCBI SNP database:  ftp://ftp.ncbi.nlm.nih.gov/snp/organisms/ 
bee_7460).  Given the relatively small number of methylated CpGs in the honey bee 
and the multiple-male mating behaviour of queens in this species, the impact of DNA 
polymorphism on epigenetically influenced phenotypes could be substantial. 
Importantly, our findings suggest that the currently available methylomes20, 51, which 
are processed via bs-map filtering that eliminates most SNP-generated CpGs as 
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sequencing errors, need to be carefully reanalysed to improve their applicability in 
epigenetic studies. Only fully-annotated methylomes can be used to evaluate the 
physiological and evolutionary potential of epialleles generated by sequence 
polymorphism. 
To date only a small number of studies investigated the contribution of a 
genetic component to both variable DNA methylation and gene expression, as well as 
genome-level differences in gene expression linked to DNA methylation. In a recent 
effort, Wagner et al36 have shown that although genetic and methylation variation 
jointly explains 31% of gene expression variation in their fibroblast samples, the 
underlying mechanisms appear multifaceted and diverse, with a close interplay with 
other epigenetic marks. Importantly, their results show that in addition to positive 
correlation similar to our findings, intragenic DNA methylation can also be negatively 
correlated with gene expression raising a possibility that various contexts may 
influence the actual directionality. They reasoned that further studies on inter-
individual variation in histone marks and chromatin accessibility, ideally in an allele-
specific manner, may bring the framework necessary to the interpretation of sequence 
and methylation variation. In this context, our data suggest that rapid progress in 
understanding of the genotype-methylome-transcriptome relationship can be achieved 
using relevant, easily accessible systems with measurable phenotypic endpoints. 
Studies in organisms with smaller, sparsely methylated genomes, such as the honey 
bee, reduce the molecular complexity to manageable components. The resolution of 
our analyses in the honey bee suggests that further analyses of genes like AmLAM 
may help us to overcome some general bottlenecks in this field regarding the 
interdependence of genetic and epigenetic factors, their coordination via specific 
pathway and assigning causality to DNA methylation above the levels of genes and 
proteins, especially with complex phenotypes. 
 
Methods  
Biological material  
SDI hives were established as described in Lockett et al 21 using artificially 
inseminated queens from Dewar Apiaries (Queensland). Drone fathers were killed and 
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preserved in 95% ethanol before shipment. All collected specimens were snap frozen 
in liquid nitrogen and stored at -800C.  Handling and dissections were done as per our 
standard protocols52-54. A total of 10 colonies were initially sampled to identify allelic 
variants. To analyse the effect of allelic variation on the methylation state we wanted 
to compare alleles within a hive and between hives; we selected three SDI hives where 
heterozygous individuals were present, and where the allelic variants could be 
compared in this manner. The total number of individuals analysed by BS-seq were 21 
(10 from hive 1, 5 from hive 2 and 6 from hive 3). For expression analysis individuals 
from three methylated states were analysed: 9 without methylation, 33 with one 
methylated allele, and 16 with both alleles methylated. 
DNA and RNA extraction 
DNA and RNA isolation were performed as described previously54-56. Briefly, DNA 
was purified using the MasterPure DNA purification kit from Epicentre 
Biotechnologies. For expression analysis RNA was extracted using TRIzol® 
(Invitrogen), and where DNA was required from the same starting material DNA was 
extracted from the Trizol interface using a standard phenol-chloroform method. To 
assess RNA quality 1-2 µL of each RNA sample was denatured with formamide, 
containing 0.01% SybrGreen and evaluated by agarose gel electrophoresis (1.5% 
agarose; 20V/cm). 
Sanger sequencing 
To perform direct sequencing 20ng of genomic DNA was amplified with AmLAM 
specific primers: 5’TGGCAAAGAGATAATAACGAGATA3’, and 5’ 
TCTTATTTAGACGCTTTGGTAGTA3’. The PCR product was purified utilising 
Agencourt® AMPure® XP PCR Purification system (Beckman Coulter). 100 ng of 
purified PCR product was sequenced with 9.6 pmol of the above primers, along with 
the primers 5’CTTCAACTGTTGCTTCGTCCA3’ and 
5’CCACTTACTTGCGAGGTAGCA3’, and sequencing was performed using the 
Applied Biosystems 3730 capillary sequencer.  
Genotyping 
AmLAM alleles were determined via a combination of direct sequencing (see above) 
and genotyping of three polymorphisms (Figure 1, Table S2):  pm-1, a 12bp deletion 
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in exon16 (ex16del); pm-2, c.2825 A>T SNP (ex18A>T), and pm-3, c.2241C>T SNP 
(ex15C>T). For all three polymorphisms 20ng of genomic DNA was amplified. For 
pm-1 PCR products were run into a 2% agarose gel at 8V/cm, and products were sized 
utilising a 100 bp DNA ladder (Promega™). For pm-2 and pm-3 PCR products were 
digested utilising RsaI or NlaIII as per the manufacturer’s protocol (New England 
Biolabs). The digested PCR product was then run into a 2% agarose gel at 8V/cm, and 
sized utilising a 100 bp DNA ladder (Promega™). 
DNA bisulfite conversion and amplicon preparation 
1.5µg of genomic DNA was bisulfite converted using the QIAGEN Epitect® Bisulfite 
Kit, as per the manufacturer’s protocol. The converted DNA was amplified via a nested 
PCR reaction with AmLAM specific primers, see Table S2 for BS-seq specific 
primers. The PCR products were purified utilising Agencourt® AMPure® XP PCR 
Purification system (Beckman Coulter). 
NGS library preparation 
Libraries were prepared from 500-600ng of each amplicon utilising the NEBNext® 
DNA Library Prep Master Mix for Illumina®, and NEBNext® Multiplex Oligos for 
Illumina® Index Primers Set 1 and Set2 (New England Biolabs). Size selection of 
adaptor ligated DNA was performed using Agencourt AMPure XP beads (Beckman 
Coulter), with the bead:DNA ratio of the first bead selection 0.9X, followed by a 
second bead selection with bead:DNA ratio at 0.2X. Each library was eluted in 30 µL 
of 0.1X TE, library size confirmed via agarose gel electrophoresis, and diluted to a 
final concentration of 4nM. 
NGS MiSeq sequencing 
Next generation sequencing was performed on Illumina MiSeq instrument using 
MiSeq Reagent Kit v3 (Illumina) and 600 cycles. PhiX spike was added at 5% 
concentration as recommended by Illumina for low-diversity libraries. 
Bisulfite Sanger sequencing 
Purified PCR products were digested with EcoRI and HindIII and cloned into 
pBluescript KS+ plasmid (Stratagene). Recombinant clones were identified via white-
blue selection on X-gal plates and false-positives were excluded after electrophoretic 
analysis of plasmid sizes in phenol-chloroform bacterial lysates. Plasmids for Sanger 
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sequencing were prepared from 3 ml liquid cultures of recombinants using QIAprep 
Spin Miniprep Kit (QIAGEN). Sanger sequencing was performed by AGRF Brisbane. 
Sequencing results were visualised using ChromasPro v.1.11 (Technelysium P/L). 
Genome-wide methylation analysis 
A custom script was written to extract differential methylation data from whole-
genome bisulfite sequencing results. Genomic scaffold coordinates of each methylated 
cytosine together with methylation level information from each bs-seq sample were 
combined in a table and sorted on position. Using a window of 500 nucleotides the 
table was searched for regions containing at least ten (10) mCpGs with an average 
difference of not less than fifty percent (50%) between two selected samples. 
Analysis of bs-seq results 
For each individual analysed the frequency at which a mCpG occurred was calculated 
across all reads using custom Python scripts and open-source software. The process 
comprised of two steps. In the first, pairs of reads with the 30 nucleotide sequence 
starting at position 4 matching exactly the last 30 nucleotides of the primers used for 
nested amplicon PCR were extracted from FASTQ files, aligned with in silico 
bisulfite-converted genomic template using MUSCLE 57, overlapping regions (if any) 
were proportionally truncated and, after removing all aligner-introduced gaps, both 
reads were combined into one continuous sequence and appended to a separate file  for 
each amplicon and each library/sample. In addition, a quality filter was applied, 
rejecting all sequences shorter than 90% of the length of the template or containing in 
excess of 5% gaps; an adjustment was applied in relation to indel-containing 
SVs/alleles. In the second step, batches of sequences from the “extract” files were re-
aligned with the template using MUSCLE (to eliminate any potential positional errors 
introduced by read indels), the aligned template sequence was used to calculate 
positional information of all the expected CpGs and SNPs, and the positional data were 
used to score methylation status [ie. 0 for T and 1 for C occurring at a CpG position] 
and extract SV data [ie. the nucleotide at a SNP position and the read length for indels] 
for each combined read pair. The data were next appended to a separate table for each 
amplicon and each library/sample. The final tables were used to calculate and graph 
allele-specific methylation data using Excel (and PIL scripts for some graph types). 
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Methylation density was calculated as the percentage of methylated CpG motifs found 
across the AmLAM amplicons. 
Expression analysis 
AmLAM, lncRNA antisense and allele-specific transcripts levels were quantitated via 
RT-PCR (see Table S2 for quantitative PCR primers). cDNA was synthesized from 
2.5 µg of RNA using Maxima reverse transcriptase (Thermo Scientific), as per the 
manufacturer’s protocol and amplified using a SYBR® green I based assay. All RT-
PCR experiments were performed utilising the Applied Biosystems® StepOnePlus™ 
Real-Time PCR System. Gene expression was normalised against both CAM and TBP, 
and relative expression calculated utilising the 2−ΔΔCT method, as previously 
described58-60. 
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Figure legends  
Figure 1 
Manually annotated AmLAM gene model showing all exons in two mutually exclusive 
transcript variants. The alternatively spliced and methylated exons are shown against 
orange and grey backdrops respectively. The four polymorphisms used for genotyping 
are shown in an insert (Y= C or T, K= G or T, W=A or T, DEL=12bp deletion). The 
region analysed by bisulphite sequencing is indicated by the grey line in the insert, 
with individual CpG sites represented by vertical lines. Those CpG sites affected by 
sequence variations are shown in red. 
 
Figure 2 
Methylation levels of the region spanning exon 16 and exon 18 of the αLAM gene. To 
follow the inheritance of methylation across a generation a single male drone was 
mated with a queen; haploid drones develop from unfertilised eggs laid by the queen, 
and diploid workers/queens develop from fertilised eggs. BS-sequencing was 
performed on individuals collected from three hives (#1-3). 
A. Methylation density of the four AmLAM alleles analysed: LAMC+CT, LAMC+GA, 
LAMCΔGA, and LAMT+GT across two amplicons, ex1617 and ex1718. It should be noted 
that no sequence variation was present in the ex1617 amplicon that allowed for the 
discrimination between the LAMC+CT and LAMT+GT alleles, and as such individuals 
from hive #2 were excluded from the methylation density analysis for ex1617. B. 
Schematic of the most frequent patterns of methylation linked to the LAMC+CT and 
LAMCΔGA alleles found in hive #1. C. Pedigree of hive #1 showing the percentage 
frequency that one of the 25 CpG sites in the analysed region was found to be 
methylated, 0% indicating that the CpG was never found to be methylated, 100% 
indicating that the CpG was always found to be methylated. BS sequencing was 
performed on the founding drone and queen, and their progeny at multiple stages of 
development (48 hour larva, 96 hour larva, and pupal stages). To account for potential 
tissue-specific methylation effects, two tissue types were analysed in adult and pupal 
stages, the brain/head and thorax; larvae were processed whole. Where two tissue types 
were analysed brain/head results are indicated in the top panel, thorax in the bottom 
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panel. Note that in individuals of the LAMC+CT/ LAMC+CT genotype individual alleles 
could not be distinguished from one another, the percentage frequency result has been 
duplicated to indicate ploidy. 
 
Figure 3 
 Differential methylation of the LAMC+CT allele. A. Methylation patterns for founding 
individuals from SDI hives #1 and 2. B. All methylation patterns covered by Illumina 




Relative expression of AmLAM and a lncRNA antiLAM transcript at multiple stages 
of development. Transcript levels were measured via quantitative PCR and normalised 
against CAM and TBP transcript levels; normalised results from CAM and TBP were 
averaged. Expression of both transcripts in 48 hour larvae, and pupal thorax and 
abdomen relative to a single pupal abdomen sample are shown. The level of 
significance is indicated by: *p <.05; **p <.01; *** p<.001; **** p<.0001. The 




Figure S1 Discovery of methylation/SV link. A. Comparison of methylation levels 
between worker and drone embryos bs-seq samples in a ~1 kb genomic fragment of 
chromosome 4 (LG4, gi: 323388984, ref: NC_007073.3) covering AmLAM  exons 16 
to 18.  B. Methylation patterns in individual reads from Sanger bisulfite sequencing of 
amplicons covering exons 16-17 (ex1617) and 17-18 (ex1718). Circles – CpG 
positions, green – SNP-dependent, red – novel (this study). Blue – SVs revealed in this 
study, lines – SNPs, box – 12 nt deletion. Arrows show positions of SVs correlating 




Figure S2 ClustalW Multiple sequence alignment of Bos taurus, Drosophila 
melanogaster, and Apis mellifera lysosomal alpha mannosidase (UniProtKB 
references Q29451, Q9VKV1 and H9K948 respectively). Drosophila and bovine 
LAM are known to be proteolytically cleaved into five peptides, which have been 
highlighted: A-peptide (red), B-peptide (orange), C-peptide (light blue), D-peptide 
(green) and E-peptide (dark blue). The conserved catalytic nucleophile residue is 
indicated by a box. The residues affected by the 12 bp deletion identified in the honey 
bee population are indicated in red (either Q861-S864, or H862-Q865), it is predicted 
that the deletion occurs at the end of the D-peptide. Sequence variations identified in 
the SDI hives which result in an amino acid substitution are highlighted in yellow 
(859Y>M, 924K>R, and 942Y>T). 
 
Figure S3. Relative expression of AmLAM across multiple developmental stages and 
tissue types. Transcript levels were measured via quantitative PCR and normalised 
against CAM and TBP transcript levels; normalised results from CAM and TBP were 
averaged. For workers, drones and queens whole larvae and pupal abdomen were 
analysed. Tissues were dissected from 96 hour larvae and adults. Expression of the 
AmLAM transcript, relative to worker pupa thorax, is indicated by the gradient scale; 
examples of a two-fold, eight-fold and >100-fold higher level of AmLAM expression 
are shown. 
 
Figure S4 AmLAM (GB44223) alleles identified in three Single Drone Inseminated 
(SDI) hives, LAMC+GA, LAMCΔGA, LAMT+GT, and LAMC+CT. Genotypes of individuals 
from the three hives are indicated by the grey boxes, with maternal and paternal origin 
of the alleles shown. Light grey boxes indicate those genotypes not found in the SDI 
hives analysed. 
 
Figure S5 Allelic ratio of LAM alleles in two SDI hives. The expression of individual 
LAM alleles was determined via qPCR in heterozygous individuals. The allelic ratio 
was calculated for individuals in SDI hive 1 as LAMCΔGA/LAMC+CT, and in SDI hive 




Table. S1 Polymorphism in the AmLAM locus summary  
Table. S2 LAM PCR reaction conditions 
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All figures included in the manuscript “Differentially methylated obligatory 
epialleles modulate context-dependent LAM gene expression in the honey bee Apis 
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Primary: Initial denaturation 
at 94°C for 5 min, followed 
by 25 cycles of 94°C for 15 
s, 60°C for 15 s,  72°C for 1 
min, and a final extension at 
72°C for 5 min. 
Nested: Initial denaturation 
at 94°C for 5 min, followed 
by 40 cycles of 94°C for 15 
s, 60°C for 15 s,  72°C for 1 
min, and a final extension at 
















Primary: Initial denaturation 
at 95°C for 5 min, followed 
by 25 cycles of 95°C for 30 
s, 60°C for 30 s, 72°C for 1 
min, and a final extension at 
72°C for 5 min. 
Nested: Initial denaturation 
at 95°C for 5 min, followed 
by 40 cycles of 95°C for 30 
s, 63°C for 30 s, 72°C for 1 
min, and a final extension at 
















Initial denaturation at 94°C 
for 5 min, followed by 35 
cycles of 94°C for 30 s, 60°C 
for 30 s, 72°C for 30s, and a 














Table S2 (continued) 
















Initial denaturation at 94°C 
for 5 min, followed by 35 
cycles of 94°C for 30 s, 
60°C for 30 s, 72°C for 30s, 
and a final extension at 




























Initial denaturation at 95°C 
for 5 min, followed by 40 
cycles of 95°C for 15 s, 
60°C for 20 s, 72°C for 30 s, 




































2.4 Supplementary figure 
 
Relative expression of AmLAM and the lncRNA antisense transcript in adult brain and 
stomach 
The expression of AmLAM and the lncRNA antisense transcript was assessed in the 
brains and stomachs of newly emerged bees of two genotypes from hive 1 
(n=3/condition, see figure S6). 
 No significant difference in AmLAM expression was observed between the brains of 
individuals with one methylated allele (M(+/-)= 1.03±0.3) or both methylated alleles 
(M(+/+) =0.97±0.09; t(2)= 4.3, p= .79), nor was any significant difference observed in 
the stomach between genotypes (M (+/-)= 0.69±0.06, M(+/+)= 0.74±0.03, t(2)=3.18, 
p=.29). 
Whilst there was a higher level of expression of the lncRNA antisense transcript in the 
brains and stomachs of individuals with both alleles methylated, this difference was 
not significant. Expression of individuals with one allele methylated in the brain 
(M=0.47±0.14) and stomach (M=0.17±0.06) was only marginally lower than in 
individual brains (M=0.83±0.22, t(3)=3.18, p=.097) or stomachs (M=0.28±0.06, 








Figure S6: Relative expression of AmLAM and the lncRNA antisense transcript 
in adult brain and stomach. Transcript levels were measured via quantitative PCR 
and normalised against CAM and TBP transcript levels; normalised results from CAM 
and TBP were averaged. Expression of each transcript is represented relative to a 
single adult brain (+/-) sample. The methylation status of an allele is indicated by – 








































































In vitro and in vivo inhibition of LAM activity 
 
3.1 Introduction  
The identification of differentially methylated AmLAM epialleles in chapter 2 led to 
the question: what effect, if any, might such epiallelic variation have on LAM function 
and phenotype more broadly? Our finding that the AmLAM epialleles correlate with 
transcriptional differences during early larval stages indicates that these epialleles have 
the potential to influence phenotype, yet it is unclear how this might occur. The 
observed transcriptional differences may have a minimal effect on phenotype and 
fitness, or they may indeed have either deleterious or advantageous effects on the 
honey bee population. So, what effect might an alteration of LAM activity have on the 
honey bee?  
Lysosomal α-mannosidase (LAM) belongs to family 38 of the glycoside hydrolases 
(GH38). The GH38 family are class II α-mannosidases that play a critical role in 
catalysing the hydrolysis of asparagine-linked oligosaccharides during biosynthesis 
and catabolism across a number of cellular contexts1, 2. These α-mannosidases are 
classed into a number of different subfamilies based on their localisation, biochemical 
properties and substrate specificities; they include lysosomal α-mannosidase, likely to 
have a role in scavenging degraded glycoproteins, the cytosolic α-mannosidase and 
the well-characterised golgi α-mannosidase3.  
LAM has been characterised across a number of eukaryotes. It is localised within the 
lysosome, typically has a pH optimum of 4.0-4.5, is activated by Zn2+, and has a broad 
substrate specificity, hydrolysing at α1,2, α1,3 and α1,6 linkages during catabolism1. 
Structural characterisation of this enzyme in B. taurus and D. melanogaster has shown 
that LAM is proteolytically cleaved into five peptides (A-E), with peptides A and B 
forming the active-site domain4, 5. Mutations disrupting this active site and other 
critical residues have been well described in cattle, guinea pigs, cats and humans and 
cause the autosomal recessive disease, α-mannosidosis6-9. In cases of α-mannosidosis 
the deficiency of LAM leads to the accumulation of partially degraded mannose-rich 
oligosaccharides within the lysosome causing lysosomal vacuolation which eventually 
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leads to mental retardation, hearing loss, skeletal abnormalities and immune 
deficiency10, 11.  
Effects similar to α-mannosidosis have been observed in cases of locoism, a condition 
which commonly occurs in livestock that consume the common locoweed, so named 
for its neurological effects. Grazing on the locoweed, which includes several species 
such as Swainsona canescens, Astragalus mollissimus, and Oxytropis lambertii, 
induces a phenocopy of α-mannosidosis, which occurs when these plant species 
contain the indolizidine alkaloid, swainsonine12-14. Swainsonine is produced by fungal 
endophytes that colonise these species, and causes significant livestock losses 
worldwide15, 16. It is believed to bind reversibly to LAM, inhibiting its activity, and 
when consumed for prolonged periods will induce a phenocopy of α-mannosidosis12.  
This sensitivity of LAM to swainsonine has been demonstrated across a number of 
species including D. melanogaster, sheep and cattle17-19.  In livestock the onset of 
symptoms typically occurs after 2-3 weeks of continuous grazing on poisonous plants. 
Livestock chronically exposed to swainsonine exhibit decreased weight, 
hyperexcitibility, nervousness, muscle incoordination, and with continued exposure 
will die; where the individual is pregnant abortions and birth defects occur20. This 
exposure has been shown to cause the accumulation of oligosaccharides such as 
Man5GlcNA2 and Man4GlcNA2 in the kidney and brain of livestock and the resulting 
lysosomal vacuolation occurs across most cells, with eventual neuronal vacuolation 
causing the described neurological effects20. 
A. mellifera is known to forage on species such as Astragalus and Oxytropis but only 
anecdotal evidence indicates that such foraging can lead to deleterious effects. Early 
reports indicate that the locoweed is toxic to the bee; adult bees have been found dead 
on Astragalus lentiginosus blooms, with additional reports indicating that brood are 
killed, pupae mummify and die, and queens within affected colonies stop laying21-25. 
These effects have been attributed to selenium contained within these species, yet, 
there is no direct evidence that this is the case and so it remains a possibility that 
swainsonine is causative of these toxic effects25. Although the occurrence of colony 
collapse disorder (CCD) has led to substantial research into the effects of various 
environmental toxins and pesticides on honey bee health, the sensitivity of the honey 
bee LAM to swainsonine has not been investigated.  
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The severe consequences associated with an inactive LAM are indicative of the critical 
role of this enzyme. Its ubiquitous expression and role in core housekeeping processes, 
glycoprotein catabolism, is conserved across many species, yet in A. mellifera little 
investigation into the function of LAM has been undertaken. In the solitary bee, 
Megachile rotundata, LAM has been reported to play a role in immune function26, and 
the high expression of LAM during larval stages and very high expression in the larval 
digestive tract, shown in chapter 2, suggests that LAM has an important functional role 
during development and might be involved in digestion. Additionally, the correlation 
between the epiallelic variation and differential LAM expression during larval 
development led us to posit that this epiallelic variation could affect larval growth and 
influence the developmental trajectory of larvae.  
3.2 Aims 
Given the paucity of evidence regarding the function of LAM in the honey bee we 
aimed to investigate the role of this enzyme further using a knockdown approach. Any 
physiological or phenotypic effects in response to an inhibition of LAM could provide 
insight into its function and shed light on what influence the AmLAM epialleles might 
have on phenotype and fitness. As a natural inhibitor of LAM swainsonine treatment 
could provide insight into how a deficiency or reduction of LAM activity might 
influence phenotype in the honey bee.  
Given that only anecdotal evidence indicates the honey bee is sensitive to this alkaloid 
we first conducted a series of in vitro experiments to demonstrate that swainsonine 
does indeed inhibit mannosidase activity in the honey bee, and explored the 
mechanism of this inhibition. We then, since AmLAM epiallelic variation correlates 
with transcriptional differences during early larval stages, used swainsonine to inhibit 










3.3.1 Sensitivity of A. mellifera mannosidase to swainsonine, in vitro 
Swainsonine inhibits mannosidase activity in A. mellifera 
To determine whether A. mellifera is sensitive to swainsonine the mannosidase activity 
of A. mellifera protein extracts were determined in the presence of swainsonine at 
concentrations ranging from 5-8000 nM, with the inhibitor and substrate added 
simultaneously to the protein extract. Maximal inhibition is reached at swainsonine 
concentrations of 8000 nM, and 50% of mannosidase activity is inhibited at 
swainsonine concentrations between 145.9-179.9 nM (mean IC50 =162 nM, n= 8, see 
figure 3.1).  
Swainsonine inhibition of mannosidase activity



















Figure 3.1: Swainsonine inhibition of mannosidase activity in A. mellifera. Protein 
extracts were prepared from 48-96 hour larvae; individuals from three separate hives 
were pooled (N=6-10/pool, total of 8 pooled samples) and mannosidase activity 
determined in the presence of 5-8000 nM of swainsonine. The percent total activity 
was calculated as the amount of nitrophenol produced in the presence of swainsonine 
over the nitrophenol produced in the absence of swainsonine (assay conditions: 1mM 
substrate, pH 4.6, 37°C).  The IC50 is estimated between 145.9-179.9 nM, with the 
average IC50 162 nM (R
2=0.9854, Hill Slope = -1.143). 
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Swainsonine binds in a competitive and reversible manner 
To gain insight into the mechanism of action of swainsonine in A. mellifera the 
inhibition constant, Ki, was determined over 10 inhibitor and 6 substrate 
concentrations. The observed inhibition of mannosidase activity is competitive, with a 
Ki value determined over two replicates as 152.3±17.49  nM (95% CI [117.3-187.2]) 
and 223.6±27.41 nM, ( 95% CI [168.8-278.4]); the Ki for swainsonine is therefore 
estimated to be in range of 135-251 nM (see figure 3.2).  
To determine whether swainsonine binding is reversible extracts were preincubated 
with a swainsonine concentration near to 10xKi (~1600 nM), diluted 1:30 and 
incubated with substrate. This was repeated with a swainsonine concentration near to 
5xKi (~800 nM), diluted 1:5 and incubated with substrate. Little activity was recovered 
in the preincubated sample after dilution (see figure 3.3), this is typical of irreversible 
binding or reversible inhibitors that dissociate slowly from the enzyme. The slight 
recovery of activity after 60 minutes at a concentration of 800 nM is suggestive of the 
latter (see figure 3B).  
Figure 3.2: Ki estimates of swainsonine (next page). Mannosidase activity was 
determined over time and initial velocity calculated in the presence of varying 
concentrations of swainsonine (0-8000 nM), and the inhibition constant, Ki, 
determined (GraphPad Prism). A) Preliminary estimates with swainsonine 
concentrations ranging from 40-8000 nM indicated a Ki of 107.6±20.6 nM 
(Km=1290±232). The Ki, of swainsonine was then determined with 10 concentrations 
of swainsonine (5-8000 nM) using high (B) and medium (C) concentrations of enzyme 
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Effect of preincubation on inhibition








No preincubation: 1600 nM SW
No preincubation: 48 nM SW
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Figure 3.3: Effect of preincubation on swainsonine inhibition.  Mannosidase 
activity was determined in the absence swainsonine (100% activity) and in the 
presence of swainsonine with, or without precinubation. A) Mannosidase activity was 
determined at swainsonine concentrations 10xKi (~1600 nM) and 0.3xKi (~48 nM) 
without preincubation and with a 30 minute preincubation of enzyme with a 
subsequent 30x dilution into substrate. B) Mannosidase activity was determined at 
swainsonine concentrations 5xKi (~800 nM) and near to the Ki (160 nM) without 
preincubation and with a 30 minute preincubation, with a subsequent 5x dilution into 




3.3.2 LAM sensitivity to the indolizidine alkaloid, swainsonine in vivo 
 
Effects of swainsonine exposure on mannosidase activity and LAM gene expression in 
larvae  
To ascertain the effects of swainsonine on honey bee development larvae were reared 
in the laboratory on a larval diet containing 20 µM and 100 µM concentrations of 
swainsonine for a period of eight days, prior to their transfer into capsules for pupation. 
A larval diet containing swainsonine did not increase mortality within the first eight 
days of development; 20% (N=10/50) of larvae reared in the control condition did not 
survive, similar to those reared on a diet containing 20 µM (21%, N=14/66) and 100 
µM (10.5%, N=7/67) of swainsonine and there was no significant difference in the 
number of larvae that died between conditions (F(2,18)= 0.29, p =.75). Additionally, 
no clear phenotypic differences occurred and no significant differences in weight were 
observed at day 4 (F(2,33)= 0.52, p= .60, by one-way ANOVA), or day 8 (F(2,33)= 
2.92, p=0.07, by one-way ANOVA) between conditions. 
Four days after exposure to swainsonine, (96 hour larval stage) a significant decrease 
in mannosidase activity occurred; a 13-fold and 18-fold higher level of mannosidase 
activity was observed in larvae fed the control diet (M=690±60 U/mg) than in the 20 
µM (M=53±8 U/mg, t(3)=3.18, p=.0002; d= 14.90) and 100 µM (M=39±12 U/mg, 
t(3)=3.18, p= .0002; d= 15.05) conditions, respectively, see figure 3.4A. No significant 
effect of swainsonine treatment on the level of AmLAM gene expression was observed 
between groups (F(2,12) = 0.98, p= .40, by one-way ANOVA, see Figure 3.4B). 
Further exposure to swainsonine increased mannosidase inhibition. Eight days after 
exposure to swainsonine (192 hour larval stage) a 54-fold and 95-fold higher level of 
mannosidase activity was observed in the control group (M=294±80 U/mg) than in the 
20 µM (M=6±4 U/mg, t(3)=3.18, p=.006; d=5.09) and 100 µM (M=3±2 U/mg, 
t(3)=2.45, p=.005; d= 5.13) conditions, respectively, see figure 3.4A. Additionally, 
whilst no effect on AmLAM expression was observed at day 4, a significantly higher 
level of AmLAM expression was observed in larvae fed a diet containing 20 µM of 
swainsonine (M=1.28±0.03, t(6)= 2.45, p= .01; d= 7.62), and 100 µM of swainsonine 
(M=1.22±0.09, t(8) = 2.31, p=.03; d= 5.30) than in larvae reared on a control diet 
(M=0.7±0.1), see figure 3.4B. 
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After day 8 larvae were transferred to capsules for pupation and emergence, which 
typically occurs at day 21-22. Of the control group 60% (N=6/10) survived pupation 
and all surviving individuals emerged by day 22. Of the larvae reared on a diet 
containing 20 µM of swainsonine 45.5% survived (N=5/11) and by day 22 only 60% 
(N=3) of surviving individuals emerged. For those larvae reared on a diet containing 
100 µM of swainsonine 73% survived pupation (N=14/19) and by day 22 only 57% 
(N=8/14) of surviving individuals emerged. 
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Figure 3.4: Mannosidase activity and AmLAM gene expression in larvae reared 
on a diet containing 20 µM and 100 µM of swainsonine. Larvae were reared in the 
laboratory on a larval diet containing 20 µM (N=3) and 100 µM (N=3) of swainsonine, 
and mannosidase activity (A) and AmLAM gene expression (B) determined in whole 
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individuals at 96 hours (4 day exposure, N=3) and 192 hours (8 days exposure, N=3). 
A significantly lower level of mannosidase activity was observed in treated 
individuals, with an increase in AmLAM gene expression observed after a prolonged 
exposure of 8 days (results relative to control group). The level of significance is 
indicated by *p<.05; **p<.01; *** p<.001.  
3.3.3 Swainsonine exposure causes a developmental delay  
 
The findings from section 3.3.2 suggest that swainsonine may cause a delay in 
development, with fewer treated individuals (~60%) emerging by day 22. To confirm 
these findings the developmental time course and survival of individuals reared on a 
diet containing 100 µM of swainsonine was assessed.  
Effects of swainsonine during larval development 
Within the first eight to nine days of exposure to swainsonine no increase in mortality 
was observed. 19.8% mortality occurred in the control condition (N=19/96) and 20.2% 
mortality occurred in larvae reared on a diet containing 100 µM of swainsonine 
(N=18/89) by day 8. On day 9 the mortality of swainsonine treated individuals 
increased to 30.4% (N=27/89), but was not found to be significantly higher than the 
mortality rate of the control condition (20.8%, N=20/96; Z= -1.48, p=.14).  
Typically laboratory reared larvae are large enough for transfers into capsules by day 
8-9. Of those surviving larvae fewer swainsonine treated individuals (24%; N=16/67) 
were ready for pupation than in the control group on day 8, where a significantly higher 
proportion of individuals were ready for pupation (46%; N=34/74; Z=2.74, p=0.006), 
suggesting that swainsonine may decrease the rate of larval growth. However, by day 
9 all remaining larvae across both conditions were ready for pupation, with the 
exception of a small percent of individuals that failed to thrive (1.3%, N= 1/74, of 
control and 3.0%, N= 2/67, of swainsonine treated larvae).   
Effects of swainsonine during pupal development  
To assess the effect of swainsonine on pupal development individual pupal phases, as 
determined by the colouration of the compound eye and thorax27 were assessed from 
day 15 until day 23, when all surviving individuals emerged (see Figure 3.5). 
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On day 15 there was a significantly higher proportion of surviving individuals in the 
control group (N=50/58) that had reached the Pp (pink eye, white thorax) phase than 
the swainsonine treated group (N=23/38; Z= 2.88, p= .004), and a significantly higher 
proportion of swainsonine treated individuals remained in the earlier Pw (white eye, 
white thorax; N=15/38) developmental phase than the control group (N=2/58; Z=-
4.52, p < .00001).  
Significant effects were seen again on day 17, where a higher proportion of the control 
group had entered the Pbl (brown eyes, light pigmentation of the thorax) 
developmental phase (N= 10/56) than the swainsonine treated group (N=1/37, Z=2.22, 
p=.03). At day 21 a significantly higher proportion of the swainsonine treated group 
(N=18/35) remained in the Pbm (brown eyes, medium pigmentation of the thorax) 
phase than the control condition; on day 21 a higher proportion of control individuals 
were in the Pbd (brown eyes, dark pigmentation of the thorax) phase or had emerged 
(N=10/56; Z=-3.34, p=.0007). 
At no time point was there a greater proportion of swainsonine treated individuals in a 
more advanced developmental stage than the control group, and the onset of each 
developmental phase was seen to be delayed by approximately one day in treated 
individuals. During pupation although a higher mortality rate was observed in treated 
individuals (37.0%, N=20/54) than the control condition (23.2%, N=16/69) this 
difference was not significant (Z=-1.68, p=0.093), suggesting that swainsonine 
treatment only marginally affects survival during pupation. 
Swainsonine treatment during development increases mortality 
Given that swainsonine was not found to increase mortality during larval stages, but 
appeared to have marginal effects on survival during pupation we tested the overall 
effect of swainsonine on survival into adulthood. Mortality in swainsonine treated 
individuals (55.1%, N=49/89) across all developmental stages, from early larval to 
emergence, was significantly higher than control individuals (38.5%, N=37/96; 
Z=2.25, p=.02), indicating that swainsonine exposure during development reduces the 





Figure 3.5: The timing of pupal developmental phases in untreated individuals 
(A) and swainsonine treated individuals (B). The colouration of the compound eye 
and thorax was monitored in swainsonine treated individuals to assess the rate of 
development. During early pupation both the eye and body remain white (Pw). 
Colouration begins with the eyes, which transition from white to pink (Pp), to dark 
pink (Pdp) and finally to brown (Pb). Once the eyes darken to brown the thorax begins 
to develop colour, and the body transitions from light in colour (Pbl), to medium (Pbm) 













































































































































Effects of swainsonine treatment on adult emergence and post emergence survival 
Of the individuals transferred for pupation 76.8% of the control condition (N=53/69) 
and 63.0% (N=34/54) of larvae exposed to swainsonine emerged successfully. All 
surviving individuals had emerged by day 23 and no significant difference in the 
emergence rate was observed between conditions (Z=1.68, p=0.093). Whilst a higher 
percentage of control individuals (13.3%, N=7/53) emerged early, between days 18-
20, this was not significantly higher than for swainsonine treated individuals (3.0%, 
N=1/34; Z= 1.62, p=.11). The majority of individuals in both conditions emerged on 
days 21 and 22; no significant difference in the proportion of individuals that emerged 
on day 21 (control=19/53, swainsonine=11/34; Z=0.34, p=.74) or on day 22 
(control=25/53, swainsonine=15/34; Z=0.28, p=.78) was observed. However, on day 
23, a significantly higher proportion of control individuals (96.2%, N=51/53) had 
emerged than swainsonine treated individuals (77.1%, N=27/34; Z=-2.51, p=0.01), 
suggesting that swainsonine may marginally delay emergence in some individuals (see 
figure 3.6A). 
Newly emerged bees were transferred to a cage and mortality and phenotype observed 
over 5 days. Significant losses for those bees reared on a diet containing swainsonine 
occurred; by day 5 82.4% (N=28/34) of treated bees had died, significantly higher than 
in the control condition where at day 5 only 6.52% of bees had not survived (N=3/46; 
Z=6.88, p<.00001, see figure 3.6B). Additionally, it was observed that the movement 
of treated bees was impaired; the honey bees were observed trembling, and appeared 




Figure 3.6: The timing of emergence and survival of newly emerged bees exposed 
to swainsonine. A) The percentage of individuals emerging between days 16-23; 
significant differences were observed only at day 23. B) The percentage of caged 
newly emerged bees that did not survive over a five day period after emergence (day 











































































































3.4.1 The mechanism of swainsonine inhibition of mannosidase activity in the 
honey bee  
We provide the first evidence that A. mellifera mannosidase activity is sensitive to the 
indolizidine alkaloid swainsonine. IC50 estimates indicate that swainsonine 
concentrations between 146-180 nM will see a 50% reduction in activity; this is near 
to previously reported IC50 values for mammalian and jack bean mannosidases, that 
have been estimated at 200 nM28, 29. Interestingly, the Ki estimate for A. mellifera (Ki: 
135-251 nM) is higher than that reported for the mammalian enzyme (Ki: 70 nM), 
indicating that A. mellifera may be less sensitive to swainsonine than other 
organisms12. 
In vitro inhibition studies indicate that swainsonine is a competitive inhibitor of A. 
mellifera mannosidase activity. This inhibition is increased upon preincubation, and 
while binding is reversible swainsonine appears to dissociate slowly from the A. 
mellifera enzyme. Our findings are similar to studies of the mammalian and jack bean 
α-mannosidases, where swainsonine is a known competitive inhibitor. Swainsonine 
binds tightly to the jack bean α-D-mannosidase and this binding it is also influenced 
by preincubation28, and in the case of mammalian lysosomal α-mannosidase 
swainsonine inhibition is reversible upon dilution12.  
Importantly, the mechanism of swainsonine binding is complex and not fully 
understood. The degree of reversibility is affected by the extent of preincubation, with 
suggestion that two modes of binding exist, a rapid and irreversible binding, and a slow 
and reversible mode of binding20, 29.  In our study little mannosidase activity was 
recovered, indicating that irreversible binding may indeed occur. Given that the 
mechanism of binding and the effects of preincubation will affect IC50 and Ki estimates 
further analysis of the interactions between swainsonine and A. mellifera 
mannosidases is required to fully determine whether A. mellifera is more resistant to 
the effects of swainsonine than other organisms. 
Previous studies have also shown that swainsonine inhibits both the lysosomal α-
mannosidase and golgi mannosidase II in vitro29, but is believed to primarily inhibit 
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the lysosomal form in vivo since swainsonine is more likely to accumulate within the 
lysosome12. The results presented here are reflective of its effects on the lysosomal 
enzyme, since the conditions utilised are optimal for the lysosomal form, with assay 
conditions performed at pH 4.6. This low pH would limit the activity of the golgi 
mannosidase II, and in D. melanogaster the golgi mannosidase II enzyme has been 
shown to have little activity below pH 5.018. Indeed, the IC50 inhibition studies indicate 
the detection of a single enzyme (Hill slope = -1.143), suggesting little interference 
from the golgi mannosidase II enzyme. The future purification of the A. mellifera 
lysosomal α-mannosidase and subsequent inhibition and mechanism of action studies 
will confirm our findings, and provide definitive IC50 and Ki estimates for the honey 
bee. 
3.4.2 Effects of swainsonine on honey bee development  
Our results indicate that a prolonged exposure to swainsonine has sub-lethal effects on 
larval and pupal development, with newly emerged bees eventually succumbing to the 
toxic effects of this alkaloid. In early larval stages mannosidase activity is significantly 
decreased in treated individuals and continued exposure, up until pupation, further 
decreases activity. This indicates that during larval development exposure to 
swainsonine via the diet will result in an accumulation of the toxin, and the increase in 
AmLAM gene expression after eight days of exposure suggests that, in vivo, 
swainsonine does indeed affect the lysosomal α-mannosidase, as has been reported in 
other organisms.  
Exposure to swainsonine causes a subtle decrease in the rate of larval growth and this 
developmental delay continues throughout pupation, where the development of 
swainsonine treated individuals is delayed by approximately one day. These sub-lethal 
effects observed during larval and pupal development could reflect that, as in cases of 
loco-poisoning in livestock, a prolonged exposure is necessary for the onset of severe 
symptoms; the effects on early development are subtle, and the toxicity of swainsonine 
only becomes apparent during late larval and pupal stages, and upon emergence.   
Studies of swainsonine poisoning in mammals indicate that locoism results from the 
progressive accumulation of partially degraded oligosaccharides causing extensive 
lysosomal vacuolation and tissue disruption20. This first affects the liver and kidney, 
causing general malaise, with eventual neuronal vacuolation causing severe 
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neurological symptoms and death. The onset of loco-like symptoms in newly emerged 
bees, who display altered locomotor activity and do not survive beyond 5 days post-
emergence, indicates that a prolonged exposure to swainsonine, at high concentrations, 
induces locoism in the bee.  Whilst we have not examined treated individuals for 
lysosomal vacuolation in this study, it is certainly likely that such vacuolation would 
occur, and the future examination of treated individuals for such vacuolation would 
solidify our findings. 
Given that LAM is involved in general metabolic processes and cellular turnover an 
inhibition of its activity during larval development could certainly reduce overall larval 
growth, explaining the observed developmental delay during these stages. 
Alternatively, this delay could reflect the need for resources to be allocated away from 
larval growth to survive poisoning and allow detoxification processes to occur. 
Numerous alkaloids are toxic to the honey bee30, and in newly emerged bees exposed 
to the alkaloid nicotine detoxification processes are up-regulated, and this is associated 
with altered energy metabolism31. A similar response after exposure to swainsonine 
could explain our findings, where fewer energetic resources are available for larval 
development and subsequent metamorphosis, explaining the sub-lethal effects 
observed in this time period. 
In the honey bee LAM is very highly expressed in the digestive system during larval 
stages. The significance of this finding remains unknown, but it is possible that LAM 
may be involved in the processing of components of the larval diet. Larval 
development in the bee is highly dependent on diet, and any shift in the availability of 
nutrients would have important implications on such development. The switch from 
royal jelly to worker jelly, for instance, has a profound effect on development, causing 
a larva to develop into a worker rather than a queen, and nurse bees are known to 
tightly regulate various components in the larval diet, such as sugar content, to guide 
worker development32, 33. 
Whilst no shift in the developmental trajectories, that of queen vs worker, is apparent 
in swainsonine treated individuals, larval growth is affected and a delay in 
metamorphosis occurs. Typically, a spike in juvenile hormone at the end of larval 
development initiates metamorphosis, and within the hive nurse bees increase the 
amount of sugar in larval food during the fifth instar to cause this spike34, 35. If 
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swainsonine treatment causes vacuolation in the larval gut absorption may be 
compromised, and the delay seen in our study may result from an alteration in the 
uptake of key nutrients required for metamorphosis.  
Indeed, swainsonine is known to induce apoptosis in vivo. It has been widely studied 
for its anti-tumour effects, and it has been shown to delay the growth of tumour cells 
by inducing apoptosis36-38. The administration of swainsonine via the larval diet could 
certainly result in the larval digestive system undergoing vacuolation and apoptosis, 
compromising nutrition. The abnormal locomotor activity and eventual death of newly 
emerged bees also suggests that such swainsonine induced apoptosis and vaculolation 
inevitably affects the honey bee brain.  
Analysing the extent of apoptosis in the larval gut and brains of treated individuals and 
determining whether swainsonine induces apoptotic pathways in the bee, for instance 
through the upregulation of caspases, would help reveal the mechanism of swainsonine 
toxicity. Furthermore, the analysis of juvenile hormone titres in swainsonine treated 
individuals, as well as those pathways known to influence growth and cell survival, 
would similarly provide interesting clues as to how swainsonine delays growth. Any 
shifts in juvenile hormone levels or insulin signalling could indicate that swainsonine 
delays development by affecting the larval gut of developing workers and 
consequently nutrition39.  
LAM is one of many N-glycosylated proteins found in royal jelly40, many of which 
are high-mannose type glycoproteins41. The lysosomal catabolism of N-linked 
glycoproteins has been studied extensively and LAM is essential to such processing42. 
The fact that LAM itself is found in royal jelly and is highly expressed in the larval 
gut certainly indicates that one of the functions of LAM might relate to nutrition, and 
interestingly, suggests it may help digest royal jelly components.  
In the present study we have assessed the effects of swainsonine on worker 
development. Given that queen development is dependent on larvae being reared on a 
diet of royal jelly an interesting extension of our study would be to investigate the 
effect of swainsonine on queen development. Queen development is highly dependent 
on increases in juvenile hormone titres from the third instar, where hormone levels 
must breach a certain threshold for the full maturation of a queen39. Developing queens 
could be more sensitive to the malabsorption of larval diet and/or royal jelly 
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glycoproteins, and so whilst worker development is only marginally delayed in 
response to swainsonine treatment, queen development might be more profoundly 
affected. 
3.4.3 Environmental implications of our findings 
Several known pesticides, including the well-known neonicotinoids, are known to 
affect honey bee health, and have been widely researched in the context of recent 
honey bee losses. Such pesticides have been reported to delay larval development and 
reduce adult longevity43, cause apoptosis in honey bee tissues44 and in the case of 
imidacloprid, a commonly used neonicotinoid insecticide, have been shown to induce 
neuronal apoptosis45. Whilst the doses of swainsonine used in our study are unlikely 
to reflect the environmental exposures to honey bees foraging on the locoweed they 
highlight the importance of investigating locoism in the bee further.  
If swainsonine exposure, at lower environmentally meaningful doses, causes similar 
effects on larval growth and adult longevity this has the potential to negatively impact 
colony health. Foraging bees that are sensitive to swainsonine could display altered 
behaviours, such as diminished learning and memory, and any losses of adults or shifts 
in larval development or nutrition would be detrimental. Developmental delays can 
increase sensitivity to pesticides or Varroa43, and cause changes in the division of 
labour within a hive, having long term effects on hive productivity and fitness46. 
Swainsonine thus presents as a potential environmental stressor for the honey bee, and 
should be investigated accordingly. 
3.4.4 Insights into LAM epiallelic variation 
Our study has shown that the honey bee displays a similar level and mode of toxicity 
to swainsonine as other organisms. These findings suggest that LAM function in the 
honey bee is conserved and is therefore likely to play a similar role in glycoprotein 
catabolism and metabolism as has been shown in other species. The knockdown of 
LAM activity in developing larvae slows growth, and at this stage it is unclear whether 
this results from swainsonine induced apoptosis and general toxicity, or the inhibition 
of LAM activity itself. Whilst this lack of clarity makes it difficult to assign function 
to the differentially methylated AmLAM epialleles it does indicate that these 
epialleles, which cause differential AmLAM expression in larval stages, may cause 
subtle differences in larval metabolism and the rate of development. 
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Differences in larval metabolism and growth can have a decided impact on adult 
behaviour and morphology. Indeed, a recent study has shown that food deprivation 
during late larval stages causes shifts in metabolism, juvenile hormone titres and 
glycogen storage which allow for adults be more resistant to the effects of starvation 
later in life47. Additionally, studies have shown that differences in temperature during 
pupation cause shifts in the timing of emergence, and eventual task specialisation and 
adult behaviour48. Both temperature and larval diet are tightly regulated within a hive 
for this reason, and adult bees have the capacity to increase the temperature of a cell49 
and alter larval diet32 to maintain stability within a colony.  
If the AmLAM epialleles modulate metabolic rate and development then their 
presence in the honey bee population could generate variation in adult longevity or 
task specialisation, which might be advantageous in particular contexts. A genetically 
diverse population promotes flexibility, and hives with higher variability have been 
shown to respond more adequately to external and internal cues, for instance, multiply-
mated hives display better thermoregulation and foraging outcomes50, 51. Perhaps by 
influencing the way in which a developing larva might respond to diet or temperature 
within the hive the AmLAM epialleles can generate such variation, or might 
predispose an individual to a particular behaviour. Assessing whether genotype biases 
in behavioural specialisation or caste occur and comparing the metabolic rate of 
individuals with distinct epigenotypes could indicate how AmLAM epiallelic variation 
affects phenotype in the honey bee.  
Additionally, determining whether genotype itself influences whether a developing 
larva is sensitive to swainsonine is of interest. The treatment of larvae with 
swainsonine via the diet, presented in this chapter, was performed in ungenotyped 
larvae. Could the AmLAM epialleles somehow influence swainsonine sensitivity? 
Future experiments, exposing genotyped individuals to swainsonine during 
development, is recommended to clarify this issue. 
3.5 Conclusions 
We have shown that swainsonine competitively inhibits A. mellifera mannosidase 
activity. The treatment of developing larvae with swainsonine causes sub-lethal effects 
during development and death shortly after emergence, indicating that high 
concentrations of swainsonine are toxic to the bee. These findings highlight the 
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importance of determining if naturally occurring concentrations of swainsonine found 
in the locoweed have similar effects. Our knockdown of LAM activity suggests that 
LAM has an important role in metabolism in the bee, and we propose that the AmLAM 
epialleles might generate differences in larval metabolism and growth. Additional 
studies investigating this further will provide interesting clues as to how the LAM 
epialleles influence fitness in the bee. 
 
3.6 Materials and methods   
 
3.6.1 Protein extracts  
All samples were homogenised in a PBS solution (137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2PO4) containing 1mM ZnCl2 and cOmplete
™, EDTA-free 
protease inhibitor cocktail (1X; Roche), henceforth referred to as homogenisation 
buffer. Whole larvae and pupae were snap frozen in liquid nitrogen and stored at -80°C 
until analysis. Samples were homogenised in chilled homogenisation buffer (250 
µL/100mg of tissue), centrifuged at 14 000 x g for 15 minutes at 4°C, the supernatant 
collected for the activity assay and diluted where necessary (OD within 0.1-1.5). 
3.6.2 IC50 and Ki estimates 
To determine the IC50 and Ki values tissue extracts were prepared from 48-96 hour 
larvae from three separate hives and were pooled (n=6-10/pool, total of 8 pooled 
samples). Samples were prepared at per 3.6.1 and diluted 1:10 in homogenisation 
buffer. The rate of nitrophenol production was determined for 10 inhibitor (5-8000 
nM) and 6 p-nitrophenyl-α-D-mannopyranoside substrate concentrations (0.5 mM, 
0.75 mM, 1.0 mM, 2.5 mM, 5.0 mM and 7.0 or 8.0 mM) for each pooled sample, at 
37°C, pH 4.6, 100 mM acetate buffer. The reaction was terminated with 250 µL of 100 
mM sodium carbonate and p-nitrophenyl production measured at 410 nm using a 
spectrophotometer (Multiskan RC). The Ki value and IC50 range (at a 1 mM substrate 
concentration) were calculated using the GraphPad Prism curve fitting software. 
3.6.3 The effects of preincubation 
To determine the effects of preincubation on swainsonine inhibition, mannosidase 
activity was determined in the absence of swainsonine (100% activity) and in the 
presence of swainsonine with and without a 30 minute preincubation. Tissue extracts 
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were preincubated for 30 minutes at 37°C without swainsonine and with 1600 nM of 
swainsonine (near to 10 times the estimated Ki). These preincubated extracts were then 
diluted 30 times into substrate and mannosidase activity determined at standard 
conditions (1 mM, pH 4.6, 37 °C, 30 minute incubation). Parallel to this mannosidase 
activity was determined for the same extract with 1600 nM and 48 nM of swainsonine 
(near to 0.3 times the estimated Ki), with the substrate and inhibitor added 
simultaneously, that is without preincubation. 
Similarly, tissue extracts were preincubated for 30 minutes without swainsonine 
(100% activity) and with 800 nM of swainsonine (near to 5 times the estimated Ki), 
and subsequently diluted 5 times into substrate and mannosidase activity determined 
under standard conditions (1 mM, pH 4.6, 37 °C, 30 minute incubation). Parallel to 
this mannosidase activity was determined for the same extract with 800 nM and 160 
nM of swainsonine, with the substrate and inhibitor added simultaneously.  
3.6.4 Standard Mannosidase activity assay 
10 µL of each sample was incubated with 1 mM p-nitrophenyl-α-D-mannopyranoside 
in 100 mM acetate buffer (pH 4.6) in a total volume of 50 µL for 30 minutes at 37°C 
(see supplementary materials for optimisation experiments). The reaction was 
terminated with 250 µL of 100 mM sodium carbonate and p-nitrophenyl production 
measured at 410 nm using a spectrophotometer (Multiskan RC). To ensure accuracy 
all samples were assayed at two dilution points and the average LAM activity 
calculated. Specific activity was determined as the units of LAM over total protein 
(mg), see below. 
LAM activity was determined using this following equation: 
LAM activity (U/mL) = 
(ODsample−ODblank)× total reaction vol (mL)
time× slope× sample vol(mL)
×DF 
 
Units: 1 Unit (U) of LAM will catalyse the conversion of 1 µmole of p-Nitrophenyl-
α-D-mannopyranoside to p-nitrophenol and α-D-mannose per minute at 37°C 




3.6.5 Total protein assay 
Total protein was determined utilising the Thermo Scientific™ Coomassie (Bradford) 
protein assay kit, as per the manufacturer’s protocol. Briefly, 5 µL of each standard or 
sample were mixed with 250 µL of the Coomassie reagent, and the sample incubated 
for 10 minutes at room temperature. The absorbance was measured at 600 nm using a 
spectrophotometer (Multiskan RC). The protein concentration was estimated from the 
BSA standard curve using Microsoft excel. To ensure accuracy all samples were 
assayed at two dilution points and the average total protein calculated. 
3.6.6 AmLAM gene expression 
As per methods outlined in chapter 2. 
3.6.7 Rearing of honey bee larvae and in vivo swainsonine treatment 
Honey bee larvae were exposed to swainsonine via the larval diet. On day 1 first instar 
worker larvae were removed from the comb and each placed into a well of a 48 well 
microtitre plate containing larval diet with or without swainsonine (300 µL of larval 
diet/ well). The larval plates were placed inside a dessicator containing a saturated 
solution of potassium sulphate (60 g/ 400 mL dH2O), and reared at 34.5°C, humidity 
90%. 
To make the larval diet a solution of 2% yeast, 12 % fructose, 12 % glucose was filtered 
(Watman filter paper) and nystatin added for a final amount of 0.15 mg/g of larval diet. 
To this solution swainsonine (Cayman Chemical, 50 mM swainsonine stock in 100% 
ethanol, stored at -20°C) was added for a final concentration of 20 µM or 100 µM, or 
an equal volume of 100% ethanol for the control condition. This solution was mixed 
1:1 (w/w) with royal jelly for the final larval diet preparation. 
On day 2 and day 3, 50 µL of larval diet, with or without swainsonine, was added to 
each well and stirred 10 times. On day 4 developing larvae were transferred to 24 well 
plates using a Taklon brush, each well containing 500 µL of freshly prepared larval 
diet with or without swainsonine. From day 5 until larvae were ready for pupation 75 
µL of larval diet was added to each well, and stirred 10 times.  
On day 8 to 9, when larvae were observed as ready for pupation, larvae were removed 
from the wells using a Taklon brush, excess larval diet removed by gently rolling each 
larva on a clean Kimwipe and then placed on a petri dish and left to defecate (34.5°C, 
humidity 90%). After the larvae had defecated (approximately 6-7 hours) they were 
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transferred into gelatine capsules (diameter 8 mm, volume 1 mL, PST Australia) with 
15 small holes in the lid. Capsules were mounted on small petri dishes and incubated 
at 32°C, humidity 70%. On day 14 of development the capsules were cut to allow the 
newly emerged bees to emerge, which typically occurs from day 17-21. 
Survival was monitored daily and during pupation the colouration of the compound 
eye and thorax27 was assessed from day 15 until each bee began to emerged. Upon 
emergence the newly emerged bees were transferred to a cage, supplied with a diet of 
honey and survival monitored for 5 days. 
3.6.8 Biological material 
For in vitro experiments (Results, Section 3.31) protein extracts were prepared from 
48-96 hour larvae collected from three separate single drone inseminated hives, hive 
1, hive 2 and hive 3 (see Chapter 2, figure S4). Individual larvae were snap frozen in 
liquid nitrogen and stored at -80˚C until protein extraction. For in vivo experiments, 
developing larvae exposed to swainsonine (Results, Section 3.32 and Section 3.33) 
were collected from single naturally mated hive, Canberra, genotypes unknown. 
Larvae were harvested from brood frames taken from the hive and treated as per 3.6.7.  
3.7 LAM activity optimisation 
3.7.1 Optimal pH of LAM assay 
Varying concentrations of substrate, 1.5-3.0 mM, were utilised to assess AmLAM 
activity at pH 4.0, pH 4.6, pH 5.2 and pH 5.6. A previously published protocol18 
utilised a substrate concentration of 2 mM at pH 5.2. Whilst the variation in 
absorbances at these pHs is minimal, it is apparent that the maximal activity is at pH 




Figure S3.1: Optimal pH for the LAM activity assay across four substrate 
concentrations (1.5-3.0 mM). The optimal pH, at which the highest activity occurs, 
was found to be pH 4.6. 
3.7.2 Enzyme kinetics of the LAM activity assay 
To re-optimise the LAM activity assay at pH 4.6 homogenised tissue extract was 
incubated with varying concentrations of substrate and the initial velocity at each 
concentration determined. This was performed using low, medium, high and very high 
concentrations of enzyme, at 37°C, between 1-45 minutes, and the Km found to be 
1164.5 ±159.4 µM, 1214.7 ± 93.4 µM, 1065.87 ±119.6 µM, and 2084.8 ± 249.8 µM 
respectively, utilising GraphPad Prism, see figure S3.2. For low to high enzyme 
concentrations the average Km =1148.4±124.1 µM; a substrate concentration in the 
range of 1024-1272 µM is therefore ideal for the LAM assay, and samples with very 
high enzyme concentrations are to be diluted to fall within the low-high range (OD 
<1.5).   
To optimally perform inhibition assays and to determine LAM activity in A. mellifera 
tissue homogenates should be incubated with 1000 µM of substrate (a concentration 
at or slightly below the Km52) at pH 4.6 at 37°C for 30 minutes, and samples diluted 











































Figure S3.2 Enzyme kinetics of the LAM assay (previous page). Velocity vs substrate concentration for the LAM assay at pH 4.6. To 
determine the Km of the LAM activity assay four concentrations of enzyme (designated very high, high, medium and low) were used to 
determine the initial velocity of each reaction at different concentrations of substrate. Km estimates were determined as one-half the 









































Km= 1214.7 ± 93.4µM 
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Preliminary insights into AmLAM function and epiallelic variation 
 
4.1 Introduction 
The availability of new sequencing technologies has revolutionised the way in which 
we can analyse DNA methylation. We can now determine genome-wide levels of 
methylation with relative ease, and can perform in-depth analyses of differentially 
methylated regions, such as in chapter 2. The difficulty now lies in assigning function 
to such DMRs, and the variability and context-dependent nature of differential 
methylation adds to this difficulty.  
During the course of our study into AmLAM epiallelic variation and the link between 
these epialleles and phenotype, a number of novel hypotheses were explored. Chapter 
3 involved exploring the role of AmLAM in larval growth using a knockdown strategy. 
Within this chapter several additional lines of investigation are presented, providing 
preliminary insights into AmLAM function and epiallelic variation.  
4.2 Results and discussion 
 
4.2.1 LAM isoform expression 
 
In D. melanogaster two LAM isoforms have been reported, namely, two alternatively 
spliced isoforms incorporating either exon 7 (isoform 7) or exon 8 (isoform 8). We 
analysed these transcripts and found that across all stages these transcripts are co-
expressed, without any clear differences between AmLAM expression and the 
expression of isoform 7 or 8, within an individual (see figure 4.1).  
The co-expression of the alternatively spliced AmLAM isoforms, which reflect the expression 
patterns of the general AmLAM expression shown in chapter 2, suggest that neither of the 
isoforms are tissue- or developmental-specific, at least not in contexts analysed here. In our 
preliminary study single replicates were analysed across development, and additional 
individuals analysed for queen (n=4) and worker (n=4) larvae at 96 hours (see Figure 4.1C). 
The expression of these isoforms has not yet been analysed in the context of the AmLAM 
epialleles, and it would be interesting to assess if the epialleles correlate with the expression 










































































































































Figure 4.1: Expression of alternatively spliced AmLAM transcript variants. The 
expression of AmLAM and two isoforms, incorporating either exon 7 or exon 8 by qPCR  in 
A) worker larvae, B) drone larvae and C) adult gonads and 96 hour queen and worker larvae. 
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All results are relative to a pooled pupal sample and normalised against CAM and TBP 
transcript levels. 
4.2.2 A role for AmLAM in sperm-egg interactions and fertility? 
The finding that AmLAM is moderately-highly expressed in the honey bee testes led 
us to investigate whether there was a potential role for LAM in fertility. 
Honey bee queens are polyandrous, mating with several drones early in their life and 
storing sperm in a specialised organ known as a spermathecae. This ability to store 
sperm long term has led to significant research into the role of the spermathecal and 
seminal fluids in maintaining sperm cell viability1, 2, and LAM is one of many proteins 
that have been identified in the honey bee seminal fluid1. 
The multiple-mating of honey bee queens and the subsequent storage of sperm from 
multiple drones will lead to sperm competition, and components of the seminal fluid 
are known to influence such competition in social insects3. These findings, coupled 
with evidence from mammals demonstrating a role for α-D-mannosidase in sperm-egg 
interactions, albeit non-lysosomal forms4, led us to investigate whether lysosomal α-
mannosidase enzyme activity was detectable in sperm or seminal fluid. 
Within the first week of a drone’s adult life sperm cells migrate from the testes to the 
seminal vesicles, where further maturation occurs. Immature drones are defined as 
those whose sperm has not yet migrated to the seminal vesicles and whose testes are 
visibly large, mature drones as those whose testes are small but with some residual 
sperm cells, and very mature drones as individuals whose sperm has completely 
migrated to the seminal vesicles and whose testes are very small.  
We determined LAM enzyme activity in the testes and seminal vesicles of immature 
(N=5), mature (N=3) and very mature (N=3) drones. Little activity was detected in the 
seminal vesicle across any age, and the highest activity was detected in the testes of 
immature drones, suggesting that the high activity is associated with immature sperm 
cells or the testes, rather than seminal fluid itself (see figure 4.2A). Activity in the 
testes of immature drones was significantly higher than in mature (t(6)= 2.45, p= 
.0009) or very mature drones (t(6)= 2.45, p= .0007). No significance difference was 
found between immature, mature or very mature drones (F(2,8)=2.11, p=.18, by one-
way ANOVA). To test this further we pooled semen from the seminal vesicles of a 
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number of mature drones (N=10/pool, one pooled sample analysed) and determined 
LAM activity associated with sperm cells and seminal fluid, together with the mucous 
glands. We found a low level of activity in both sperm and seminal fluid fractions, 
with the highest activity found in the mucous glands (see figure 4.2B).  
This suggests that the recent identification of the LAM protein in honey bee seminal 
fluid1 may be primarily due to mucous gland secretions, rather than the seminal fluid 
itself. These findings show that LAM activity in sperm cells and seminal fluid is not 
high. Of course, the low activity does not negate the possibility that LAM is involved 
in sperm competition in some way, and the high activity found in the mucous glands 
could in fact indicate that there is a role for LAM in fertility. A similar study analysing 
LAM activity in genotyped drones might provide greater clues as to whether the 
AmLAM epialleles increase LAM activity in the semen or mucous glands of drones.














































Figure 4.2: LAM enzyme activity the testes, seminal vesicles and components of drone 
semen. A) Comparison of the relative activity of LAM in testes and seminal vesicles of 
immature, mature and very mature drones. B) Comparison of the relative activity of LAM 
found in seminal fluid, sperm cells and mucous glands.  
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4.2.3 A potential AmLAM genotype bias in queens 
In chapter 2 we identified several AmLAM epialleles that correlate with changes in 
AmLAM gene expression during early larval development. This correlation, between 
the methylated alleles and an increase in gene expression occurs in 48 hour old larvae, 
but not during pupal or adult stages. The additional finding in chapter 3 that an 
inhibition of LAM slows larval growth suggests that LAM has an important role in 
larval metabolism. During early larval development key transcriptional switches occur 
in response to diet, which lead to the development of a queen or worker. Any variation 
in LAM function due to epiallelic variation at such early stages could have an impact 
on queen or worker development.  
Here, we assessed the frequency of genotypes across two hives utilised in chapter 2, 
hives 1 and 2, to determine whether genotype biases exist. We found that whilst there 
was no bias amongst workers there may be a bias in genotype amongst queens (see 
Table 4.1). Given the small numbers of queens produced within a hive this observed 
genotype bias remains preliminary, but the bias towards heterozygous individuals of 
the LAMC+CT/ LAMCΔGA genotype, rather than the LAMC+CT / LAMC+CT genotype, 
where both alleles are methylated, suggests that the former genotype is somehow 
advantageous for queen development.  
Given the expressional differences observed at 48 hours it may be that a lower 
AmLAM expression level in early stages of development is beneficial for queen 
development, or it is possible that the AmLAM epialleles may affect queen survival 
or the digestion of royal jelly, leading to such biases. Examining additional hives for 
genotype biases and analysing the rate of growth and survival of queens would provide 
some interesting clues as to how the AmLAM epialleles might affect queen 
development.    
Table 4.1: AmLAM genotype frequencies across two hives 
 Genotype Worker Queen 








Hive 2 LAMC+CT/LAMT+GT 0.49 
(N=20/41) 
- 





4.2.4 No correlation between the AmLAM epialleles and LAM enzyme activity 
 
Whilst we have found correlations between the AmLAM epialleles and transcriptional 
differences we have not observed any correlations with phenotype. Indeed, the 
differences in AmLAM expression observed in chapter 2 may not necessarily have an 
effect at the protein level. To gain insight into whether the AmLAM epialleles 
influence phenotype we analysed the activity of LAM in genotyped individuals.  
Worker and queen larvae, between the 72-96 hour stages, were analysed across hives 
1 and 2. We did not find any correlation between genotype and LAM enzyme activity 
(see figure 4.3A-C) nor did we find any differences in the effects of swainsonine on 
this activity (figure 4.3D). In hive 1 worker larvae no significant difference was 
observed between genotype (M(+/-) =823±84U/mg, n=4; M(+/+)=690±102 U/mg, 
n=2; t(2)=4.30, p=.25, see Figure 4.3A). Nor were any difference found between hive 
2 worker larvae (M(-/-)=291±35 U/mg, n=4; M(+/-) =310±71 U/mg, n=2; t(1)=12.7, 
p=.78, see figure 4.3B) or hive 1 queen larvae (M(+/-)=392±95 U/mg, n=3; 
M(+/+)=376±65 U/mg, n=2; t(3)=3.18, p= .84, see figure 4.3C). This indicates that the 
AmLAM epialleles are unlikely to, at the 72-96 hour larval stage, have an effect on 
LAM activity. 
It is important to note that the analysis of LAM activity in genotyped 48 hour larvae, 
the stage at which a correlation between genotype and expression has been shown, was 
not possible at the time of this analysis. As such, it is difficult to definitively say that 
the AmLAM epialleles do not have an effect on LAM enzyme activity, and analysing 
individuals at this critical developmental stage is of great interest.  
Additionally, the significant difference in total LAM enzyme activity between worker 
and queen larvae in hive 1 requires further investigation. Workers in hive 1 
(M=779±105 U/mg) present with an almost two-fold higher level of LAM enzyme 
activity than queens (M=386±75 U/mg; t(9)=2.26, p<.00001), suggesting that caste-
specific differences in LAM activity occur. However, the similar level of enzyme 
activity in hive 2 worker larvae (M=287±43 U/mg) to hive 1 queen larvae indicates 
that other factors, such as age- or hive-specific effects on LAM enzyme activity occur. 
Comparing LAM activity in age-matched worker and queen larvae from controlled 





Figure 4.3: LAM enzyme activity and swainsonine sensitivity in genotyped individuals. 
LAM enzyme activity was determined in worker larvae (A) and queen larvae (B) from hive 1 
and in worker larvae from hive 2 (C). The sensitivity of larval extracts to swainsonine (D) was 




























































































































































4.2.5 Acute exposure to swainsonine in newly emerged bees 
 
In chapter 3 we found that the honey bee is sensitive to the alkaloid swainsonine and 
demonstrated that a prolonged exposure during larval development is toxic and results in the 
death of newly emerged bees. Given that adult bees are most likely to be exposed to 
swainsonine we tested the effects of a high, acute exposure to swainsonine in newly emerged 
bees. 
To simulate an acute exposure to swainsonine newly emerged caged bees were topically 
exposed to an acute dose of swainsonine (10 mM). All treated individuals (n=30) survived 
treatment, and no obvious behavioural differences were observed between treated and 
untreated individuals 24 hours after exposure. Whilst no clear phenotypic effects were seen 
analysis of mannosidase activity in the brains and fat bodies of treated individuals indicate that 
an acute exposure to swainsonine causes a significant decrease in mannosidase activity; in 
both brain (t(5)= 2.57, p=.04) and fat body tissue (t(5)= 2.57, p=.02) mannosidase activity was 
significantly higher in untreated individuals when compared with treated individuals (~1.6-3.1 
fold higher level of activity, see figure 4.4), indicating that an acute exposure inhibits 
mannosidase activity. 
The changes in mannosidase activity in response to swainsonine without apparent toxicity are 
not unexpected given that the toxic effects of swainsonine are typically observed after a 
prolonged exposure to the alkaloid. Acute exposure to swainsonine has been shown to increase 
serum swainsonine levels and alter other metabolic indicators without the onset of ‘locoism’ 
in sheep5. The transient inhibition of mannosidase activity in the bee following an acute 
exposure, whilst not lethal or able to induce toxicity, may result in a temporary alteration in 
metabolic activity that could result in diminished health.  
Given that swainsonine decreases mannosidase activity in the brain, assessing the neurological 
effects of swainsonine treatment in adults is of interest. With both an acute and prolonged 
exposure, at swainsonine concentrations near to the likely environmental dose, the proboscis 
extension reflex (PER) assay could be utilised to assess any effects on learning and memory, 
and locomotor behavioural assays could be used to determine if treatment affects locomotion. 
Comparing these effects in newly emerged bees to older foragers could provide an indication 
as to whether older foragers are better able to resist the effects of swainsonine, or are in fact 













Figure 4.4: Mannosidase activity in newly emerged bees after an acute exposure to 
swainsonine. To simulate an acute exposure to swainsonine ~1 µL of 10 mM swainsonine 
was applied to the thorax of newly emerged bees, and mannosidase activity analysed in brain, 
fat body and whole gut 24 hours after exposure. Mannosidase activity was significantly higher 
in the brains (t(5)= 2.57, p=.04) and fat bodies (t(5)= 2.57, p=.02) of untreated individuals, the 




Within this chapter several novel lines of evidence have been explored, presenting some 
preliminary insights into LAM function. The studies presented here represent several small 
pilot studies; in many cases the limited availability of biological materials restricted the 
analysis of large sample sizes. As such the findings within this chapter are preliminary, but do 
offer some novel insights into LAM function and the effect of the AmLAM epialleles. 
The co-expression of the two alternatively spliced isoforms will be interesting to explore in 
the context of the AmLAM epialleles, as will the identified genotype biases observed in 
queens. Importantly, while correlations between the AmLAM epialleles and transcriptional 
changes have been made, it would be of great interest to demonstrate a correlation between 
these epialleles and LAM enzyme activity. Additionally, our findings that swainsonine reduces 
mannosidase activity in adult brain and fat body indicates that the sensitivity of the honey bee 
to this alkaloid should be investigated further.
A c u t e  e x p o s u r e  t o  s w a in s o n in e  in  n e w ly  e m e r g e d  b e e s
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4.5 Materials and methods 
 
4.5.1 AmLAM and AmLAM isoform expression analysis (methods for section 4.2.1) 
To synthesise cDNA 2.5 µg of total RNA was incubated with 1 µL of 50 mM oligo(dT) 
primer at 80°C for 5 minutes, and immediately placed on ice. In a total reaction volume 
of 20 µL, 4 µL of RT buffer (250 mM Tris-HCl (pH 8.3 at 25°C), 375 mM KCl, 15 mM 
MgCl2, 50 mM DTT), and 1 µL of 10 mM dNTPs were added to each preparation. 
Samples were incubated at 50°C for 2 min, 1 µL of Maxima reverse transcriptase added, 
and further incubated at 50°C for 30 minutes. The cDNA preparation was diluted 3X in 
TE, and further diluted 1:10 in dH20 for analysis. All cDNA samples were analysed in 
triplicate. 
 2µL of the diluted cDNA was amplified in a final volume of 20µL with reaction 
components in the following final concentrations: 1X Colourless GoTaq® Flexi Buffer, 
1µM of each primer, 2.5mM MgCl2, 0.1mM of each dNTP, 0.25X SYBR® green I 
(1:1000), and 1.25U of GoTaq® Hot Start Polymerase. All RT-PCR experiments were 
performed utilising the Applied Biosystems® StepOnePlus™ Real-Time PCR System, 
with the following cycling conditions:  Initial denaturation at 95°C for 5 min, followed by 
40 cycles of 95°C for 15 s, 60°C for 20 s, 72°C for 30 s, and a final melt curve analysis 
step. Amplified products were analysed via gel electrophoresis to confirm a single 
product. 
Efficiencies for the target and reference amplicons were calculated utilising a 4-fold serial 
dilution. The efficiencies for the AmLAM target (E=1.92, R2=0.996), isoform 7 target 
(E=1.85, R2=0.982), isoform 8 target (E=1.96, R2=0.991) and reference genes CAM 
(E=2.03, R2=0.998) and TBPQ (E=1.98, R2=0.996) were close to 100%, but as the 
efficiency for the isoform 7 target was lower relative expression was calculated using the 
efficiency values (E−ΔΔCT), as previously described (Livak and Schmittgen, 2001). Primer 
sequences for the AmLAM, TBP and CAM targets were as per Table S2, chapter 2, and 
isoform 7 and 8 targets amplified using the primers listed in table 4.1 of this chapter. 
Table 4.1: Primers used for AmLAM isoform analysis 
 126 
 
Target Primer sequence 
Isoform 7 Forward: TATCAACAAGCGGAAATGTACT 
Reverse: TTAAGTAGCACGATGGTGTAGA 
Isoform 8 Forward: ACATGCTGAAATGTGGTTCACT 
Reverse: CGTCATCTTTCGTCGTCCATTG 
 
4.5.2 Preliminary LAM activity assay (methods for section 4.2.2) 
A preliminary p-nitrophenyl-α-D-mannopyranoside based assay was adapted from a 
previously published protocol6, where the optimal pH for LAM activity was determined 
to be pH 5.2 (100mM acetate buffer), at 37°C with p-nitrophenyl-α-D-mannopyranoside 
at a concentration of 2 mM. All samples were homogenised in a PBS solution (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) containing 1mM ZnCl2 and 
cOmplete™, EDTA-free protease inhibitor cocktail (1X; Roche), henceforth referred to as 
homogenisation buffer.  
Testes and seminal vesicles were dissected from immature and mature drones, 
homogenised in 250 µL of chilled homogenization buffer, centrifuged at 16 100 x g for 
15 minutes at 4°C, supernatant collected and analysed undiluted and diluted 1:2 and 1:4. 
Semen was collected from the seminal vesicles of 10 mature drones with a syringe and 
suspended in 200 µL of homogenization buffer, and the sample was centrifuged at 900 x 
g to pellet sperm cells. Sperm cells were homogenised with a pestle in 100 µL of 
homogenization buffer and analysed undiluted. The supernatant containing the seminal 
fluid fraction was removed, centrifuged for 10 minutes at 4°C to remove residual sperm 
cells and concentrated 5X using a column (spun at 12000 x g for 24 minutes at 4°C). The 
mucous glands of these same drones were dissected and homogenized in 200 µL of 
homogenization buffer for parallel analysis. 
10 µL of each sample was incubated with 2 mM p-nitrophenyl-α-D-mannopyranoside in 
100 mM acetate buffer (pH 5.2) in a total volume of 50 µL for 1-2 hours at 37°C, together 
with a blank (10 µL + 40 µL of dH2O) and serially diluted nitrophenol standard. The 
reaction was terminated with 250 µL of 100 mM sodium carbonate and p-nitrophenyl 
production measured at 410 nm using a spectrophotometer (Multiskan RC). The 
concentration of p-nitrophenyl was determined for each sample, and where multiple 
dilutions were assayed the average concentration calculated. One unit of lysosomal α-
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mannosidase activity is defined as the amount of enzyme that catalyses the release 1 μmol 
of p-nitrophenol in 1 min at 37 °C. Results are expressed as the total number of AmLAM 
units per mL of homogenised tissue. 
4.5.3 AmLAM genotyping (methods for section 4.2.3) 
Genotyping was performed as per section 2.2, see methods, subheading “genotyping”, 
page 33. 
4.5.4 Standard LAM activity assay (methods for section 4.2.4 and 4.2.5) 
10 µL of each sample was incubated with 1 mM p-nitrophenyl-α-D-mannopyranoside in 
100 mM acetate buffer (pH 4.6) in a total volume of 50 µL for 30 minutes at 37°C. The 
reaction was terminated with 250 µL of 100 mM sodium carbonate and p-nitrophenyl 
production measured at 410 nm using a spectrophotometer (Multiskan RC), and LAM 
activity calculated as per the equation outlined in chapter 3. To ensure accuracy all 
samples were assayed at two dilution points and the average LAM activity calculated. 





Insights from AmLAM epialleles 
 
5.1 General discussion and future directions 
  
Elucidating the extent to which the underlying genetic sequence influences epigenomic 
states and phenotype is fundamental to understanding the heritability of complex traits 
and disease. Extensive work in mammals and plants demonstrates that cis- and trans-
acting polymorphisms influence a number of epigenetic states, including DNA 
methylation and histone modifications, and that these genotype-driven epigenomic 
differences mediate phenotypic variation. Here, we have demonstrated that such 
genotype-driven epiallelic variation also occurs in the honey bee. 
The honey bee is a widely-studied model organism from which we can understand how 
epigenomic processes guide phenotype. Intragenic DNA methylation in the honey bee 
frequently occurs across ubiquitously expressed genes, and this methylation has been 
shown to modulate transcription in a number of contexts1, 2. Many associations between 
differential DNA methylation and phenotype have been made, including differences in 
colony fitness, task specialisation, learning and memory. Our discovery of differentially 
methylated obligatory epialleles reiterates the need to interpret any associations between 
differential methylation and phenotype in the context of the underlying DNA sequence.  
Given that near to 220,000 SNPs across the honey bee genome have the potential to 
influence DNA methylation, these effects may be startling. Indeed, a recent study also 
identified ASM in the honey bee, and has highlighted how such ASM is likely 
confounding investigations into parent-of-origin effects on DNA methylation3. The next 
challenge will be to identify the extent of ASM genome-wide in the bee and integrate such 
analyses with those of other epigenetic marks, such as histone-modifications, and their 
effects on the honey bee transcriptome. 
The correlation between the LAM epialleles and context-dependent transcriptional 
changes also provides insight into the role of DNA methylation in the honey bee. Across 
many organisms, including the bee, high gene body methylation correlates with regions 
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that are actively transcribed1, 4-8. In our study the highly methylated state correlates with 
an increase in the expression of the LAM transcript during early larval stages, as well as 
an increase in the expression of a lncRNA antisense transcript, reaffirming the view that 
gene body methylation correlates with active transcription. Furthermore, the expression 
of this lncRNA transcript aligns with evidence in mammals, where it has been shown that 
intragenic DNA methylation can modulate the expression of microRNAs and lncRNA 
transcripts9-11.  
We have shown that LAM is ubiquitously expressed, with variation across certain 
developmental stages and tissue types. Of interest is the high level of LAM expression 
found in the larval gut, which may occur due to LAM being involved in the digestion of 
larval diet. Experimentally manipulating the larval diet, by altering the ratio of royal jelly 
to glucose and fructose for instance, or by starving developing larvae and subsequently 
analysing LAM expression could provide insight into whether this is the case. Additional 
exploration of whether LAM might be involved in the digestion of more complex diets, 
such as pollen, might also be an interesting avenue to explore. 
Importantly, during metamorphosis the larval gut undergoes significant change, and high 
levels of apoptosis have been observed12. LAM is likely involved in general cell turnover, 
and in those tissues where significant levels of apoptosis are occurring a high expression 
of LAM is not unexpected. Could the high expression of LAM in the larval gut reflect 
such change during metamorphosis, rather than a role for LAM in the digestion of diet? 
Possibly, determining if there is a correlation between LAM expression and apoptosis 
would shed light on this. 
Of course the question remains, what effect do the LAM epialleles have on fitness? We 
have shown the epialleles modulate expression in a context-dependent manner, but have 
yet to show that these expressional differences have a direct effect on LAM activity or 
phenotype. The transcriptional effects seen in young larvae and the observed genotype 
bias in queen larvae suggests that such effects on fitness may occur during larval 
development, and should be explored further.  
Our knockdown of LAM using the alkaloid swainsonine suggests that an inhibition of 
LAM activity slows larval and pupal growth, and causes locoism and death in newly 
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emerged bees. This delay in growth might suggest that LAM regulates metabolic rate in 
some way, but these effects may also be a function of the general toxicity of swainsonine 
to the honey bee. As such, it is difficult to draw definitive conclusions as to the potential 
effects of the LAM epialleles from these experiments, but these results do present some 
interesting possibilities.  
If the LAM epialleles cause differential LAM activity during larval development and 
modulate the rate of larval growth or the response of larvae to diet, this would certainly 
generate phenotypic variation and, as discussed in chapter 3, could result in differences in 
task specialisation, for instance. Given that a deficiency of LAM during development is 
lethal, would the lower expression of LAM during early development, as seen in 
individuals of a given epigenotype, have detrimental effects on fitness? Or alternatively, 
could the increased LAM expression in those carrying the methylated alleles provide a 
selective advantage for those larvae? Comparing the metabolic activity and growth rate of 
larvae with the LAM epialleles and determining whether differences in eventual task 
specialisation occur, such as a greater tendency to become precocious foragers, could 
provide insight into whether this is the case.  
Differences in the metabolic activity of workers, queens and drones exist, and each caste 
is reared on a distinct larval diet13. The additional finding in chapter 4 that genotype biases 
might exist amongst queens, and that differential LAM activity might occur between 
queens and workers of a similar age could imply that LAM activity is caste specific and 
that queen development is more sensitive to fluctuations in LAM activity. Of course, the 
findings from chapter 4 are preliminary, and between-hive differences indicate additional, 
unknown factors, may affect LAM activity during larval development. Comparing LAM 
expression and activity in carefully age-matched individuals from distinct epiallelic 
backgrounds is essential to understanding if between-hive, age- or caste-specific effects 
are confounding our findings.  
One of the difficulties associated with controlling for genetic background by using single 
drone-inseminated hives is the instability associated with these colonies14. Our use of SDI 
hives in chapter 2 was integral to the identification of the obligatory methylated LAM 
epialleles, but also prevented us from performing in-depth studies of their effects on larval 
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growth or colony fitness. Establishing hives from queens inseminated with the semen of 
3-4 drones could improve the stability of the hive, whilst still controlling for genetic 
background.  
Using such multiply-mated hives, we could then determine the rate of larval growth in 
workers and queens of distinct epigenotypes and assess any biases in survival or adult task 
specialisation amongst colony members. Such an investigation would allow for a greater 
understanding as to why the differentially methylated LAM epialleles have persisted in 
the honey bee population and provide insights into how the LAM epialleles influence 
phenotype.  
5.2 Conclusions 
Our identification of methylated obligatory epialleles within the honey bee population is 
the first such example identified within this species. This finding highlights the need to 
shift the way we interpret the relationships between DNA methylation and phenotype in 
this organism. Whilst the honey bee remains a wonderful model from which we can 
understand the contribution of epigenomics to phenotype, without properly integrating all 
aspects of this process, namely the underlying sequence, epigenetic marks and relevant 
environmental signals, we run the risk of misinterpreting the role for marks such as DNA 
methylation in directing transcriptional changes.  
High genetic variability amongst individuals within a hive is integral to maintaining 
colony fitness. Our knockdown of LAM activity suggests that the LAM epialleles might 
introduce variability in the metabolic rate of colony members, which would be 
advantageous for a colony that must respond to a range of external and internal cues. 
Additionally, although somewhat tangential to our initial aims, the discovery that the 
honey bee is sensitive to the alkaloid swainsonine, highlights the need to investigate the 
extent to which this toxin may affect honey bee health. The future investigation of both 
these avenues of research will provide some interesting insights into honey bee biology 
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6.1 DNA Methylation and Gene Regulation in Honeybees: From Genome-Wide 
Analyses to Obligatory Epialleles 
 
Chapter 1 of this thesis was incorporated into the book chapter: 
Wedd, L. Maleszka, R (2016) DNA Methylation and Gene Regulation in Honeybees: 
From Genome-Wide Analyses to Obligatory Epialleles. In: Advances in Experimental 
Medicine and Biology, Volume 945, Eds. Jeltsch, A. & Jurkowska, R. Springer 
International Publishing Switzerland 
DNA Methylation and Gene Regulation in Honeybees: From Genome-Wide Analyses to 
Obligatory Epialleles describes work contained within this thesis, together with additional 
work performed by the Maleskza laboratory. It includes a theoretical discussion by 
Ryszard Maleszka, and is presented here to provide the reader with deeper insight into 
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Abstract                      In 
contrast to heavily methylated mammalian genomes, invertebrate genomes are only sparsely 
methylated in a ‘mosaic’ fashion with the majority of methylated CpG dinucleotides found 
across gene bodies. Importantly, this gene body methylation is frequently associated with 
active transcription, and studies in the honeybee have shown that there are strong links 
between gene body methylation and alternative splicing. Additional work also highlights that 
obligatory methylated epialleles infl uence transcriptional changes in a context-specifi c 
manner. Here we discuss the current knowledge in this emerging fi eld and highlight both 
similarities and differences between DNA methylation systems in mammals and 
invertebrates. Finally, we argue that the relationship between genetic variation, differential 
DNA methylation, other epigenetic modifi cations and the transcriptome must be further 
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Amongst all fields of biomedical research, it is ‘epigenetics’ that is emerging as a principal 
discipline bridging the gap between genotype and phenotype. One reason for such a 
prominent standing of epigenetic concepts in modern biology is the flexible and ever-
expanding definition of what the term ‘epigenetics’ actually means. Over 70 years ago, 
Waddington originally introduced the word ‘epigenetics’ (derived from the word ‘epigenesis’) 
as ‘a suitable name for the branch of biology which studies the causal interactions between 
genes and their products which bring phenotype into being’ (Jablonka and Lamb 2002). This 
new definition implied that translating the genetic blueprint into a functional organism 
requires a control system whose mode of action is over and above, or in addition to, the 
classical genotype. His ideas were incited by the realisation that phenotypes are remarkably 
stable in spite of environmental pressure, a phenomenon that he referred to as 
developmental canalisation, whereby development is buffered against environmental or 
genetic variation by evolutionarily selected gene networks. He illustrated this concept by the 
famous epigenetic landscape with valleys or channels representing the optimal 
developmental trajectories. The key idea behind this imaginary topography is that a set of 
instructions carving the trajectory towards an optimal phenotype is selected by responses to 
recurring environmental insults in an organism’s adaptive niche (Waddington  1957) . 
Phenotypic plasticity is another feature of the living world, distinct from canalisation but 
equally important, that also is independent of the underlying DNA sequence. Cellular 
differentiation in multicellular organisms or phenotypic polymorphisms in social insects are 
generated by epigenetic mechanisms, not by genetic differences. These two contrasting 
aspects of phenotypic changeability that are uncoupled from genetic variation are central to 
the study of epigenetics. At present, epigenetics is a very wide fi eld of study, covering 
virtually all aspects of biology ranging from morphogenesis to transgenerational epigenetic 
inheritance. For more detailed discussions on the origins and changing concept of 
epigenetics, see recent review and opinion articles (Jablonka and Lamm 2012; Haig  2004,  
2012) .  
In modern times the distinction between genetic and epigenetic control system has been 
associated with specific biochemical processes. Typically, DNA methylation and histone 
modifications are itemised as epigenetic mechanisms, but non- coding RNAs, chromatin 
remodelling and even prions are often included (Halfmann and Lindquist 2010). In this 
context, it is worth noting that only DNA methylation is part of the DNA molecule chemical 
DNMT DNA methyltransferase 
LAM Lysosomal alpha-mannosidase 
MeCP Methyl-CpG-binding factor 
miRNA microRNA small non-coding RNA of about 22 
nucleotides 
mRNA messenger RNA 
PTM Post-translational modification 
RdDM RNA-directed DNA methylation system 
TET Ten-eleven translocation enzyme 
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entity. It is thus clearly distinguished from other epigenetic mechanisms, such as chromatin 
modification and non-coding RNAs, which are associated with, but separate from, DNA. For 
over 50 years DNA methylation, or more specifically cytosine methylation, has been studied 
extensively in mammals, initially as a mechanism of gene silencing via hyper- methylation of 
promoters associated with the CpG islands and later as a genome-wide modification. In 
contrast, only a couple of studies in the late 1990s have shown that 5-methylcytosine can be 
detected in DNAs extracted from various invertebrate species (Tweedie et al.  1997; Regev et 
al.  1998), and it is largely through the recent honeybee genomic research that methylomics 
took a centre stage as an important mechanism of gene regulation in insects and 
invertebrates. In this article, we discuss DNA methylation as part of gene regulatory system in 
invertebrates, with special reference to the honeybee, Apis mellifera . 
 
Genotype to Phenotype  
The existence of a multicellular organism depends upon the transformation of an apparently 
simple, static genetic ‘code’ into function. With perfect timing the genetic information 
contained within that first single cell is translated into a series of complex cellular signals that 
guide development. As each cell differentiates, unique transcriptional profiles are established 
and their functional roles are specified. This transition from genotype to phenotype, termed 
epigenesis , is infinitely complex and results from interactions between the underlying 
genetic sequence, chemical modifications on DNA and chromatin and environmental cues. 
Yet, how exactly do these layers of information contribute to establishing phenotype?  
 Foremost, the DNA sequence itself interacts with the transcriptional machinery to produce 
the multitude of proteins necessary for a functioning organism. The human genome, for 
instance, encodes approximately 21,000 protein-coding genes whose sequences are 
transcribed to generate our proteome (Clamp et al.  2007). Gene transcription occurs when 
RNA polymerase II (RNA Pol II) interacts with these genomic regions to produce a transcript. 
This is governed by numerous functional elements, such as enhancers or promoters, 
associated with the coding regions that interact with various activators and transcription 
factors to facilitate the assembly of the pre-initiation complex and subsequent transcription 
by RNA Pol II (Fig.  1) . 
Importantly, to generate the full repertoire of proteins required to build a complex and fully 
functioning organism, each gene must be expressed in a precise spatio-temporal pattern. To 
achieve this, numerous control mechanisms have evolved to tightly regulate transcription. 
These range from modulating transcription initiation and elongation, which can alter whether 
a gene is expressed or not and how a transcript is processed, to post-translational processes 
that can, for instance, fi ne-tune the level of a transcript through the degradation of an mRNA 
product. In addition, epigenetic control systems have evolved to coordinate the action of 
thousands of genes and to provide an interface between the genome and environment. Each 





Fig. 1 General model of transcription in the honeybee showing the key elements involved in the initiation and elongation 
of pre-mRNA. Splicing is assumed to occur co-transcriptionally with DNA methylation affecting the conditional usage of 
weak exons. In insects, methylated cytosines have been found predominantly in intragenic regions, often in proximity of 
splice sites. DNA methylation may affect binding kinetics of sequence-specific factors (DBP) either by disrupting their 
binding, as in the CTCF model (Shukla et al.  2011), or by recruiting methyl-CpGbinding factors such as MeCP2 (Maunakea 
et al.  2013). In both models, such factors promote exon recognition either by pausing the spliceosome/RNA pol II 
complex (Shukla et al.  2011) or by recruiting histone deacetylases to maintain low acetylation levels of alternatively 
spliced exons, which could reduce transcription elongation (Maunakea et al.  2013). TF- transcription factor 
 
The Epigenetic Control of Gene Expression  
Epigenetics encompasses those mechanisms and processes that are involved in facilitating 
transcriptional changes via various covalent modifications made to DNA itself or the histone 
proteins around which DNA is wrapped; these post-translational modifications (PTMs) are 
numerous and include methylation, acetylation, phosphorylation, ubiquitination and many 
other PTMs. The manner in which these modifications can influence transcription is complex, 
and it is likely that a given mark can lead to both gene activation and repression, depending 
on its location and the genomic context (Kouzarides 2007;  Jones  2012) . Importantly, none 
of these modifications works in isolation, instead they interact together to produce a unique 
epigenetic cellular ‘signature’.  
 This signature, termed a cell’s epigenome, describes all epigenetic modifications found 
across the genome. For each cell type within an organism, and across different 
developmental stages and disease states, the epigenome will vary, leading to a vast number 
of possible epigenomes (Bernstein et al.  2007). Through analysing patterns of DNA 
methylation, histone modifications, chromatin accessibility and RNA expression across 
diverse cell lineages, human epigenomic maps are being catalogued (Kundaje et al.  2015;  
Bernstein et al.  2010). These large-scale pursuits are leading to a greater understanding of 
how the epigenome contributes to cell specification and development and how alterations to 
the epigenome contribute to disease and phenotypic variation. However, defining the exact 
role that a given epigenetic modification plays in directing transcriptional changes still 
remains a challenge. This difficulty will be discussed here in the context of one of the 
extensively studied epigenomic modifications, DNA methylation. 
DNA Methylation  
In all vertebrates and in the majority of invertebrates, the cytosine nucleotide in DNA can be 
modified by the addition of a methyl group to its 5-carbon. This modification typically occurs 
at cytosines in CpG dinucleotides and is prevalent in mammalian genomes where up to 80 % 
(over 20 million) (Smith and Meissner  2013 ) of cytosines in the CpG context are methylated 
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(Bird  2002) . In comparison, the proportion of methylated CpGs in insect genomes is an 
order of magnitude lower ranging from approximately 0.1 to 1 % (Lyko and Maleszka  2011). 
The realisation that this covalent modification could stably propagate information 
throughout development led to considerable research into its role as an epigenetic mark 
(Holliday and Pugh  1975;  Riggs  1975) . It has since been shown that DNA methylation plays 
a key role in biological processes such as X-inactivation, genomic imprinting and transposon 
silencing across a number of organisms. In each of these instances, methylation is engaged in 
gene silencing, and this remains one of the more commonly considered functions of DNA 
methylation. This is evident in mammals where the methylation of promoter regions has long 
since been associated with gene repression (Jones and Takai  2001) . However, considerable 
variation in the distribution of methylation across organisms and additional evidence that 
methylation associates with active transcription indicates that the relationship between DNA 
methylation and transcription is complex and not fully understood. Insight into its 
functionality can be gained through understanding how DNA methylation patterns are 
established and by analysing the evolutionary origins of this mark and its genomic location 
(Suzuki and Bird 2008 ; Regev et al.  1998).  
 Box: Epigenetics and Epigenomics  
• Epigenetics is a broad term that covers many areas of biological research that involve 
gene regulation. It includes both heritable and non-heritable chemical modifications, 
such as DNA methylation and hydroxymethylation, histone modifications, microRNAs 
and non-coding RNAs. 
• Epigenetic processes can be defined as control systems that combine a number of 
epigenomic modifications whose actions, responsive to both internal and external 
environments, underlie the self-organising properties of gene networks. 
• Epigenomics is a study of genome-wide modifications of DNA and chromatin that 
allows mapping the epigenetic status of all genes in a context- dependent manner, e.g., 
in various tissues or throughout development. Each organism has hundreds of 
epigenomes, minimally one for each cell type. 
• The epigenetic status of a gene can be altered through environmental events such as 
changes in diet or exposure to toxins often resulting in disease. 
 
Table. 1 Examples of mosaic distribution of DNA methylation toolkit in selected metazoan species 
 Lineage   Species  
 DNMT  
 TET  
M ethyl  
CpGs   1   3  
Mammalia  All  ●   ●●●    ●●●     Yes  
Hymenoptera Apis mellifera 
 (honeybee)  
●●    ●   ●    Yes  
Nasonia spp. 
 (parasitic wasps)  
●●●    ●   ●    Yes  
Homoptera Acyrthosiphon pisum 
 (pea aphid)  
●●    ●   ●    Yes  
Coleoptera Tribolium castaneum 
 (fl our beetle)  
●    –   ●   Yes  
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Lepidoptera Bombyx mori 
Spodoptera spp. 
●    –  ●    Yes  
Diptera  Flies, mosquitos   –   –  ● a   No  
Nematoda Caenorhabditis elegans 
 (free living roundworm)  
 –   –   –   No  
Trichuris trichiura 
 (whipworm, parasitic)  
 –  ● b   –   ?  
Placozoa Trichoplax adhaerens 
 (the only extant member of this 
phylum)  
 –   –  ●    No  
Cnidaria Nematostella vectensis 
 (sea anemone)  
●   ●   ●    Yes  
Black dots indicate the number of genes encoding DNMT paralogs in various species a In Drosophila TET demethylates N 6 
-methyladenine (6 mA) and this process correlates with transposon expression (Zhang et al.  2015)  
bA highly conserved relative of DNMT3 in T. trichiura available in GenBank (KFD71641.1) needs to be validated by 
additional analyses. If confirmed, the whipworm would be the only nematode with a gene encoding a DNMT and the 
only species so far having DNMT3, but no DNMT1 and TET  
Establishing DNA Methylation Patterns in Invertebrates  
The overall level and patterns of DNA methylation that are established across a genome, 
what is termed a methylome, are determined in a cell- and tissue-specific manner. 
Throughout embryogenesis and cell differentiation, DNA methyltransferases (DNMTs) 
establish DNA methylation patterns and then maintain these patterns across cell divisions. 
Two families of DNMTs exist: one referred to as DNMT1, which preferentially methylates 
hemimethylated cytosine residues and the other as DNMT3 family, which catalyses the de 
novo methylation of DNA (Goll and Bestor 2005). Another important protein family relevant 
for DNA methylation are TET dioxygenases that remove methyl groups from modified 
cytosines (see a section below). All these proteins are well conserved and they are present 
across a wide variety of vertebrates and invertebrates. However, as shown in Table 1 , one 
salient aspect of DNA methylation is its dispensability. The distribution of the DNA 
methylation toolkit in Metazoa is mosaic with a variety of distinct patterns ranging from  
  
Fig. 2 Outline of postembryonic developmental reprogramming in honeybees by nutritionally driven epigenomic 
mechanisms 
   
 
 








   
 









a total loss of both DNMT and TET enzymes to partial losses and duplications. Many species, 
including most nematodes, advanced Dipteran insects and Placozoa have lost DNA 
methylating enzymes and apparently recruited other epigenetic mechanisms to regulate 
gene expression. Given this contrasting utilisation of an ancient biochemical modification, the 
extent to which DNA methylation is advantageous if maintained in a given lineage remains 
unclear (Lyko and Maleszka 2011 ; Kucharski et al.  2008; Zemach et al.  2010). 
Initially, it was considered that DNA methylation patterns were established by the de novo 
activity of the DNMT3 family during embryogenesis and then these patterns were maintained 
by DNMT1, the ‘maintenance’ DNMT. However, recent work indicates that the classical roles 
of DNMT1 and DNMT3s in establishing methylation patterns need to be redefined to include 
the apparent de novo activity of DNMT1 and DNMT3s’ contribution to maintenance (Jeltsch 
and Jurkowska 2014). The variation of DNMTs across invertebrates is also suggestive of 
diverse roles for these enzymes; Bombyx mori, for instance, lacks DNMT3 but still methylates 
its genome and it is therefore likely that DNMT1 provides de novo activity in this organism 
(Lyko and Maleszka 2011; Xiang et al.  2010). The honeybee, A. mellifera , is known to possess 
two copies of DNMT1 together with one DNMT3 gene and has become a focal model for 
exploring the relationship between DNA methylation and phenotypic plasticity in 
invertebrates. For instance, differential methylation patterns in this organism are correlated 
with the establishment of two distinct castes, that of queen and worker, from identical 
genetic information (Lyko and Maleszka 2011; Kucharski et al.  2008). This process is driven 
by differential feeding during postembryonic development that affects metabolic fl uxes, 
hormonal changes, global DNA methylation and gene expression (Maleszka 2008; Miklos and 
Maleszka 2011 ; Foret et al.  2012; Kucharski et al.  2015) (Fig.  2) . Newly hatched female 
larvae fed a complex diet known as royal jelly develop into long-lived reproductive queens, 
whereas larvae fed less nutritious worker jelly develop into functionally sterile short-lived 
workers. Interference with DNA methylation by knocking down DNMT3 in larvae reared in 
vitro mimics the effect of royal jelly on postembryonic development suggesting that dietary 
ingredients have the capacity to affect epigenomic settings (Kucharski et al.  2008). Although 
this result clearly implicates DNA methylation in a diet-controlled developmental division 
between long-lived highly fertile queens and short-lived functionally sterile workers (Fig. 2), it 
does not provide an unambiguous mechanistic explanation of this process based on defined 
enzymes with known properties. Given the emerging view that all DNMTs are not only 
functionally interweaved but also cooperate with histone modifiers, the impact of DNMT3 
silencing on honeybee phenotypes is more likely the outcome of a global effect that creates a 
disturbance in a highly interconnected epigenomic regulatory system. For the purpose of 
moving forward insect epigenetics, one needs to focus on unravelling the functions of both 
DNA and histone modifiers before a model of this intriguing epigenetic phenomenon can be 
generated. In this context, the queen bee food, royal jelly (RJ), may well hold clues to this 
problem. RJ is a complex mixture of unique compounds with poorly understood 
characteristics (Maleszka 2014 ). Some of these compounds have been identified as histone 
deacetylase inhibitors and it is reasonable to assume that many other ingredients in RJ also 
have potent epigenetic properties, possibly affecting DNA/RNA modifying enzymology. 
Cloning and in vitro characterisation of the honeybee DNMTs and other genes combined with 
 142 
 
examining the effects of RJ components will provide unprecedented clues to the nature of 
dietary impacts on epigenetic machinery (Fig. 2). 
Caste determination in A. mellifera is an illustrative example of Waddington’s developmental 
canalisation, whereby epigenetic processes have been recruited to conditionally modulate 
the expression of one genome using an environmental cue. Although various cellular 
elements have the ability to respond to environmental changes, their combined and 
coordinated action has evolved in honeybees as a controlling mechanism for reprogramming 
the entire larval development with critical consequences for cellular and organismal 
phenotypes. A limited number of genes can be epigenetically programmed to yield more 
than one organismal outcome, suggesting that epigenomic modifiers are able to relax 
evolutionary constrains on development. These modifiers operate by recruiting only a subset 
of an organism’s gene repertoire and reusing it in a combinatorial manner to remodel 
multiple subnetworks (Maleszka, 2014).  
Importantly, DNA methylation patterns are governed not only by the de novo and 
maintenance activity of DNMTs but also by the passive loss of methylation during replication 
and active demethylation by the family of ten eleven translocation (TET1-3) dioxygenases 
(Pastor et al. 2013). Demethylation by TETs is critical to ensure the flexibility of methyl marks 
whose responsive nature is contingent on their reversibility. These enzymes oxidise 5-
methylcytosine (5mC) to 5- hydroxymethylcytosine (5hmC) that can be further converted to 
5-formyl- cytosine and 5-carboxyl-cytosine. Recent findings including genome-wide mapping 
of 5hmC at a single-base resolution in mammalian brain (Lister et al.  2013)  reveal a complex 
picture consistent with the idea that both 5mC and 5hmC can act as independent epigenetic 
marks. In addition to their role as methylcytosine dioxygenases,  
   
Fig. 3 Transgenerational inheritance of obligatory methylated epialleles of the gene coding for lysosomal alpha-
mannosidase (LAM) in A. mellifera . A single male drone was mated with a queen; haploid drones develop from 
unfertilised eggs and diploid workers/queens develop from fertilised eggs. The level of methylation of the two alleles, 
LAM C+CT  and LAM C ΔGA,  across an  intragenic region of LAM (exons 16 to exons 18) is indicated: 0 % indicating a CpG 
site was never found to methylated, 100 % indicating that a CpG site was always found to be methylated. The 
transgenerational inheritance of methylation patterns, irrespective of factors such as caste or developmental stage and 




mammalian TETs perform other functions including interactions with metabolic enzymes and 
other proteins, participation in transcriptional regulation, telomere elongation and conveying 
cellular signals (Pastor et al.  2013; Lu et al.  2014). TETs have also been implicated in histone 
modifications. For example, TET2 promotes histone O-GlcNAcylation during TET2-dependent 
gene transcription by recruiting O-GlcNAc transferase to chromatin (Chen et al.  2013).  
 Yet, whilst active demethylation has been relatively well investigated in mammals, little is 
known of these processes in invertebrates. Recent work in A. mellifera has highlighted that a 
conserved TET enzyme in this organism is capable of converting methylated cytosine residues 
to 5-hydroxymethylcytosines (5hmC), as in mammals and is likely to play an important role in 
establishing DNA methylation patterns, although the exact nature of this role remains 
unclear (Wojciechowski et al.  2014). In contrast to mammals that have three TET paralogs, 
only one TET has been found in A. mellifera and in most of other invertebrates. TET proteins 
are absent in organisms such as nematodes, which have lost the genes encoding DNMT1 and 
DNMT3 as well as, a tRNA-methylating enzyme (known as DNMT2). One puzzling feature of 
the honeybee TET is its very high level of expression, especially in the brain that does not 
translate into a substantial number of 5hmCs. In most tissues fewer than 3000 5mhCs have 
been detected corresponding to 4–5 % of the methylated cytosines. Only in testes and 
ovaries the levels of 5hmC in A. mellifera (7–10 %) appear to be more comparable to those in 
some mammalian situations. Given this discrepancy between TET expression and the scarcity 
of 5hmC in the honeybee genome, it is likely that this protein performs other roles not 
related to cytosine demethylation. A broader functionality of invertebrate TETs is consistent 
with its expression in Drosophila that has no DNA methylation toolkit and does not require 
demethylation of genomic cytosines. It is noteworthy that a few studies have reported the 
presence of low levels of highly localised and asymmetrical methylated cytosines in 
Drosophila genome (Takayama et al.  2014; Capuano et al.  2014). If confirmed, these results 
would indicate novel enzymatic machinery capable of modifying DNA in certain contexts.  
A recent breakthrough study in Drosophila has shown that removal of the TET gene increases 
N6-methyladenine (m6A) levels in DNA, but has no effects on RNA in which m6A is common 
(Zhang et al.  2015).  Drosophila TET null mutants show a lethal phenotype beginning at the 
pupal stage with the last survivors dying 3 days post-eclosion. This finding suggests that a 
single relative of TETs in insects has the potential to catalyse a variety of chemical 
modifications not necessarily involving 5mC. Even more intriguing is a new study showing 
that in Drosophila, TET has the capacity to add hydroxymethylcytosine to RNA and that this 
modification is most prominent in the brain where it is important for promoting translation 
of mRNAs (Delatte et al.  2015). Whether or not a similar TET activity exists in other insects 
remains to be determined, but it is conceivable that high levels of TET transcripts in A. 
mellifera brain are needed for RNA hydroxymethylation. Further exploration of 
demethylation and hydroxymethylation dynamics is required to fully understand both the 
role of TET in DNA/RNA methylation patterning and in other hitherto unidentified functions 
amongst invertebrate organisms.  
H ow are DNA methyltransferases and TET dioxygenases guided to a given genomic region? 
Recent models indicate that these enzymes are recruited to specific genomic locations via 
their interactions with other epigenetic modifiers and that these interactions are dependent 
 144 
 
on the chromatin environment (Jones and Liang 2009; Jeltsch and Jurkowska 2014). Work in 
mammals, for instance, has highlighted that various histone post-translational modifications 
(PTMs) and chromatin remodelling factors are likely to be involved in recruiting DNMTs to a 
genomic location (Jones and Liang 2009). It is likely that similar mechanisms operate in 
insects, but until these are explored in the context of differential DNA methylation, the role 
these factors play in establishing DNA methylation patterns will remain unknown. To this end 
extensive PTMs have been described in A. mellifera using mass spectrometry (Dickman et al.  
2013), and genome-wide chromatin immunoprecipitation-b ased approach (ChiPseq) has 
been applied to map-specific histone PTMs in the ant C. floridanus (Simola et al.  2013). 
Although the exact recruitment mechanism of the DNA methylation and demethylation 
machinery in insects is still unknown, the distribution of methylated cytosines across the 
genome of A. mellifera has been mapped at single-base resolution providing initial impetus 
for studies on how DNA methylation might be contributing to a variety of cellular processes. 
DNA Methylation Patterns Across Invertebrates  
 The targeting of methylation across the genome appears to take on two distinct types of 
patterns: global DNA methylation and mosaic DNA methylation (Suzuki and Bird 2008). In the 
case of global DNA methylation, which is typical of vertebrates, the genome is densely 
methylated throughout most tissues and developmental stages. In humans, for instance, the 
majority of CpG sites across the genome are methylated with the exception of small 
unmethylated domains, typically near regulatory regions such as promoters, termed CpG 
islands (Ehrlich et al.  1982). In contrast, in invertebrate genomes, distinct domains are 
methylated and unmethylated in a ‘mosaic’ fashion (Suzuki and Bird 2008; Tweedie et al.  
1997). The overall level of this mosaic methylation varies; for instance, A. mellifera contains a 
much lower level of methylation when compared to invertebrates such as Ciona intestinalis 
(Feng et al.  2010). However, several features of DNA methylation patterning are conserved.  
This important epigenetic mark has long been associated with the transcriptional silencing of 
genomic regions. Across a wide range of organisms, it is frequently targeted to repetitive 
elements and transposons; A. thaliana, together with the mouse and zebrafish all exhibit 
such methylation, and disruption of DNA methylation leads to the reactivation of these 
elements, showing that the methylation of these regions is critical to their silencing 
(Bourc’his and Bestor  2004;  Kato et al.  2003; Feng et al.  2010). Additionally, genomic 
imprinting, whereby a gene or chromosomal region are transcriptionally controlled in a 
parent-of-origin manner, is frequently associated with methylation and silencing. In 
mammals and plants imprinted genes are differentially methylated and disruption of DNA 
methyltransferase activity leads to the aberrant expression of the maternal and/or paternal 
transcript (Li et al.  1993; Jullien et al.  2006 ).  
Yet, whilst it is clear that DNA methylation has been utilised by many organisms to maintain 
genome stability and regulate imprinted regions, this does not extend to all species. Whereas 
moderate levels of methylation have been observed across transposons in C. intestinalis, 
other invertebrate genomes do not exhibit such methylation; in A. mellifera , for example, 
transposons are not targeted for methylation (Feng et al.  2010; Zemach et al.  2010). 
However, transposons are not as frequent in A. mellifera as they are in some other species, 
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suggesting that a mechanism controlling mobile genomic elements may be less critical for 
this organism. Additionally, not all species utilise DNA methylation to establish imprints; 
organisms such as C. elegans do not have a functional methylation system, yet still present 
with imprinted genes, and there is no current evidence for genomic imprinting via DNA 
methylation in A. mellifera (Sha and Fire 2005). It thus appears that whilst DNA methylation 
can be critical for transcriptional silencing in many contexts, this is not always the case.  
Rather, the more conserved feature of eukaryotic DNA methylation is the distribution of 
methylation at gene bodies. Gene body methylation has been identified across numerous 
organisms, and it is likely that its occurrence predates the last common ancestor of plants 
and animals (Feng et al.  2010). It is characterised by methylation across the introns and 
exons of protein-coding genes. In vertebrates and plants, this gene body methylation is 
prevalent and has been shown to frequently occur in those regions that are highly expressed 
(Ball et al.  2009;  Zilberman et al.  2007).  
 In invertebrates, methylation predominantly occurs across gene bodies. The vase tunicate C. 
intestinalis, the parasitoid wasp  Nasonia vitripennis , the carpenter ant  Camponotus 
floridanus ,  A.mellifera,  and lower  Metazoa such as the sea anemone  Nematostella 
vectensis all display high levels of gene body methylation, and the regions with high gene 
body methylation also correlate with genomic regions that are actively transcribed (Feng et 
al.  2010; Wang et al.  2013; Zemach et al.  2010; Foret et al.  2009; Bonasio et al.  2012; 
Tweedie et al.  1997). To date, in all insects in which methylation has been analysed at a 
genome-wide scale, 5mC appears to be limited almost exclusively to CpG dinucleotides with 
only marginal levels found at non-CpG sites. Whether this pattern is a universal feature of all 
insects awaits sequencing of methylomes in more species representing diverse evolutionary 
lineages. In A. mellifera, intragenic DNA methylation is higher in exons than introns, and 
those genes, which are highly methylated, are often ubiquitously expressed, with evidence 
that this type of methylation modulates the expression of these transcripts (Foret et al.  
2009; Lyko et al.  2010). These common findings suggesting that intragenic DNA methylation 
is associated with active transcription, have important implications for understanding how 
this mark might direct transcription.  
The correlation between intragenic DNA methylation and the expression of ‘housekeeping’ 
genes has led to the suggestion that DNA methylation functions in these contexts by 
preventing spurious transcription. By methylating intragenic regions, the initiation of 
transcription at cryptic sites within coding regions can be prevented (Weber and Schubeler  
2007). For those genes which are frequently transcribed, such as the ubiquitously expressed 
housekeeping genes, this would represent an important mechanism, whereby transcription 
can be controlled and transcriptional noise reduced (Zilberman et al.  2007; Suzuki et al.  
2007). This hypothesis is supported by a recent work, which has demonstrated that gene 
body methylation is negatively correlated with transcriptional noise (Huh et al.  2013). 
However, alternative suggestions, based on work in A. thaliana, indicate that it is the rate of 
transcription of these moderately expressed transcripts that induces intragenic methylation, 
as opposed to methylation itself influencing transcription (Zilberman et al.  2007).  
 146 
 
 Yet, given that key differences in the DNA methylation system exist between A. thaliana and 
other eukaryotic model organisms, the relationship between intragenic methylation and the 
rate of transcription may not be universal. DNA methylation patterns in A. thaliana and other 
flowering plants are established via an RNA-directed DNA methylation system (RdDM) where 
RNA molecules, small interfering RNAs (siRNAs), guide de novo methylation (Chan et al.  
2005; Bao et al.  2004). The proposed model that transcription itself causes intragenic 
methylation is based upon the spurious transcription of these siRNAs (Zilberman et al.  2007). 
Amongst invertebrate models, there is no current evidence for an RdDM system and 
therefore the intragenic DNA methylation seen in these species may have alternate 
functions.  
Table. 2 Examples of genes with cassette exons whose expression correlates with differential methylation 




 (Lyko et al.  2010)  
 3   Creates a truncated 
protein by introducing a 
premature STOP codon  
 In a heterodimer, the 
truncated protein is predicted 
to inhibit trans-membrane 
activity of the full-length 
protein  
 GB43446  
 Anaplastic lymphoma 
kinase (ALK)  
(Foret et al.  2012)  
 25   Creates a different 
interacting domain by 
changing the N-terminal 
sequence of ALK  
 Modifi es selection of protein 
partners interacting with ALK  
 GB43543  
 Glycine receptor (Foret 
et al.  201 )  
 8   Extends the intracellular  
TM3-4 loop by 36 bp  
(12aa)  
 New gating properties of the 
glycine channel with the 
insertion. The cassette exon is 
found mostly in GlyR expressed 
in the brain and sensory organs  
 
Indeed, several lines of evidence indicate a number of functional roles for intragenic DNA 
methylation in mammals, including the regulation of non-coding RNAs and transcription 
elongation. Both microRNAs (miRNAs) and long non-coding RNA (lncRNA) transcripts have 
been shown to be influenced by intragenic DNA methylation, with important transcriptional 
consequences (Kulis et al.  2013; Cheung et al.  2011; Lujambio et al.  2007). By altering 
chromatin structure, DNA methylation can reduce the efficiency of transcription elongation 
(Lorincz et al.  2004). Intragenic DNA methylation has been shown to influence elongation; 
exonic differential methylation modulates binding of the CTCF transcription factor, altering 
RNA Pol II processing and the alternative splicing of a transcript (Shukla et al.  2011). Further 
evidence indicates that intragenic DNA methylation modulates alternative splicing 
(Maunakea et al.  2013;  Foret et al.  2012 ) and leads to the cell- and tissue-specific 
expression of alternative transcripts (Maunakea et al.  2010)  across a number of species 
suggesting that this function of intragenic DNA methylation is commonplace and likely to 
have important biological consequences (Kulis et al.  2013).  
 In A. mellifera differential intragenic DNA methylation has similarly been correlated to 
alternative splicing. High intragenic DNA methylation has been observed near alternative 
splice sites, and the differential methylation of these regions has been linked to the 
expression of condition-specific alternatively spliced transcript variants (Table  2)  (Lyko and 
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Maleszka  2011; Foret et al.  2012; Kucharski et al. 2016; Maleszka et al.  2016). Some of 
these cases support the Shukla et al. (Shukla et al.  2011) model whereby methylation inhibits 
binding of a CTCF factor that can promote inclusion of weak upstream exons by mediating 
local RNA polymerase II pausing. In the case of anaplastic lymphoma kinase (Table 2), low 
methylation correlates with exon 25 inclusion at high frequency. In the adult brain, where the 
methylated regions show much lower methylation relative to larvae, the majority of the 
available ALK transcripts (81 %) have been found to contain exon 25 (Foret et al. 2012). Thus, 
differential methylation of this sequence seems to affect the dynamics of exon 25 inclusion 
and generates ALK isoforms with different amino-termini in the intracellular domain that 
could interact with distinct partners. This suggests that the DNA methylation seen across the 
genes of A. mellifera can, in particular contexts, elicit transcriptional changes. 
 4.3  Does DNA Methylation Direct Gene Expression?  
 Although several clear relationships between DNA methylation and transcription have 
emerged over the past decades, including the link between intragenic DNA methylation and 
active transcription, this relationship is not entirely straightforward. Whilst there are a 
number of cases where DNA methylation has been shown to directly influence transcription, 
for instance, Shukla et al (Shukla et al.  2011) provide a direct relationship between 
methylation and alternative splicing, much evidence is largely correlative, derived from 
genome-wide analyses (Zemach et al.  2010; Feng et al.  2010; Schultz et al.  2015). In the 
case of invertebrate models, the few examples seen in A. mellifera indicate that intragenic 
DNA methylation is likely to play an important role in eliciting transcriptional changes. Yet, 
these studies also highlight that such changes are context-dependent and do not necessarily 
eliminate the possibility that they result as a function of other processes that are simply 
associated with differential DNA methylation.  
For some time it has been acknowledged that DNA methylation does not stand alone in 
directing transcriptional changes but that it is coupled with other epigenetic marks, such as 
histone modifications (Fuks 2005; Cedar and Bergman 2009 ). The epigenetic modifications 
and DNA methylation itself are also influenced by genetic variation (Kilpinen et al.  2013; 
McVicker et al.  2013; Kasowski et al.  2013; Furey and Sethupathy 2013). The complexity of 
these interactions makes it difficult to ascertain whether DNA methylation itself directs 
transcriptional changes or if other factors, such as the underlying DNA sequence, play a more 
substantive role, and this has become an important avenue of research across the 
epigenetics field (Schubeler 2012).  
Cis- and trans- acting polymorphisms have been shown to lead to differentially methylated 
regions across a number of organisms (Richards 2006 ; Schubeler  2012 ). In mammals, 
obligatory methylated epialleles have been well documented and numerous studies have 
established the linkage between allelic variation and a methylated state across many cell 
types (Kerkel et al.  2008; Schilling et al.  2009; Shoemaker et al.  2010). Importantly, epiallelic 
variation is a key contributor to phenotypic variation, where these epialleles influence 
transcription across different cellular contexts (Gutierrez-Arcelus et al.  2013; Schubeler  
2012) . In A. mellifera and other invertebrate models, although DNA methylation is critical, 
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there has been little investigation into how genetic variability might be contributing to 
differential DNA methylation.  
In a recent study differential intragenic DNA methylation of the gene encoding for lysosomal 
alpha-mannosidase (LAM) was correlated with sequence variation, providing the fi rst 
evidence for an obligatory methylated epiallele within the A. mellifera population (Wedd et 
al.  2016). In contrast to pure epialleles that arise from stochastic genotype-independent 
events, obligatory differentially methylated epialleles are generated by sequence variants 
(Richards 2006). The methylated status of the LAM epiallele in A. mellifera has been found to 
increase LAM expression in a context-specific manner, along with the expression of a long 
non-coding RNA transcript. LAM epialleles have been found to be inherited in the classical 
Mendelian manner with no apparent evidence of imprinting (Fig.  3). This result not only 
further supports the link between intragenic DNA methylation and active transcription but 
also indicates that obligatory epialleles in A. mellifera will likely contribute to phenotypic 
variation in a context-specific manner, as has been demonstrated across other species.  
 Given that phenotypic differences in A. mellifera are generated by tightly controlled 
epigenetic changes, any impact that genetic variation might have on this epigenetic layer of 
information could be profound. In the context of DNA methylation, substantial work in social 
insects like A. mellifera has shown that differential DNA methylation patterns correlate with 
transcriptional changes and phenotypic variation, but fewer studies interpret these changes 
in the context of any underlying sequence variation. The discovery of obligatory epialleles in 
the A. mellifera population highlights the importance of interpreting differential DNA 
methylation patterns more carefully and investigating the extent to which epiallelic variation 
influences phenotype in this organism. The availability of ultra-deep next-generation bisulfite 
sequencing technologies, as used in the LAM study, will facilitate interpreting these patterns 
accurately in the context of developmental, tissue-specific and stochastic effects that are 




 Invertebrates such as A. mellifera represent an important model from which a broader 
understanding of DNA methylation, and its role in directing transcription, can be drawn 
(Lyko and Maleszka 2011; Maleszka  2014 ). Importantly, this is reliant on the accurate 
interpretation of insect methylomes, and without performing in-depth analyses of 
differential methylation patterns in A. mellifera there is a risk of misinterpreting the 
biological significance of such marks (Kucharski et al.  2015). To achieve a full 
understanding of how this epigenetic modification links genotype to phenotype, the 
relationship between DNA methylation patterns, genetic variability and other epigenetic 
marks must be understood and interpreted in the context of additional factors, such as 
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6.2 Developmental and loco-like effects of a swainsonine-induced inhibition of α-
mannosidase in the honey bee, Apis mellifera 
 
Since the submission of this thesis the results presented in Chapter 3 have been published 
in the manuscript: 
 
Wedd, L., Ashby, R., Foret, S., & Maleszka, R. (2017). Developmental and loco-like 
effects of a swainsonine-induced inhibition of α-mannosidase in the honey bee, Apis 
mellifera. PeerJ, 5, e3109 
 
This paper includes a further exploration of the effect of swainsonine exposure on 
metabolic pathways in the honey bee. It discusses the results of the findings seen in chapter 
3 in light of these additional analyses, and has been presented here to provide the reader 
with a greater insight into LAM function. 
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ABSTRACT 
Background. Deficiencies in lysosomal a-mannosidase (LAM) activity in animals, 
caused either by mutations or by consuming toxic alkaloids, lead to severe 
phenotypic and behavioural consequences. Yet, epialleles adversely affecting LAM 
expression exist in the honey bee population suggesting that they might be 
beneficial in certain contexts and cannot be eliminated by natural selection. 
Methods. We have used a combination of enzymology, molecular biology and 
metabolomics to characterise the catalytic properties of honey bee LAM (AmLAM) 
and then used an indolizidine alkaloid swainsonine to inhibit its activity in vitro and 
in vivo. 
Results. We show that AmLAM is inhibited in vitro by swainsonine albeit at slightly 
higher concentrations than in other animals. Dietary exposure of growing larvae to 
swainsonine leads to pronounced metabolic changes affecting not only saccharides, 
but also amino acids, polyols and polyamines. Interestingly, the abundance of two 
fatty acids implicated in epigenetic regulation is significantly reduced in treated 
individuals. Additionally, swainsonie causes loco-like symptoms, increased mortality 
and a subtle decrease in the rate of larval growth resulting in a subsequent 
developmental delay in pupal metamorphosis. 
Discussion. We consider our findings in the context of cellular LAM function, larval 
development, environmental toxicity and colony-level impacts. The observed 
developmental heterochrony in swainsonine-treated larvae with lower LAM activity 
offer a plausible explanation for the existence of epialleles with impaired LAM 
expression. Individuals carrying such epialleles provide an additional level of 
epigenetic diversity that could be beneficial for the functioning of a colony whereby 
more flexibility in timing of adult emergence might be useful for task allocation. 
Subjects Biochemistry, Developmental Biology, Molecular Biology, Toxicology 
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INTRODUCTION 
Alleles with undesirable phenotypic effects are subject to the pressure of natural selection that 
acts by eliminating less fit variants out of a population (Eyre-Walker et al., 2002; Sunyaev et al., 
2001). Yet, individuals carrying such alleles exist in human and other populations (Eyre-Walker 
& Keightley, 2007; Eyre-Walker, Woolfit & Phelps, 2006; Kondrashov, 1995; Trask et al., 2016) 
posing a question what keeps natural selection from getting rid of them? Recently, we have 
uncovered several differentially methylated obligatory epialleles of the gene coding for 
lysosomal α-mannosidase (AmLAM, GB44223) in the honey bee population (Wedd, Kucharski & 
Maleszka, 2016; Wedd & Maleszka, 2016). These epialleles correlate with context-dependent 
changes to AmLAM gene expression, with certain epialleles found to be associated with a lower 
expression of AmLAM. In humans and animals a LAM deficiency leads to a severe impairment 
in cellular function, which can lead to death (Borgwardt, Lund & Dali, 2014; Malm & Nilssen, 
2008). Taking into consideration the severe consequences of LAM deficiency in humans and 
animals, the persistence of such alleles including those associated with lower expression of 
LAM in the honey bee population is somewhat puzzling. This study was designed to shed more 
light on this interesting phenomenon and explores the effects of swainsonine, a natural 
inhibitor of LAM, on honey bee development. 
 
LAM belongs to family GH38 of the glycoside hydrolases, or class II α-mannosidases that play 
a critical role in catalysing the hydrolysis of asparagine-linked oligosaccharides during 
biosynthesis and catabolism across a number of cellular contexts (Daniel, Winchester & 
Warren, 1994; Gonzalez & Jordan, 2000). These enzymes are classed into a number of different 
subfamilies based on their localisation, biochemical properties and substrate specificities; they 
include lysosomal α-mannosidase, likely to have a role in scavenging degraded glycoproteins, 
the cytosolic α-mannosidase and the well-characterised Golgi α-mannosidase (Henrissat & 
Bairoch, 1993; Nemcovicova et al., 2013). 
 
LAM has been characterised across a number of eukaryotes. It is localised within the 
lysosome, typically has a pH optimum of 4.0–4.5, is activated by Zn2+, and has a broad substrate 
specificity, hydrolysing at α1,2, α1,3 and α1,6 linkages during catabolism (Daniel, Winchester & 
Warren, 1994; Gonzalez & Jordan, 2000; Henrissat & Bairoch, 1993; Nemcovicova et al., 2013). 
Structural characterisation of this enzyme in Bos taurus (cattle) and Drosophila melanogaster 
  




(vinegar fly) has shown that LAM is proteolytically cleaved into five peptides (A–E), with 
peptides A and B forming the active-site domain. Mutations disrupting this active site and other 
critical residues have been well described in cattle, guinea pigs, cats and humans and cause the 
autosomal recessive disease, α-mannosidosis(Berg et al., 1999). In cases of α-mannosidosis the 
deficiency of LAM leads to the accumulation of partially degraded mannose-rich 
oligosaccharides within the lysosome causing lysosomal vacuolation, which eventually leads to 
mental retardation, hearing loss, skeletal abnormalities and immune deficiency (Borgwardt, 
Lund & Dali, 2014). 
Effects similar to α-mannosidosis have been observed in cases of locoism, a condition which 
commonly occurs in livestock that consume the common locoweed, so named for its 
neurological effects. Grazing on the locoweed, which includes several species such as 
Swainsona canescens, Astragalus mollissimus, and Oxytropis lambertii, induces a phenocopy of 
α-mannosidosis, which occurs when these plant species contain the indolizidine alkaloid, 
swainsonine (Molyneux & Panter, 2009). Swainsonine is produced by fungal endophytes that 
colonise these species, and causes significant livestock losses worldwide (Cook, Gardner & 
Pfister, 2014). It is believed to bind reversibly to LAM, inhibiting its activity, and when 
consumed for prolonged periods will induce a phenocopy of α-mannosidosis (Dorling, Huxtable 
& Colegate, 1980). 
This sensitivity of LAM to swainsonine has been documented in a number of species 
including D. melanogaster, sheep and cattle (Nemcovicova et al., 2013). In livestock the onset 
of symptoms typically occurs after 2–3 weeks of continuous grazing on poisonous plants. 
Livestock chronically exposed to swainsonine exhibit decreased weight, hyperexcitability, 
nervousness, muscle incoordination, and with continued exposure will die; where the individual 
is pregnant abortions and birth defects occur (Molyneux & Panter, 2009). This exposure has 
been shown to cause the accumulation of oligosaccharides such as Man5GlcNAc2 and 
Man4GlcNAc2 in the kidney and brain of livestock and the resulting lysosomal vacuolation 
occurs across most cells, with eventual neuronal vacuolation causing the described neurological 
effects. 
The Western honey bee A. mellifera is known to forage on species such as Astragalus and 
Oxytropis but only anecdotal evidence indicates that such foraging can lead to deleterious 
effects. Early reports indicate that the locoweed is toxic to the bee; adult bees have been found 
dead on Astragalus lentiginosus blooms, with additional reports indicating that brood are 
killed, pupae mummify and die, and queens within affected colonies stop laying (Beckwith, 
1898; Vansell & Watkins, 1934). Although the occurrence of colony collapse disorder (CCD) has 
led to substantial research into the effects of various environmental toxins and pesticides on 
honey bee health, the sensitivity of the honey bee LAM to swainsonine has not been 
investigated. 
In view of the severe consequences associated with an inactive LAM and its conserved 
ubiquitous expression and role in core housekeeping processes, glycoprotein catabolism, the 
identification of differentially methylated LAM epialleles in the honey bee raises the question: 
what effects, if any, might such epiallelic variation have on LAM function and phenotype more 
broadly? To understand the existence of these epialleles and explore LAM function in more 
  




detail we utilised swainsonine as a surrogate system to generate individuals with impaired 
LAM function. As a natural inhibitor of LAM, swainsonine treatment provides a convenient tool 
to investigate how deficiencies of LAM affect both larval development and adult behaviour. 
We have conducted a series of in vitro and in vivo experiments, including a seminal analysis 
of a swainsonine-induced metabolome to demonstrate that this alkaloid inhibits α-
mannosidase activity in the honey bee and leads to considerable metabolic and developmental 
changes in exposed individuals. We discuss these findings in the context of LAM function, 
development and colony-level impacts and propose that differentially methylated epialleles 
generate an additional level of epigenetic diversity that might be advantageous for a self-
organising system. 
MATERIALS AND METHODS 
Biological material 
All honey bee specimens came from our Canberra colonies. Larvae were harvested from brood 
frames taken from the hive and incubated at 35 ◦C, 80% humidity and snap frozen in liquid 
nitrogen if required. Tissue dissections were carried out in a standard bee Ringer solution 
(Bicker, 1995). Larvae were grown in vitro as described previously (Kucharski et al., 2008). To 
facilitate the larval-pupal transition and enhance adult emergence, larvae were transferred just 
before spinning the cacoon to gelatine capsules with small holes at one end. For more details 
regarding honey bees and specimen preparations see previous publications (Becker et al., 
2016; Kucharski, Foret & Maleszka, 2015; Kucharski, Maleszka & Maleszka, 2016; Wedd, 
Kucharski & Maleszka, 2016). 
Molecular methods 
All molecular protocols are described in detail in our previous publications; RNA 
extractions (Kucharski, Maleszka & Maleszka, 2007; Wojciechowski et al., 2014), qPCR 
analyses, quality controls (Becker et al., 2016; Kucharski, Maleszka & Maleszka, 2016), 
primers and conditions for LAM amplification (Wedd, Kucharski & Maleszka, 2016). 
Enzymatic assay 
All larval samples were homogenised in a chilled PBS buffer containing 1 mM ZnCl2 and 
cOmpleteTM EDTA-free protease inhibitor cocktail (1X; Roche). 250 µL of buffer was added per 
100 mg of tissue, the sample homogenised and centrifuged at 14,000× g for 15 min at 4 ◦C and 
the supernatant collected for the activity assay. 
10 µL of each extract was incubated with p- nitrophenyl- α-D-mannopyranoside in 100 mM 
acetate buffer (pH 4.6) in a total volume of 50 µL at 37 ◦C. For the Ki value and IC50 estimates the 
rate of nitrophenol production was determined in the presence of swainsonine (10 inhibitor 
concentrations ranging from 5–8,000 nM) across six p-nitrophenyl- α-Dmannopyranoside 
substrate concentrations (0.5 mM, 0.75 mM, 1.0 mM, 2.5 mM, 5.0 mM and 7.0 or 8.0 mM); the 
Ki value and IC50 range were calculated using the GraphPad Prism curve fitting software. For the 
standard assay LAM activity was determined with 1.0 mM p-nitrophenyl- α-D-
  




mannopyranoside. All reactions were terminated with 250 µL of 100 mM sodium carbonate and 
p-nitrophenyl production measured at 410 nm using a spectrophotometer (Multiskan RC). 
LAM activity was determined using a nitrophenol standard curve (1,000 µM, 500 µM, 250 
µM, 125 µM, 62.5 µM, 31.25 µM, 15.63 µM and 7.8 µM concentrations), using the following 
equation: 
ODsample−ODblank×total reaction vol(mL) 
LAM activity (U/mL) =        × Dilution Factor(DF) 
time× slope×sample vol(mL) 
Units: 1 Unit (U) of LAM will catalyse the conversion of 1 µmole of p- nitrophenyl-α-D-
mannopyranoside to 4-nitrophenol and α-D-mannose per minute at 37 ◦C at the indicated pH 
(pH 4.6). OD = optical density. 
Metabolomic analyses 
Single larvae were hand-homogenised with a plastic pestle for 30 s in 100 µL of chilled (4 ◦C) 
methanol. A further 400 µL of chilled (4 ◦C) methanol was added to bring the final volume to 
500 µL. The samples were sonicated in a sonic bath for 1 min before 40 µL of 0.1mg/mL L-
norvaline (MW 117.15g/mol, Sigma N-7627) was added to each sample as an internal standard. 
Following incubation at 60 ◦C in a water bath for 15 min, with vortexing every 5 min, 280 µL of 
chloroform was added and mix thoroughly by inversion before incubation in a water bath at 37 
◦C for a further 5 min. After adding 550 µL of water and thorough mixing, the samples were 
centrifuged at 14,000 rpm for 5 min at room temperature. Aliquots of 50 µL were collected 
from the upper methanol phase (approx. 500 µL) and placed in brown GC-MS glass vials for 
analysis. Samples were dried down in a speedivac at 40 ◦C for 1 h before being sent for analysis. 
Samples were derivatised in methoxyamine, HCl in anhydrous pyridine (10 uL– 20 mg/ml) for 
90 min at 37 ◦C, while agitated at 37 rpm, and N-methyl-N-(trimethylsilyl)trifluoroacetamide (15 
uL derivatisation grade, Sigma-Aldrich 394866-10 X 1ML) for 30 min at 37 ◦C, while agitated at 
37 rpm, using an online Gerstel Multipurpose Sampler MPS (GERSTEL GmbH and Co.KG, 
Germany). The derivatised samples were analysed by GC-MS with a full MS scan range of 40–
600 m/z, with an acquisition rate of 4 scans/sec, and the solvent delay of 5.6 min (Agilent 
7890A, Agilent 5975C MS inert XL EI/CI MSD with triple axis detector, Santa Clara, CA). Samples 
were injected at a volume of 1uL, with a splitless injector temperature of 230C, and separated 
on an Agilent J&W VF-5ms 5% phenyl-methyl column (30 m length × 0.25 mm internal 
diameter, 0.25 um film thickness). The temperature programme applied for GC separation was: 
70 ◦C for 1 min, ramping at 15 ◦C/min to 325 ◦C and held for 3 min. Total run time was 21 min 
with a helium carrier flow rate of 1 ml/min at 12.445 psi. Temperature of the MS transfer line 
was 250C. 
Metabolites were screened using MetabolomeExpress (Carroll, Badger & Harvey Millar, 
2010) and AMDIS software package (Halket et al., 1999) and identified using retention indices 
(C12-C36 n-Alkanes, 5 uL at 147 mg/L) against the Golm Metabolome Database (GMD) (Kopka 
et al., 2005). The peak areas of detected analytes were normalised against the internal 
standard L-Norvaline. All readings were measured in triplicate. 
  





Swainsonine inhibits mannosidase activity in A. mellifera 
To determine whether A. mellifera is sensitive to swainsonine, mannosidase activity was 
determined in the presence of swainsonine at concentrations ranging from 5 to 8,000 nM, with 
the inhibitor and substrate added simultaneously. Maximal inhibition is reached at swainsonine 
concentrations of 8,000 nM, and 50% of mannosidase activity is inhibited at swainsonine 
concentrations between 145.9 and 179.9 nM (mean IC50 = 162 nM, n = 8) (Fig. 1). 
Swainsonine binds in a competitive and reversible manner 
To gain insight into the mechanism of action of swainsonine in A. mellifera the inhibition 
constant, Ki, was determined over 10 inhibitor and 6 substrate concentrations. The observed 
inhibition of mannosidase activity is competitive, with a Ki value determined over two 
replicates as 152.3 ± 17.49 nM (95% CI [117.3–187.2]) and 223.6 ± 27.41 nM, (95% CI [168.8–
278.4]); the Ki for swainsonine is therefore estimated to be in range of 135–251 nM (Figs. S1A–
S1C). To determine whether swainsonine binding is reversible, extracts were 
 
Figure 1 Swainsonine inhibition of mannosidase activity in A. mellifera. Tissue extracts were prepared from 48–
96 h larvae; individuals from three separate hives were pooled (n= 6–10/pool, total of 8 pooled samples) and 
mannosidase activity determined in the presence of 5–8,000 nM of swainsonine. The percent total activity was 
calculated as the amount of nitrophenol produced in the presence of swainsonine over the nitrophenol produced 
in the absence of swainsonine (assay conditions: 1 mM substrate, pH 4.6, 37 ◦C). The IC50 is estimated between 
145.9 and 179.9 nM, with the average IC50 162 nM (R2 = 0.9854, Hill Slope =−1.143). 
preincubated with a swainsonine concentration near to 10 × Ki (∼1,600 nM) followed by a 1:30 
dilution into substrate; it was found that little activity was recovered in the preincubated 
sample after dilution (Fig. S2), which is typical of irreversible binding or reversible inhibitors 
that dissociate slowly from the enzyme. A further analysis at 5 × Ki (∼800 nM) followed by 1:5 
dilution into substrate showed a slight recovery of activity after 60 min, which suggests that 
binding is reversible (Fig. S2B). 










The effects of swainsonine exposure on mannosidase activity and AmLAM gene 
expression in larvae 
To ascertain the effects of swainsonine on honey bee development, larvae were reared in the 
laboratory on a larval diet containing 20 µM and 100 µM concentrations of swainsonine for a 
period of eight days, prior to their transfer into capsules for pupation. 
A larval diet containing swainsonine did not increase mortality within the first eight days of 
development; 20% (N =10/50) of larvae reared in the control condition did not survive, similar 
to those reared on a diet containing 20 µM (21%, N =14/66) and 100 µM (10.5%, N =7/67) of 
swainsonine, and there was no significant difference in the number of larvae that died between 
conditions (F(2,18) = 0.29, p = .75). Additionally, no well-defined phenotypic differences 
occurred and no significant differences in weight were observed at day 4 (F(2,33)=0.52), p=.60, 
by one-way ANOVA), or day 8 (F(2,33)=2.92, p=0.07, by one-way ANOVA) between conditions. 
Four days after exposure to swainsonine, (96 h larval stage, Fig. 2) a significant decrease in 




Figure 2 Mannosidase activity and AmLAM gene expression in larvae reared on a diet containing 20 µM and 100 
µM of swainsonine. Larvae were reared in the laboratory on a larval diet containing 20 µM and 100 µM of 
swainsonine, and mannosidase activity (A) and AmLAM gene expression (B) determined in whole individuals at 96 
h (4 day exposure) and 192 h (8 days exposure). A significantly lower level of mannosidase activity was observed 
in treated individuals, with an increase in AmLAM gene expression observed after a prolonged exposure of 8 days. 
The level of significance is indicated by ∗p < .05; ∗∗p < .01; ∗∗∗p<.001. 
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was observed in larvae fed the control diet (M = 690±60 U/mg) than in the 20 µM (M = 53± 8 
U/mg, t(3) = 3.18, p = .0002; d = 14.90) and 100 µM (M = 39±12 U/mg, t(3) = 3.18, p =.0002; d = 
15.05) conditions, respectively, Fig. 2A. No significant effect of swainsonine treatment on the 
level of AmLAM gene expression was observed between groups (F(2,12) = 0.98), p =.40, by one-
way ANOVA (Fig. 2B) suggesting that transcriptional profiling is not sufficient to evaluate the 
extent to which this alkaloid affects its expression after exposure for only four days. 
Further exposure to swainsonine increases mannosidase inhibition. Eight days after 
exposure to swainsonine (192 h larval stage) a 54-fold and 95-fold higher level of mannosidase 
activity was observed in the control group (M = 294±80 U/mg) than in the 20 µM (M = 6±4 
U/mg, t(3) = 3.18, p =.006; d = 5.09) and 100 µM (M = 3±2 U/mg, t(3) = 2.45, p = .005; d = 5.13) 
conditions, respectively, Fig. 2A. Additionally, whilst no effect on AmLAM expression was 
observed at day 4, a significantly higher level of AmLAM expression was observed in larvae fed 
a diet containing 20 µM of swainsonine (M =1.28±0.03, t(6)=2.45, p=.01; d =7.62), and 100 µM 
of swainsonine (M = 1.22±0.09, t(8) = 2.31, p =.03; d = 5.30) than in larvae reared on a control 
diet (M =0.7±0.1), Fig. 2B. 
After day 8 larvae were transferred to gelatine capsules for pupation and emergence, which 
typically occurs at day 21–22. Of the control group 60% (N = 6/10) survived pupation and all 
surviving individuals emerged by day 22. Of the larvae reared on a diet containing 20 µM of 
swainsonine 45.5% survived (N = 5/11) and by day 22 only 60% (N = 3) of surviving individuals 
emerged. For those larvae reared on a diet containing 100 µM of swainsonine 73% survived 
pupation (N = 14/19) and by day 22 only 57% (N =8/14) of surviving individuals emerged. 
Swainsonine exposure causes a developmental delay and loco-like symptoms 
The aforementioned findings suggest that swainsonine may cause a delay in development, 
with fewer treated individuals (∼60%) emerging by day 22. To confirm these findings the 
developmental time course and survival of individuals reared on a diet containing 100 µM of 
swainsonine was assessed. 
Within the first eight to nine days of exposure to swainsonine no increase in mortality was 
observed. 19.8% mortality occurred in the control condition (N = 19/96) and 20.2% mortality 
occurred in larvae reared on a diet containing 100 µM of swainsonine (N =18/89) by day 8. On 
day 9 the mortality of swainsonine treated individuals increased to 30.4% (N =27/89), but was 
not found to be significantly higher than the mortality rate of the control condition (20.8%, N 
=20/96; Z =−1.48, p=.14). 
Typically laboratory reared larvae are large enough for transfers into capsules by day 8–9. Of 
those surviving larvae fewer swainsonine treated individuals (24%; N = 16/67) were ready for 
pupation than in the control group on day 8, where a significantly higher proportion of 
individuals were ready for pupation (46%; N =34/74; Z =2.74, p=0.006), suggesting that 
swainsonine may decrease the rate of larval growth. However, by day 9 all remaining larvae 
across both conditions were ready for pupation, with the exception of a small percent of 
individuals that failed to thrive (1.3%, N = 1/74, of control and 3.0%, N =2/67, of swainsonine 
treated larvae). 
  




Effects of swainsonine during pupal development 
To assess the effect of swainsonine on pupal development individual pupal phases, as 
determined by the colouration of the compound eye and thorax (Rembold, Kremer & Ulrich, 
1980) were assessed from day 15 until day 23, when all surviving individuals had emerged 
(Fig. 3). 
On day 15 there was a significantly higher proportion of surviving individuals in the control 
group (N = 50/58) that had reached the Pp (pink eye, white thorax) phase than the swainsonine 
treated group (N = 23/38; Z = 2.88, p =.004). Additionally, on day 15 a significantly higher 
proportion of swainsonine treated individuals remained in the earlier Pw (white eye, white 
thorax; N = 15/38) developmental phase than the control group (N =2/58; Z =−4.52, p<.00001). 
 
Figure 3 The timing of pupal developmental phases in (A) untreated and (B) swainsonine treated individuals. 
The colouration of the compound eye and thorax was monitored to assess the rate of development. During early 
pupation both the eye and body remain white (Pw). Colouration begins with the eyes, which transition from 
white to pink (Pp), to dark pink (Pdp) and finally to brown (Pb). Once the eyes darken to brown the thorax begins 
to develop colour, and the body transitions from light in colour (Pbl), to medium (Pbm) and finally dark (Pbd). 
Significant effects were seen again on day 17, where a higher proportion of the control 
group had entered the Pbl (brown eyes, light pigmentation of the thorax) developmental phase 
(N = 10/56) than the swainsonine treated group (N = 1/37, Z = 2.22, p =.03). At day 21 a 
significantly higher proportion of the swainsonine treated group (N = 18/35) remained in the 
  




Pbm (brown eyes, medium pigmentation of the thorax) phase than the control condition; on 
day 21 a higher proportion of control individuals were in the Pbd (brown eyes, dark 
pigmentation of the thorax) phase or had emerged (N = 10/56; Z =−3.34, p=.0007). 
At no time point was there a greater proportion of swainsonine treated individuals in a more 
advanced developmental stage than the control group, and the onset of each 
developmentalphasewasseentobedelayedbyapproximatelyonedayintreatedindividuals. During 
pupation although a higher mortality rate was observed in treated individuals 
(37.0%, N = 20/54) than the control condition (23.2%, N = 16/69) this differencewas not 
significant (Z =−1.68, p = 0.093), suggesting that swainsonine treatment only marginally affects 
survival during pupation. 
Swainsonine treatment during development increases mortality 
Given that swainsonine was not found to increase mortality during larval stages, but appeared 
to have marginal effects on survival during pupation we tested the overall effect of 
swainsonine on survival into adulthood. Mortality in swainsonine treated individuals (55.1%, N 
= 49/89) across all developmental stages, from early larval to emergence, was significantly 
higher than control individuals (38.5%, N = 37/96; Z = 2.25, p =.02), indicating that swainsonine 
exposure during development reduces the likelihood of an individual surviving into adulthood. 
Effects of swainsonine treatment on adult emergence and post emergence 
survival 
Of the individuals transferred for pupation 76.8% of the control condition (N =53/69) and 
63.0% (N = 34/54) of larvae exposed to swainsonine emerged successfully. All surviving 
individuals had emerged by day 23 and no significant difference in the emergence rate was 
observed between conditions (Z = 1.68, p = 0.093). Whilst a higher percentage of control 
individuals (13.3%, N = 7/53) emerged early, between days 18–20, this was not significantly 
higher than for swainsonine treated individuals (3.0%, N = 1/34; Z = 1.62, p =.11). The majority 
of individuals in both conditions emerged on days 21 and 22; no significant difference in the 
proportion of individuals that emerged on day 21 (control = 19/53, swainsonine = 11/34; Z 
=0.34, p=.74) or on day 22 (control = 25/53, swainsonine = 15/34; Z = 0.28, p = .78) was 
observed. However, on day 23, a significantly higher proportion of control individuals (96.2%, N 
= 51/53) had emerged than swainsonine treated individuals (77.1%, N =27/34; Z =−2.51, 
p=0.01), suggesting that swainsonine may marginally delay emergence in some individuals (Fig. 
4A). 
Newly emerged bees were transferred to a cage and mortality and phenotype observed over 
5 days. Significant losses for those bees reared on a diet containing swainsonine occurred; by 
day 5 82.4% (N = 28/34) of treated bees had died, significantly higher than in the control 
condition where at day 5 only 6.52% of bees had not survived (N = 3/46; Z = 6.88, p < .00001, 
Fig. 4B). It was observed that the movement of treated bees was impaired; the honey bees 
were observed trembling, and appeared to spend more time at the bottom of the cage, 
suggesting an impairment of locomotor activity. 
  




Metabolic changes induced by dietary exposure to swainsonine 
Given the critical role of α-mannosidases in the maturation and degradation of glycoprotein-
linked oligosaccharides and previous results suggesting that swainsonine affects various 
aspects of metabolism, we have analysed the metabolomes of both control and treated larvae 
using mass spectrometry. As shown in Fig. 5, several clearly-defined categories of metabolites 
were affected by dietary exposure to this alkaloid. Distinct changes in the metabolism of amino 
acids, polyamines, saccharides, hydroxyl acids and polyols were observed in swainsonine 
treated bees. A number of components of the urea cycle, critical for disposing of excess 
nitrogen, were found to be elevated, including the amino 
 
Figure 4 The timing of emergence and survival of newly emerged bees exposed to swainsonine. (A) The 
percentage of individuals emerging between days 16–23; significant differences were observed only at day 23. 
(B) The percentage of caged newly emerged bees that did not survive over a five day period after emergence (day 
1 in cage = day 21 of emergence). 
acids aspartate and ornithine. Besides its role in the urea cycle, ornithine serves a number of 
other roles including as a precursor for the synthesis of the polyamines putrescine, cadaverine 
and spermidine, all of which showed elevated levels in swainsonine treated bees. Polyamines 
have been shown to interact with a number of negatively-charged acid residues associated 
with nucleic acids, phospholipids as well as acid-containing proteins and polysaccharides. 
Although the role of polyamines has not been fully elucidated, based on their interactions with 
acid groups, it has been suggested that they are involved in modulating cell growth, ionic 
channels, protein synthesis, protein kinases, and cell proliferation/death (Michael, 2016). Their 
elevated levels in swainsonine treated bees, which show reduced rates of developmental 
growth, may suggest that increased levels of apoptosis are occurring. Swainsonine treated bees 
also show a significant reduction in the abundance of 19 different saccharides, as well as 7 
sugar alcohols, indicative of reduced metabolic output. What is unclear is whether swainsoine 
directly alters the biochemical pathways underlying saccharide metabolism, or whether 
changes in saccharide levels are simply the result of a decline in metabolic demand associated 
with stunted growth. 
  




Interestingly, a number of metabolites unique to fruit, honey (gluconic acid and δ-
gluconolactone) or royal jelly (altrose) were found to be altered, suggesting changes in the 
metabolism of specific dietary compounds in response to swainsonine treatment. There was 
also a significant reduction in the levels of a number of critical polyols, although the 
significance of these changes is unclear. These compounds are often produced as carbon 
storage materials (Diano et al., 2006) and could be utilised by developing honey bees during 
metamorphosis when no food intake is occurring. Further, the abundance of two fatty acids 
(myrmicacin and sebacic acid) implicated in epigenetic regulation is significantly reduced in 
treated individuals. These histone deacetylase inhibitors play a crucial role in honey bees by 
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Figure 5 Swainosonine affects distinct metabolic pathways in the honey bee. (A) The number of analytes, per 
class, that were observed to be elevated or reduced in swainsonine treated larvae relative to agematched 
untreated larvae. (B) Heatmap and hierarchical clustering of metabolites that show a statistically significant 
difference in the levels seen between swainsonine treated larvae and age-matched untreated larvae. Key: C, 
untreated control sample, T, swainsonine treated samples. (continued on next page...) 
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Figure 5 (...continued) 
The first digit in each name represents the biological replicate number (e.g., C1, C2 and C3), while the second digit 
after the decimal space indicates the technical replicate number (e.g., C1.1, C1.2 and C1.3). See Table S1 for the 
full list of metabolites and Fig. S3 for principal component analysis of the GC/MS data for the swainsonine-treated 
and control samples. 
DISCUSSION 
The mechanism of swainsonine inhibition of mannosidase activity in the honey 
bee 
We provide seminal evidence that A. mellifera mannosidase activity is sensitive to the 
indolizidine alkaloid swainsonine, although the Ki estimate for A. mellifera (Ki: 135–251 nM) is 
higher than that reported for the mammalian enzyme (Ki: 70 nM), suggesting that A. mellifera 
may be less sensitive to swainsonine than other organisms (Dorling, Huxtable & Colegate, 
1980). In accord with similar studies in other system, in vitro inhibition indicates that 
swainsonine is a competitive inhibitor of A. mellifera mannosidase activity. Swainsonine binds 
tightly to the jack bean α-D-mannosidase and this binding is also influenced by preincubation 
(Kang & Elbein, 1983), and in the case of mammalian lysosomal α-mannosidase swainsonine 
inhibition is reversible upon dilution (Dorling, Huxtable & Colegate, 1980). Importantly, the 
mechanism of swainsonine binding is complex and not fully understood. The degree of 
reversibility is affected by the extent of preincubation, with suggestion that two modes of 
binding exist, a rapid and irreversible binding, and a slow and reversible mode of binding 
(Tulsiani, Broquist & Touster, 1985). Initially, we found no recovery of mannosidase activity 
after preincubation with high (10 × K i) swainsonine concentrations, which is typical of 
irreversible inhibitors. Yet, subsequent analysis at lower (5 × Ki) swainsonine concentrations 
showed some recovery. This suggests that swainsonine likely inhibits in a reversible manner, 
but we recommended further mechanism of actions studies to confirm our findings. 
Previous studies have also shown that swainsonine inhibits both the lysosomal 
αmannosidase and Golgi mannosidase II in vitro (Kang & Elbein, 1983), but is believed to 
primarily inhibit the lysosomal form in vivo since swainsonine is more likely to accumulate 
within the lysosome (Dorling, Huxtable & Colegate, 1980). Since there are three types of α-D-
mannosidases in mammals with their pH range from 4.0 to 6.5 in three different subcellular 
locations (Winchester, 1984), the results presented here are reflective of its effects on the 
lysosomal enzyme, since the conditions utilised are optimal for the lysosomal form, with assay 
conditions performed at pH 4.6. This low pH would limit the activity of the Golgi mannosidase 
II, and in D. melanogaster the Golgi mannosidase II enzyme has been shown to have little 
activity below pH 5.0 (Nemcovicova et al., 2013). Indeed, the IC50 inhibition studies indicate the 
detection of a single enzyme (Hill slope =−1.143), suggesting little interference from the Golgi 
mannosidase II enzyme. The future purification of the A. mellifera lysosomal α-mannosidase 
and subsequent inhibition and mechanism of 
  




action studies will confirm our findings, and provide definitive IC50 and Ki estimates for the 
honey bee. 
Effects of swainsonine on honey bee development 
Our results indicate that a prolonged exposure to swainsonine has sub-lethal effects on larval 
and pupal development, with newly emerged bees eventually succumbing to the toxic effects 
of this alkaloid. In early larval stages mannosidase activity is significantly decreased in treated 
individuals and continued exposure, up until pupation, further decreases activity. This indicates 
that during larval development exposure to swainsonine via the diet will result in an 
accumulation of the toxin, and the increase in AmLAM gene expression after eight days of 
exposure suggests that, in vivo, swainsonine does indeed affect the lysosomal α-mannosidase, 
as has been reported in other organisms. Such an increase in gene expression may indicate a 
compensatory mechanism against LAM inhibition. 
Exposure to swainsonine causes a subtle decrease in the rate of larval growth, and this 
developmental delay continues throughout pupation, where the development of swainsonine 
treated individuals is delayed by approximately one day. These sub-lethal effects observed 
during larval and pupal development could reflect that, as in cases of loco-poisoning in 
livestock, a prolonged exposure is necessary for the onset of severe symptoms; the effects on 
early development are subtle, and the toxicity of swainsonine only becomes apparent during 
late larval/pupal stages and upon emergence. 
Studies of swainsonine poisoning in mammals indicate that locoism results from the 
progressive accumulation of partially degraded oligosaccharides causing extensive lysosomal 
vacuolation and tissue disruption (Broquist, 1985). This accumulation first affects the liver and 
kidney, causing general malaise, with eventual neuronal vacuolation causing severe 
neurological symptoms and death. The onset of loco-like symptoms in newly emerged bees, 
who display altered locomotor activity and do not survive beyond 5 days post-emergence, 
indicate that a prolonged exposure to swainsonine, at high concentrations, induces locoism in 
the bee. 
Given that LAM is involved in general metabolic processes and cellular turnover, an 
inhibition of its activity during larval development may reduce overall larval growth, explaining 
the observed developmental delay during these stages. Alternatively, this delay could reflect 
the need for resources to be allocated away from larval growth to survive poisoning and allow 
detoxification processes to occur. Numerous alkaloids are toxic to the honey bee (Detzel & 
Wink, 1993), and in newly emerged bees exposed to the alkaloid nicotine detoxification 
processes are up-regulated, and this is associated with altered energy metabolism (Du Rand et 
al., 2015). A similar response after exposure to swainsonine could explain our findings, where 
fewer energetic resources are available for larval development and subsequent 
metamorphosis, explaining the sub-lethal effects observed in this time period. 
In the honey bee LAM is very highly expressed in the digestive system during larval stages 
(Wedd, Kucharski & Maleszka, 2016). The significance of this finding remains unknown, but it is 
possible that LAM may be involved in the processing of components of the larval diet. Larval 
development in the bee is highly dependent on diet, and any shift in the availability of nutrients 
  




would have important implications on such development (Barchuk et al., 2007; Foret et al., 
2012; Maleszka, 2008; Maleszka, 2014). The switch from royal jelly to worker jelly, for instance, 
has a profound effect on development, causing a larva to develop into a worker rather than a 
queen, and nurse bees are known to tightly regulate various components in the larval diet, 
such as sugar content, to guide worker development. Typically, a spike in juvenile hormone at 
the end of larval development initiates metamorphosis, and nurse bees increase the amount of 
sugar in larval food during the fifth instar to cause this spike (Barchuk et al., 2007). If 
swainsonine treatment causes vacuolation in the larval gut, absorption may be compromised, 
and the delay seen in our study may result from an alteration in the uptake of key nutrients 
required for metamorphosis. Indeed, swainsonine is known to induce apoptosis in vivo. It has 
been widely studied for its anti-tumour effects, and it has been shown to delay the growth of 
tumour cells by inducing apoptosis (Li et al., 2012; Sun et al., 2007). The administration of 
swainsonine via the larval diet could certainly result in the larval digestive system undergoing 
vacuolation and apoptosis, compromising nutrition. The abnormal locomotor activity and 
eventual death of newly emerged bees also suggests that such swainsonine induced apoptosis 
and vacuolation inevitably affects the honey bee brain. 
LAM is one of numerous N-glycosylated proteins found in royal jelly(Zhang et al., 2014), 
many of which are high-mannose type glycoproteins (Kimura et al., 2000). The lysosomal 
catabolism of N-linked glycoproteins has been studied extensively and LAM is essential to such 
processing (Winchester, 2005). The fact that LAM itself is found in royal jelly and is highly 
expressed in the larval gut certainly indicates that one of the functions of LAM relates to 
nutrition, and interestingly, suggests it may help digest royal jelly components. Since queen bee 
development is entirely dependent on larvae being reared on a diet of royal jelly (Barchuk et 
al., 2007; Maleszka, 2008; Weaver, 1966), an interesting extension of our study would be to 
investigate the effect of swainsonine on queen development. Developing queens could be 
more sensitive to the malabsorption of larval diet and/or royal jelly glycoproteins, and so whilst 
worker development is only marginally delayed in response to swainsonine treatment, queen 
development might be more profoundly affected. 
The extent to which this alkaloid affects global metabolism can be gleaned from our initial 
mass spectrometry analyses of swainsonine treated larvae. Forty six metabolites identified by 
this approach are indicative of several pathways involved in the metabolism of amino acids, 
polyamines, saccharides, hydroxyl acids and polyols. All detected changes are consistent with 
reduced metabolic output, increased apoptosis and epigenomic impacts on global gene 
regulation, which have been either observed or predicted for situations associated with LAM 
deficiencies (Borgwardt, Lund & Dali, 2014; Wedd, Kucharski & Maleszka, 2016). Whether 
swainsonine directly modifies certain biochemical pathways or these changes merely reflect a 
decline in metabolic demand associated with restricted growth remains to be established. It is 
clear however that LAM deficiency leads to a major disturbance in the entire metabolic 
network. 
Environmental implications of our findings 
Several known pesticides, including the well-known neonicotinoids, are known to affect honey 
bee health (Guez, Belzunces & Maleszka, 2003; Hurst, Stevenson & Wright, 2014), and have 
  




been widely researched in the context of recent honey bee losses. Such pesticides have been 
reported to delay larval development and reduce adult longevity (Wu, Anelli & Sheppard, 
2011), cause apoptosis in honey bee tissues and in the case of imidacloprid, a commonly used 
neonicotinoid insecticide, have been shown to induce neuronal apoptosis (Wu et al., 2015). 
Whilst the doses of swainsonine used in our study are unlikely to reflect the environmental 
exposures of honey bees foraging on the locoweed they highlight the importance of 
investigating locoism in the bee further. 
If swainsonine exposure, at lower environmentally meaningful doses, causes similar effects 
on larval growth and adult longevity this has the potential to negatively impact on colony 
health. Since swainsonine has been found in both pollen and nectar (Burrows & Tyrl, 2013; 
James et al., 1978), foraging bees that are sensitive to this alkaloid could display altered 
behaviours, such as diminished learning and memory, and any losses of adults or shifts in larval 
development or nutrition would be detrimental. Undesirable developmental delays can 
increase sensitivity to pesticides or Varroa mites (Wu, Anelli & Sheppard, 2011), and cause 
changes in the division of labour within a hive, having long term effects on hive productivity 
and fitness (Goulson et al., 2015). Swainsonine thus presents as a potential environmental 
stressor for the honey bee, and should be investigated accordingly. 
Insights into AmLAM epiallelic variation 
Our study has shown that the honey bee displays a similar level and mode of toxicity to 
swainsonine as in other organisms. These findings suggest that LAM function in the honey bee 
is conserved and therefore plays a similar role in glycoprotein catabolism and metabolism as 
has been shown in other species. The inhibition of LAM activity in developing larvae slows 
growth, and at this stage it is unclear whether this effect results from swainsonine induced 
apoptosis and general toxicity, or the inhibition of LAM activity itself. Whilst this lack of clarity 
makes it difficult to assign function to the differentially methylated AmLAM epialleles it does 
indicate that these epialleles, which cause differential LAM expression in larval stages, may 
cause subtle differences in larval metabolism, nutrition and the rate of development. 
Phenotypic variation between individuals within a honey bee colony is known to increase the 
stability and overall health of a colony (Jones et al., 2004; Maleszka, 2016). A genetically 
diverse population promotes flexibility, and hives with higher variability have been shown to 
respond more adequately to external and internal cues, for instance, hives founded by 
multiply-mated queens display better thermoregulation and foraging outcomes that hives with 
progenies of single-mated queens (Jones et al., 2004). Additionally, nurse bees use their bodies 
to warm up brood cells to accelerate their development (Kleinhenz et al., 2003) to facilitate 
shifts in the timing of task specialisation and adult behaviour (Becher, Scharpenberg & Moritz, 
2009). If the AmLAM epialleles modulate metabolic rate during development then their 
presence in the honey bee population could generate such phenotypic variation and timing of 
task specialisation that might be advantageous in particular contexts. 
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